ULK3
Phospho-serine (pS) is a duplicate of phospho-tyrosine (pT) in PSPA
Position-wise Probabilities
Log-Odds: Probabilities / STY Background
Sites with acceptor types representing >8% and count ≥10 are included
S Sites Probabilities
T Sites Probabilities
Log-Odds: S Sites / S Background
Log-Odds: T Sites / T Background
Sites with acceptor types representing >8% and count ≥10 are included
Motif clusters with count ≥ 10 are shown
Download
| substrate_uniprot | site | source | substrate_genes | site_seq |
|---|---|---|---|---|
| A5A3E0 | S1068 | Sugiyama | POTEF A26C1B | SLSTFQQMWISKQEyDEsGPsIVHRKCL_____________ |
| A5A3E0 | S939 | Sugiyama | POTEF A26C1B | VALDFEQEMATVAsSSSLEKsyELPDGQVItIGNERFRCPE |
| A6NKT7 | S1006 | Sugiyama | RGPD3 RGP3 | FGKKDLNFKGFSGAGEKLFSsQYGKMANKANtsGDFEKDDD |
| A6NMY6 | S26 | Sugiyama | ANXA2P2 ANX2L2 ANX2P2 LPC2B | EILCKLsLEGDHstPPsAyGsVKAytNFDAERDALNIEtAI |
| O00232 | S343 | Sugiyama | PSMD12 | DYGMELRKGsLEsPAtDVFGsTEEGEKRWKDLKNRVVEHNI |
| O00571 | S83 | Sugiyama | DDX3X DBX DDX3 | sKDKDAyssFGsRsDsRGKssFFsDRGsGsRGRFDDRGRsD |
| O00625 | S225 | Sugiyama | PIR | PDDAQQKIEPHHTAVLGEGDsVQVENKDPKRSHFVLIAGEP |
| O15143 | S323 | Sugiyama | ARPC1B ARC41 | QNLDKKAssEGGtAAGAGLDsLHKNsVsQIsVLsGGKAKCS |
| O15212 | S53 | Sugiyama | PFDN6 HKE2 PFD6 | LEAQLtENNIVKEELALLDGsNVVFKLLGPVLVKQELGEAR |
| O15305 | S230 | Sugiyama | PMM2 | KTMPGGNDHEIFTDPRTMGysVTAPEDTRRICELLFS____ |
| O15355 | S363 | Sugiyama | PPM1G PPM1C | VANAGDsRCVVsEAGKALDMsyDHKPEDEVELARIKNAGGK |
| O43175 | S280 | Sugiyama | PHGDH PGDH3 | DVFTEEPPRDRALVDHENVIsCPHLGAsTKEAQSRCGEEIA |
| O43175 | S287 | Sugiyama | PHGDH PGDH3 | PRDRALVDHENVIsCPHLGAsTKEAQSRCGEEIAVQFVDMV |
| O43290 | S378 | Sugiyama | SART1 | DGLRERELEEIRAKLRLQAQsLSTVGPRLASEYLtPEEMVT |
| O43399 | S21 | Sugiyama | TPD52L2 | MDsAGQDINLNsPNKGLLsDsMtDVPVDTGVAARtPAVEGL |
| O43852 | S300 | Sugiyama | CALU | NKDGKLTKEEIVDKyDLFVGsQAtDFGEALVRHDEF_____ |
| O60361 | S84 | Sugiyama | NME2P1 | EGLNVVKTGRVMLGEtNPADsKPGtIRGDFCIQVGRNIIHG |
| O60664 | S175 | Sugiyama | PLIN3 M6PRBP1 TIP47 | RGAVQSGVDKTKsVVtGGVQsVMGsRLGQMVLsGVDtVLGK |
| O60664 | S225 | Sugiyama | PLIN3 M6PRBP1 TIP47 | PLTDAELARIAtsLDGFDVAsVQQQRQEQSyFVRLGsLSER |
| O60716 | S252 | Sugiyama | CTNND1 KIAA0384 | sRVtRIEERyRPsMEGyRAPsRQDVyGPQPQVRVGGssVDL |
| O60841 | S214 | Sugiyama | EIF5B IF2 KIAA0741 | LQsRKGQKKNQKNKPGPNIEsGNEDDDAsFKIKTVAQKKAE |
| O75116 | S700 | Sugiyama | ROCK2 KIAA0619 | EKEKSNMEIDMTYQLKVIQQsLEQEEAEHKATKARLADKNK |
| O75122 | S1007 | Sugiyama | CLASP2 KIAA0627 | GGDATDssQTALDNKAsLLHsMPtHssPRsRDyNPyNysDs |
| O75533 | S308 | Sugiyama | SF3B1 SAP155 | ARKNRWDEtPKtERDtPGHGsGWAEtPRtDRGGDsIGEtPt |
| O75533 | S322 | Sugiyama | SF3B1 SAP155 | DtPGHGsGWAEtPRtDRGGDsIGEtPtPGAsKRKsRWDEtP |
| O75533 | T316 | Sugiyama | SF3B1 SAP155 | tPKtERDtPGHGsGWAEtPRtDRGGDsIGEtPtPGAsKRKs |
| O75937 | S81 | Sugiyama | DNAJC8 SPF31 HSPC315 HSPC331 | VLQIDPEVTDEEIKKRFRQLsILVHPDKNQDDADRAQKAFE |
| O94776 | S433 | Sugiyama | MTA2 MTA1L1 PID | ATRGtTEPHSRGHLsRPEAQsLsPyttsANRAKLLAKNRQt |
| O95359 | S2534 | Sugiyama | TACC2 | tEELDyRNsYEIEyMEKIGssLPQDDDAPKKQALYLMFDts |
| O95757 | S599 | Sugiyama | HSPA4L APG1 HSPH3 OSP94 | sIDLPIQssLCRQLGQDLLNsyIENEGKMIMQDKLEKERND |
| P00338 | T322 | Sugiyama | LDHA PIG19 | DLVKVTLtsEEEARLKKsADtLWGIQKELQF__________ |
| P00813 | S291 | Sugiyama | ADA ADA1 | AWKPDTEHAVIRLKNDQANysLNTDDPLIFKSTLDTDyQMT |
| P04075 | S336 | Sugiyama | ALDOA ALDA | GKKENLKAAQEEYVKRALANsLACQGKytPsGQAGAAAsEs |
| P04075 | S354 | Sugiyama | ALDOA ALDA | ANsLACQGKytPsGQAGAAAsEsLFVsNHAy__________ |
| P04075 | S356 | Sugiyama | ALDOA ALDA | sLACQGKytPsGQAGAAAsEsLFVsNHAy____________ |
| P04075 | S36 | Sugiyama | ALDOA ALDA | LsDIAHRIVAPGKGILAADEstGsIAKRLQsIGtENtEENR |
| P04075 | S39 | Sugiyama | ALDOA ALDA | IAHRIVAPGKGILAADEstGsIAKRLQsIGtENtEENRRFy |
| P04075 | S46 | Sugiyama | ALDOA ALDA | PGKGILAADEstGsIAKRLQsIGtENtEENRRFyRQLLLtA |
| P04083 | S189 | Sugiyama | ANXA1 ANX1 LPC1 | tsDtsGDFRNALLsLAKGDRsEDFGVNEDLADsDARALyEA |
| P04406 | S151 | Sugiyama | GAPDH GAPD CDABP0047 OK/SW-cl.12 | FVMGVNHEKYDNSLKIIsNAsCttNCLAPLAKVIHDNFGIV |
| P04406 | S241 | Sugiyama | GAPDH GAPD CDABP0047 OK/SW-cl.12 | IPELNGKLtGMAFRVPtANVsVVDLtCRLEKPAKyDDIKKV |
| P05387 | S29 | Sugiyama | RPLP2 D11S2243E RPP2 | LAALGGNssPsAKDIKKILDsVGIEADDDRLNKVIsELNGK |
| P05783 | S177 | Sugiyama | KRT18 CYK18 PIG46 | ARLAADDFRVKyETELAMRQsVENDIHGLRKVIDDTNItRL |
| P05783 | S323 | Sugiyama | KRT18 CYK18 PIG46 | VQsLEIDLDsMRNLKAsLENsLREVEARYALQMEQLNGILL |
| P05787 | S330 | Sugiyama | KRT8 CYK8 | MNRNISRLQAEIEGLKGQRAsLEAAIADAEQRGELAIKDAN |
| P05787 | S410 | Sugiyama | KRT8 CYK8 | TYRKLLEGEESRLEsGMQNMsIHtKTTSGYAGGLSSAYGGL |
| P06733 | S353 | Sugiyama | ENO1 ENO1L1 MBPB1 MPB1 | NEKsCNCLLLKVNQIGsVTEsLQACKLAQANGWGVMVsHRs |
| P06756 | S127 | Sugiyama | ITGAV MSK8 VNRA VTNR | NRDYAKDDPLEFKSHQWFGAsVRSKQDKILACAPLYHWRTE |
| P07195 | S44 | Sugiyama | LDHB | ITVVGVGQVGMACAISILGKsLADELALVDVLEDKLKGEMM |
| P07355 | S184 | Sugiyama | ANXA2 ANX2 ANX2L4 CAL1H LPC2D | sGDFRKLMVALAKGRRAEDGsVIDyELIDQDARDLyDAGVK |
| P07355 | S26 | Sugiyama | ANXA2 ANX2 ANX2L4 CAL1H LPC2D | EILCKLsLEGDHstPPsAyGsVKAytNFDAERDALNIEtAI |
| P07437 | S115 | Sugiyama | TUBB TUBB5 OK/SW-cl.56 | sGAGNNWAKGHytEGAELVDsVLDVVRKEAESCDCLQGFQL |
| P07437 | S75 | Sugiyama | TUBB TUBB5 OK/SW-cl.56 | tGGKyVPRAILVDLEPGtMDsVRsGPFGQIFRPDNFVFGQs |
| P07737 | S30 | Sugiyama | PFN1 | NLMADGTCQDAAIVGYKDsPsVWAAVPGKtFVNITPAEVGV |
| P07814 | S1473 | Sugiyama | EPRS1 EPRS GLNS PARS QARS QPRS PIG32 | CEDWIKKtTARDQDLEPGAPsMGAKSLCIPFKPLCELQPGA |
| P07814 | S1511 | Sugiyama | EPRS1 EPRS GLNS PARS QARS QPRS PIG32 | PGAKCVCGKNPAKyytLFGRsy___________________ |
| P07814 | S335 | Sugiyama | EPRS1 EPRS GLNS PARS QARS QPRS PIG32 | PIEKNLQMWEEMKKGsQFGQsCCLRAKIDMSSNNGCMRDPt |
| P07814 | S882 | Sugiyama | EPRS1 EPRS GLNS PARS QARS QPRS PIG32 | AQYKEKTGKEyIPGQPPLsQssDssPtRNsEPAGLEtPEAK |
| P07900 | S165 | Sugiyama | HSP90AA1 HSP90A HSPC1 HSPCA | AEKVTVITKHNDDEQyAWEssAGGsFtVRTDTGEPMGRGTK |
| P07900 | S169 | Sugiyama | HSP90AA1 HSP90A HSPC1 HSPCA | TVITKHNDDEQyAWEssAGGsFtVRTDTGEPMGRGTKVILH |
| P07900 | T171 | Sugiyama | HSP90AA1 HSP90A HSPC1 HSPCA | ITKHNDDEQyAWEssAGGsFtVRTDTGEPMGRGTKVILHLK |
| P08195 | S253 | Sugiyama | SLC3A2 MDU1 | FQGHGAGNLAGLKGRLDyLssLKVKGLVLGPIHKNQKDDVA |
| P08195 | S403 | Sugiyama | SLC3A2 MDU1 | SDLQQILSLLESNKDLLLtssyLsDsGstGEHtKSLVTQYL |
| P08195 | S598 | Sugiyama | SLC3A2 MDU1 | LQASDLPASASLPAKADLLLstQPGREEGsPLELERLKLEP |
| P08238 | S160 | Sugiyama | HSP90AB1 HSP90B HSPC2 HSPC3 HSPCB | AEKVVVITKHNDDEQyAWEssAGGsFtVRADHGEPIGRGTK |
| P08238 | S164 | Sugiyama | HSP90AB1 HSP90B HSPC2 HSPC3 HSPCB | VVITKHNDDEQyAWEssAGGsFtVRADHGEPIGRGTKVILH |
| P08238 | S497 | Sugiyama | HSP90AB1 HSP90B HSPC2 HSPC3 HSPCB | KEtQKsIyyItGEsKEQVANsAFVERVRKRGFEVVyMtEPI |
| P08238 | T166 | Sugiyama | HSP90AB1 HSP90B HSPC2 HSPC3 HSPCB | ITKHNDDEQyAWEssAGGsFtVRADHGEPIGRGTKVILHLK |
| P09382 | S63 | Sugiyama | LGALS1 | CLHFNPRFNAHGDANtIVCNsKDGGAWGTEQREAVFPFQPG |
| P09417 | S163 | Sugiyama | QDPR DHPR SDR33C1 | GTPGMIGYGMAKGAVHQLCQsLAGKNSGMPPGAAAIAVLPV |
| P09874 | S542 | Sugiyama | PARP1 ADPRT PPOL | RMKLTLKGGAAVDPDsGLEHsAHVLEKGGKVFSATLGLVDI |
| P0CG38 | S1068 | Sugiyama | POTEI | SLSTFQQMWISKQEyDEsGPsIVHRKCF_____________ |
| P0CG39 | S1031 | Sugiyama | POTEJ | SLSTFQQMWISKQEyDEsGPsIVHRKCF_____________ |
| P0DPH7 | S48 | Sugiyama | TUBA3C TUBA2 | HGIQPDGQMPSDKtIGGGDDsFNtFFsEtGAGKHVPRAVFV |
| P10809 | S453 | Sugiyama | HSPD1 HSP60 | EEGIVLGGGCALLRCIPALDsLtPANEDQKIGIEIIKRTLK |
| P10809 | S537 | Sugiyama | HSPD1 HSP60 | GIIDPTKVVRTALLDAAGVAsLLTTAEVVVTEIPKEEKDPG |
| P10809 | T428 | Sugiyama | HSPD1 HSP60 | GtsDVEVNEKKDRVtDALNAtRAAVEEGIVLGGGCALLRCI |
| P11142 | T64 | Sugiyama | HSPA8 HSC70 HSP73 HSPA10 | FtDtERLIGDAAKNQVAMNPtNtVFDAKRLIGRRFDDAVVQ |
| P11142 | T66 | Sugiyama | HSPA8 HSC70 HSP73 HSPA10 | DtERLIGDAAKNQVAMNPtNtVFDAKRLIGRRFDDAVVQsD |
| P11279 | S335 | Sugiyama | LAMP1 | DPAFKAANGSLRALQATVGNsYKCNAEEHVRVTKAFSVNIF |
| P12268 | S416 | Sugiyama | IMPDH2 IMPD2 | APGEYFFSDGIRLKKyRGMGsLDAMDKHLssQNRyFsEADK |
| P13639 | S23 | Sugiyama | EEF2 EF2 | NFtVDQIRAIMDKKANIRNMsVIAHVDHGKStLtDsLVCKA |
| P13639 | S38 | Sugiyama | EEF2 EF2 | NIRNMsVIAHVDHGKStLtDsLVCKAGIIAsARAGEtRFtD |
| P13639 | S593 | Sugiyama | EEF2 EF2 | SDPVVsyREtVsEEsNVLCLsKsPNKHNRLyMKARPFPDGL |
| P13667 | S126 | Sugiyama | PDIA4 ERP70 ERP72 | NILKDKDPPIPVAKIDAtsAsVLAsRFDVsGyPtIKILKKG |
| P13667 | S379 | Sugiyama | PDIA4 ERP70 ERP72 | QPEKFQSKYEPRSHMMDVQGstQDsAIKDFVLKyALPLVGH |
| P13674 | T140 | Sugiyama | P4HA1 P4HA | YFPNDEDQVGAAKALLRLQDtyNLDTDtIsKGNLPGVKHKS |
| P13797 | S110 | Sugiyama | PLS3 | AKTFRKAINRKEGICALGGTsELssEGtQHsysEEEKyAFV |
| P13861 | S58 | Sugiyama | PRKAR2A PKR2 PRKAR2 | TRLREARAPAsVLPAAtPRQsLGHPPPEPGPDRVADAKGDs |
| P14314 | S126 | Sugiyama | PRKCSH G19P1 | yNsGVICENtCKEKGRKEREsLQQMAEVtREGFRLKKILIE |
| P14618 | S202 | Sugiyama | PKM OIP3 PK2 PK3 PKM2 | SLQVKQKGADFLVtEVENGGsLGsKKGVNLPGAAVDLPAVs |
| P14618 | S77 | Sugiyama | PKM OIP3 PK2 PK3 PKM2 | sVEtLKEMIKsGMNVARLNFsHGtHEyHAEtIKNVRtAtEs |
| P14618 | T87 | Sugiyama | PKM OIP3 PK2 PK3 PKM2 | sGMNVARLNFsHGtHEyHAEtIKNVRtAtEsFAsDPILyRP |
| P14625 | S515 | Sugiyama | HSP90B1 GRP94 HSPC4 TRA1 | GVIEDHsNRtRLAKLLRFQssHHPtDItsLDQyVERMKEKQ |
| P15259 | S189 | Sugiyama | PGAM2 PGAMM | EEIVPQIKAGKRVLIAAHGNsLRGIVKHLEGMSDQAIMELN |
| P15311 | S535 | Sugiyama | EZR VIL2 | EKRITEAEKNERVQRQLLtLssELsQARDENKRTHNDIIHN |
| P15374 | S126 | Sugiyama | UCHL3 | NNKDKMHFESGSTLKKFLEEsVsMsPEERARyLENyDAIRV |
| P15531 | S122 | Sugiyama | NME1 NDPKA NM23 | GtIRGDFCIQVGRNIIHGsDsVEsAEKEIGLWFHPEELVDy |
| P15531 | S99 | Sugiyama | NME1 NDPKA NM23 | EGLNVVKTGRVMLGEtNPADsKPGtIRGDFCIQVGRNIIHG |
| P17844 | S520 | Sugiyama | DDX5 G17P1 HELR HLR1 | GKRGGFNTFRDRENYDRGYssLLKRDFGAKTQNGVYSAANY |
| P17987 | S544 | Sugiyama | TCP1 CCT1 CCTA | ILRIDDLIKLHPESKDDKHGsyEDAVHsGALND________ |
| P18615 | S113 | Sugiyama | NELFE RD RDBP | EGKLKDPEKGPVPTFQPFQRsIsADDDLQEsSRRPQRKsLy |
| P18669 | S155 | Sugiyama | PGAM1 PGAMA CDABP0006 | NIsKDRRyADLtEDQLPsCEsLKDtIARALPFWNEEIVPQI |
| P18669 | S189 | Sugiyama | PGAM1 PGAMA CDABP0006 | EEIVPQIKEGKRVLIAAHGNsLRGIVKHLEGLSEEAIMELN |
| P18669 | T159 | Sugiyama | PGAM1 PGAMA CDABP0006 | DRRyADLtEDQLPsCEsLKDtIARALPFWNEEIVPQIKEGK |
| P19338 | S458 | Sugiyama | NCL | TEADAEKTFEEKQGtEIDGRsIsLyytGEKGQNQDYRGGKN |
| P20674 | T105 | Sugiyama | COX5A | EPKIIDAALRACRRLNDFAstVRILEVVKDKAGPHKEIYPY |
| P20810 | S297 | Sugiyama | CAST | KKRKVEKDtMsDQALEALsAsLGTRQAEPELDLRsIKEVDE |
| P20810 | S577 | Sugiyama | CAST | PRDtsQsDKDLDDALDKLsDsLGQRQPDPDENKPMEDKVKE |
| P22090 | S204 | Sugiyama | RPS4Y1 RPS4Y PRO2646 | IGGANLGRVGVITNRERHPGsFDVVHVKDANGNSFATRLSN |
| P22392 | S99 | Sugiyama | NME2 NM23B | EGLNVVKTGRVMLGEtNPADsKPGtIRGDFCIQVGRNIIHG |
| P23246 | S283 | Sugiyama | SFPQ PSF | GPGGRsEEKIsDsEGFKANLsLLRRPGEKTyTQRCRLFVGN |
| P23284 | S117 | Sugiyama | PPIB CYPB | IKDFMIQGGDFtRGDGtGGKsIyGERFPDENFKLKHyGPGW |
| P23381 | T383 | Sugiyama | WARS1 IFI53 WARS WRS | DtAKQIKTKVNKHAFsGGRDtIEEHRQFGGNCDVDVSFMYL |
| P23588 | S207 | Sugiyama | EIF4B | DRNRDsDKtDTDWRARPAtDsFDDyPPRRGDDsFGDKYRDR |
| P23921 | S780 | Sugiyama | RRM1 RR1 | KEKVSKEEEEKERNtAAMVCsLENRDECLMCGS________ |
| P23921 | T774 | Sugiyama | RRM1 RR1 | KEKLKDKEKVSKEEEEKERNtAAMVCsLENRDECLMCGS__ |
| P24534 | S141 | Sugiyama | EEF1B2 EEF1B EF1B | ERLAQYESKKAKKPALVAKssILLDVKPWDDEtDMAKLEEC |
| P25788 | S243 | Sugiyama | PSMA3 HC8 PSC8 | GRHEIVPKDIREEAEKyAKEsLKEEDEsDDDNM________ |
| P26038 | S576 | Sugiyama | MSN | YKtLRQIRQGNTKQRIDEFEsM___________________ |
| P26232 | T657 | Sugiyama | CTNNA2 CAPR | EDDsDFEQEDYDVRsRtsVQtEDDQLIAGQsARAIMAQLPQ |
| P26373 | S181 | Sugiyama | RPL13 BBC1 OK/SW-cl.46 | YKKEKARVItEEEKNFKAFAsLRMARANARLFGIRAKRAKE |
| P26639 | T700 | Sugiyama | TARS1 TARS | EKISGTVNIRTRDNKVHGERtIsEtIERLQQLKEFRSKQAE |
| P27348 | S145 | Sugiyama | YWHAQ | YFRyLAEVACGDDRKQtIDNsQGAyQEAFDIsKKEMQPTHP |
| P27797 | S214 | Sugiyama | CALR CRTC | GsLEDDWDFLPPKKIKDPDAsKPEDWDERAKIDDPtDsKPE |
| P27797 | S52 | Sugiyama | CALR CRTC | GWtsRWIEsKHKSDFGKFVLssGKFyGDEEKDKGLQTSQDA |
| P28066 | S174 | Sugiyama | PSMA5 | FHMDPsGtFVQCDARAIGsAsEGAQssLQEVyHKSMTLKEA |
| P29144 | S25 | Sugiyama | TPP2 | ATEEPFPFHGLLPKKETGAAsFLCRYPEYDGRGVLIAVLDt |
| P29401 | S190 | Sugiyama | TKT | ASIYKLDNLVAILDINRLGQsDPAPLQHQMDIyQKRCEAFG |
| P29401 | S295 | Sugiyama | TKT | ysQIQsKKKILAtPPQEDAPsVDIANIRMPsLPsyKVGDKI |
| P29401 | S332 | Sugiyama | TKT | GDKIATRKAYGQALAKLGHAsDRIIALDGDtKNstFsEIFK |
| P29401 | S439 | Sugiyama | TKT | VSIGEDGPSQMALEDLAMFRsVPtstVFyPsDGVAtEKAVE |
| P29401 | S548 | Sugiyama | TKT | NIRVLDPFTIKPLDRKLILDsARAtKGRILTVEDHYYEGGI |
| P29692 | S60 | Sugiyama | EEF1D EF1D | ENGAsVILRDIARARENIQKsLAGssGPGAssGtsGDHGEL |
| P29692 | S64 | Sugiyama | EEF1D EF1D | sVILRDIARARENIQKsLAGssGPGAssGtsGDHGELVVRI |
| P29692 | S71 | Sugiyama | EEF1D EF1D | ARARENIQKsLAGssGPGAssGtsGDHGELVVRIAsLEVEN |
| P30050 | S138 | Sugiyama | RPL12 | HRSLARELsGtIKEILGtAQsVGCNVDGRHPHDIIDDINsG |
| P30050 | S26 | Sugiyama | RPL12 | DPNEIKVVYLRCtGGEVGAtsALAPKIGPLGLsPKKVGDDI |
| P30084 | S107 | Sugiyama | ECHS1 | LTGGDKAFAAGADIKEMQNLsFQDCySSKFLKHWDHLTQVK |
| P30566 | S412 | Sugiyama | ADSL AMPS | AGGSRQDCHEKIRVLsQQAAsVVKQEGGDNDLIERIQVDAY |
| P33176 | S663 | Sugiyama | KIF5B KNS KNS1 | IKSLtEyLQNVEQKKRQLEEsVDALSEELVQLRAQEKVHEM |
| P33992 | S417 | Sugiyama | MCM5 CDC46 | CsPIGVytsGKGSSAAGLtAsVMRDPssRNFIMEGGAMVLA |
| P33992 | T415 | Sugiyama | MCM5 CDC46 | EKCsPIGVytsGKGSSAAGLtAsVMRDPssRNFIMEGGAMV |
| P34896 | S17 | Sugiyama | SHMT1 | ____MTMPVNGAHKDADLWSsHDKMLAQPLKDSDVEVyNII |
| P34897 | S417 | Sugiyama | SHMT2 | ERVLELVSITANKNTCPGDRsAItPGGLRLGAPALtSRQFR |
| P35221 | T658 | Sugiyama | CTNNA1 | LDDsDFEtEDFDVRsRtsVQtEDDQLIAGQsARAIMAQLPQ |
| P35579 | S1376 | Sugiyama | MYH9 | EKQIATLHAQVADMKKKMEDsVGCLEtAEEVKRKLQKDLEG |
| P35579 | S169 | Sugiyama | MYH9 | HIyAITDtAyRSMMQDREDQsILCTGESGAGKTENTKKVIQ |
| P35606 | S350 | Sugiyama | COPB2 | MGDAEIKDGERLPLAVKDMGsCEIyPQtIQHNPNGRFVVVC |
| P36871 | S483 | Sugiyama | PGM1 | DKVYtVEKADNFEysDPVDGsIsRNQGLRLIFTDGSRIVFR |
| P39023 | S265 | Sugiyama | RPL3 OK/SW-cl.32 | HRGLRKVACIGAWHPARVAFsVARAGQKGYHHRTEINKKIY |
| P43034 | S152 | Sugiyama | PAFAH1B1 LIS1 MDCR MDS PAFAHA | IKVWDyEtGDFERtLKGHtDsVQDIsFDHsGKLLASCSADM |
| P43243 | S234 | Sugiyama | MATR3 KIAA0723 | yDRMDyEDDRLRDGERCRDDsFFGEtsHNyHKFDsEyERMG |
| P43243 | S240 | Sugiyama | MATR3 KIAA0723 | EDDRLRDGERCRDDsFFGEtsHNyHKFDsEyERMGRGPGPL |
| P43243 | T239 | Sugiyama | MATR3 KIAA0723 | yEDDRLRDGERCRDDsFFGEtsHNyHKFDsEyERMGRGPGP |
| P45974 | S783 | Sugiyama | USP5 ISOT | IDDLDAEAAMDISEGRsAADsIsEsVPVGPKVRDGPGKYQL |
| P46060 | S454 | Sugiyama | RANGAP1 KIAA1835 SD | VstFLAFPsPEKLLRLGPKssVLIAQQTDTSDPEKVVSAFL |
| P46777 | S172 | Sugiyama | RPL5 MSTP030 | RTTTGNKVFGALKGAVDGGLsIPHstKRFPGyDsEsKEFNA |
| P46777 | S230 | Sugiyama | RPL5 MSTP030 | yLMEEDEDAyKKQFsQyIKNsVtPDMMEEMyKKAHAAIREN |
| P46782 | S75 | Sugiyama | RPS5 | RYAAKRFRKAQCPIVERLtNsMMMHGRNNGKKLMTVRIVKH |
| P46783 | S146 | Sugiyama | RPS10 | TYRRSAVPPGADKKAEAGAGsAtEFQFRGGFGRGRGQPPQ_ |
| P47712 | S724 | Sugiyama | PLA2G4A CPLA2 PLA2G4 | NIDVIKEAMVESIEyRRQNPsRCsVsLsNVEARRFFNKEFL |
| P47756 | S192 | Sugiyama | CAPZB | TVMLWLQTNKSGsGtMNLGGsLtRQMEKDEtVsDCsPHIAN |
| P48444 | S253 | Sugiyama | ARCN1 COPD | KEVDNFVDKLKsEGEtIMSssMGKRTSEATKMHAPPINMES |
| P48643 | S51 | Sugiyama | CCT5 CCTE KIAA0098 | LEALKSHIMAAKAVANtMRtsLGPNGLDKMMVDKDGDVtVT |
| P48739 | S165 | Sugiyama | PITPNB | DRSQVEPADyKADEDPALFQsVKtKRGPLGPNWKKELANsP |
| P49023 | S84 | Sugiyama | PXN | DPLDQWQPSSSRFIHQQPQsssPVyGssAKtssVsNPQDsV |
| P49023 | S91 | Sugiyama | PXN | PSSSRFIHQQPQsssPVyGssAKtssVsNPQDsVGsPCsRV |
| P49327 | S324 | Sugiyama | FASN FAS | ELNGItRALCAtRQEPLLIGsTKSNMGHPEPASGLAALAKV |
| P49327 | S63 | Sugiyama | FASN FAS | GLyGLPRRsGKLKDLSRFDAsFFGVHPKQAHTMDPQLRLLL |
| P49327 | T315 | Sugiyama | FASN FAS | tGTKVGDPQELNGItRALCAtRQEPLLIGsTKSNMGHPEPA |
| P49589 | S305 | Sugiyama | CARS1 CARS | KLVPEAVGDQKALQEGEGDLsIsADRLsEKRSPNDFALWKA |
| P49589 | S34 | Sugiyama | CARS1 CARS | VQPQWsPPAGtQPCRLHLyNsLtRNKEVFIPQDGKKVTWYC |
| P49792 | S1981 | Sugiyama | RANBP2 NUP358 | FGKKDPNFKGFSGAGEKLFSsQYGKMANKANtsGDFEKDDD |
| P49792 | S3137 | Sugiyama | RANBP2 NUP358 | IPDFVCQGGDITKHDGTGGQsIyGDKFEDENFDVKHTGPGL |
| P50851 | S1725 | Sugiyama | LRBA BGL CDC4L LBA | LGALGDLSVEQPVQFRSFDRsVIVAAKKSAVSPSTFNTSIP |
| P50991 | S51 | Sugiyama | CCT4 CCTD SRB | AQIRFsNISAAKAVADAIRtsLGPKGMDKMIQDGKGDVtIt |
| P51452 | S43 | Sugiyama | DUSP3 VHR | YsLPSQPCNEVTPRIyVGNAsVAQDIPKLQKLGITHVLNAA |
| P51991 | S375 | Sugiyama | HNRNPA3 HNRPA3 | ssGsPyGGGyGsGGGsGGyGsRRF_________________ |
| P52272 | S528 | Sugiyama | HNRNPM HNRPM NAGR1 | IERMGsGVERMGPAIERMGLsMERMVPAGMGAGLERMGPVM |
| P52565 | S148 | Sugiyama | ARHGDIA GDIA1 | YIQHTyRKGVKIDKtDyMVGsYGPRAEEyEFLtPVEEAPKG |
| P53396 | S478 | Sugiyama | ACLY | EsRADEVAPAKKAKPAMPQDsVPsPRSLQGKSTTLFSRHTK |
| P54105 | S195 | Sugiyama | CLNS1A CLCI ICLN | SHLTAEGQATLERLEGMLsQsVssQYNMAGVRtEDsIRDyE |
| P55036 | S358 | Sugiyama | PSMD4 MCB1 | VLENLPGVDPNNEAIRNAMGsLAsQATKDGKKDKKEEDKK_ |
| P55036 | T264 | Sugiyama | PSMD4 MCB1 | AEAGIATTGtEDsDDALLKMtIsQQEFGRTGLPDLSSMTEE |
| P55060 | S342 | Sugiyama | CSE1L CAS XPO2 | ASVCERPHYKNLFEDQNtLtsICEKVIVPNMEFRAADEEAF |
| P55060 | S931 | Sugiyama | CSE1L CAS XPO2 | KKEHDPVGQMVNNPKIHLAQsLHKLSTACPGRVPSMVSTSL |
| P55072 | S765 | Sugiyama | VCP HEL-220 HEL-S-70 | RsVsDNDIRKyEMFAQtLQQsRGFGsFRFPsGNQGGAGPsQ |
| P55072 | T761 | Sugiyama | VCP HEL-220 HEL-S-70 | RFARRsVsDNDIRKyEMFAQtLQQsRGFGsFRFPsGNQGGA |
| P55769 | S118 | Sugiyama | SNU13 NHP2L1 | PVIACSVTIKEGSQLKQQIQsIQQsIERLLV__________ |
| P55884 | S185 | Sugiyama | EIF3B EIF3S9 | EEELLGDVLKDRPQEADGIDsVIVVDNVPQVGPDRLEKLKN |
| P57081 | T409 | Sugiyama | WDR4 | RRsPPPGPDGHAKKMRPGEAtLsC_________________ |
| P60174 | S236 | Sugiyama | TPI1 TPI | AtCKELASQPDVDGFLVGGAsLKPEFVDIINAKQ_______ |
| P60709 | S239 | Sugiyama | ACTB | VALDFEQEMAtAAssssLEKsyELPDGQVItIGNERFRCPE |
| P60709 | S368 | Sugiyama | ACTB | sLstFQQMWISKQEyDEsGPsIVHRKCF_____________ |
| P60709 | S52 | Sugiyama | ACTB | PsIVGRPRHQGVMVGMGQKDsyVGDEAQsKRGILTLKYPIE |
| P60709 | S60 | Sugiyama | ACTB | HQGVMVGMGQKDsyVGDEAQsKRGILTLKYPIEHGIVTNWD |
| P60709 | Y53 | Sugiyama | ACTB | sIVGRPRHQGVMVGMGQKDsyVGDEAQsKRGILTLKYPIEH |
| P61201 | S178 | Sugiyama | COPS2 CSN2 TRIP15 | LYLEREEYGKLQKILRQLHQsCQTDDGEDDLKKGTQLLEIY |
| P61204 | S147 | Sugiyama | ARF3 | KQDLPNAMNAAEITDKLGLHsLRHRNWYIQATCATSGDGLY |
| P61247 | S236 | Sugiyama | RPS3A FTE1 MFTL | KMLKKPKFELGKLMELHGEGsssGKAtGDEtGAKVERADGy |
| P61247 | S263 | Sugiyama | RPS3A FTE1 MFTL | GDEtGAKVERADGyEPPVQEsV___________________ |
| P61313 | S97 | Sugiyama | RPL15 EC45 TCBAP0781 | KGAtyGKPVHHGVNQLKFARsLQsVAEERAGRHCGALRVLN |
| P61604 | S64 | Sugiyama | HSPE1 | AtVVAVGsGsKGKGGEIQPVsVKVGDKVLLPEyGGtKVVLD |
| P61978 | S420 | Sugiyama | HNRNPK HNRPK | GsIIGKGGQRIKQIRHEsGAsIKIDEPLEGsEDRIITItGt |
| P61978 | S75 | Sugiyama | HNRNPK HNRPK | GAVIGKGGKNIKALRtDyNAsVsVPDssGPERILsISADIE |
| P61978 | S77 | Sugiyama | HNRNPK HNRPK | VIGKGGKNIKALRtDyNAsVsVPDssGPERILsISADIETI |
| P62249 | S9 | Sugiyama | RPS16 | ____________MPsKGPLQsVQVFGRKKTATAVAHCKRGN |
| P62258 | S148 | Sugiyama | YWHAE | YHRyLAEFAtGNDRKEAAENsLVAyKAAsDIAMtELPPTHP |
| P62266 | S45 | Sugiyama | RPS23 | KQYKKAHLGtALKANPFGGAsHAKGIVLEKVGVEAKQPNSA |
| P62277 | S14 | Sugiyama | RPS13 | _______MGRMHAPGKGLsQsALPyRRsVPtWLKLTsDDVK |
| P62701 | S204 | Sugiyama | RPS4X CCG2 RPS4 SCAR | tGGANLGRIGVITNRERHPGsFDVVHVKDANGNSFATRLsN |
| P62736 | S241 | Sugiyama | ACTA2 ACTSA ACTVS GIG46 | VALDFENEMAtAAssssLEKsyELPDGQVItIGNERFRCPE |
| P62736 | S54 | Sugiyama | ACTA2 ACTSA ACTVS GIG46 | PsIVGRPRHQGVMVGMGQKDsyVGDEAQsKRGILTLKyPIE |
| P62736 | S62 | Sugiyama | ACTA2 ACTSA ACTVS GIG46 | HQGVMVGMGQKDsyVGDEAQsKRGILTLKyPIEHGIItNWD |
| P62736 | Y55 | Sugiyama | ACTA2 ACTSA ACTVS GIG46 | sIVGRPRHQGVMVGMGQKDsyVGDEAQsKRGILTLKyPIEH |
| P62917 | S14 | Sugiyama | RPL8 | _______MGRVIRGQRKGAGsVFRAHVKHRKGAARLRAVDF |
| P63104 | S28 | Sugiyama | YWHAZ | QKAKLAEQAERyDDMAACMKsVtEQGAELsNEERNLLsVAy |
| P63104 | T30 | Sugiyama | YWHAZ | AKLAEQAERyDDMAACMKsVtEQGAELsNEERNLLsVAyKN |
| P63167 | S21 | Sugiyama | DYNLL1 DLC1 DNCL1 DNCLC1 HDLC1 | MCDRKAVIKNADMsEEMQQDsVECAtQALEKYNIEKDIAAH |
| P63241 | S100 | Sugiyama | EIF5A | DVPNIKRNDFQLIGIQDGyLsLLQDSGEVREDLRLPEGDLG |
| P63261 | S239 | Sugiyama | ACTG1 ACTG | VALDFEQEMAtAAssssLEKsyELPDGQVItIGNERFRCPE |
| P63261 | S368 | Sugiyama | ACTG1 ACTG | sLstFQQMWISKQEyDEsGPsIVHRKCF_____________ |
| P63261 | S52 | Sugiyama | ACTG1 ACTG | PsIVGRPRHQGVMVGMGQKDsyVGDEAQsKRGILTLKYPIE |
| P63261 | S60 | Sugiyama | ACTG1 ACTG | HQGVMVGMGQKDsyVGDEAQsKRGILTLKYPIEHGIVTNWD |
| P63261 | Y53 | Sugiyama | ACTG1 ACTG | sIVGRPRHQGVMVGMGQKDsyVGDEAQsKRGILTLKYPIEH |
| P63267 | S240 | Sugiyama | ACTG2 ACTA3 ACTL3 ACTSG | VALDFENEMAtAAssssLEKsyELPDGQVItIGNERFRCPE |
| P63267 | S53 | Sugiyama | ACTG2 ACTA3 ACTL3 ACTSG | PsIVGRPRHQGVMVGMGQKDsyVGDEAQsKRGILTLKyPIE |
| P63267 | S61 | Sugiyama | ACTG2 ACTA3 ACTL3 ACTSG | HQGVMVGMGQKDsyVGDEAQsKRGILTLKyPIEHGIItNWD |
| P63267 | Y54 | Sugiyama | ACTG2 ACTA3 ACTL3 ACTSG | sIVGRPRHQGVMVGMGQKDsyVGDEAQsKRGILTLKyPIEH |
| P68032 | S241 | Sugiyama | ACTC1 ACTC | VALDFENEMAtAAssssLEKsyELPDGQVItIGNERFRCPE |
| P68032 | S54 | Sugiyama | ACTC1 ACTC | PsIVGRPRHQGVMVGMGQKDsyVGDEAQsKRGILTLKyPIE |
| P68032 | S62 | Sugiyama | ACTC1 ACTC | HQGVMVGMGQKDsyVGDEAQsKRGILTLKyPIEHGIItNWD |
| P68032 | Y55 | Sugiyama | ACTC1 ACTC | sIVGRPRHQGVMVGMGQKDsyVGDEAQsKRGILTLKyPIEH |
| P68104 | T432 | Sugiyama | EEF1A1 EEF1A EF1A LENG7 | VEsFSDyPPLGRFAVRDMRQtVAVGVIKAVDKKAAGAGKVT |
| P68133 | S241 | Sugiyama | ACTA1 ACTA | VALDFENEMAtAAssssLEKsyELPDGQVItIGNERFRCPE |
| P68133 | S54 | Sugiyama | ACTA1 ACTA | PsIVGRPRHQGVMVGMGQKDsyVGDEAQsKRGILTLKyPIE |
| P68133 | S62 | Sugiyama | ACTA1 ACTA | HQGVMVGMGQKDsyVGDEAQsKRGILTLKyPIEHGIItNWD |
| P68133 | Y55 | Sugiyama | ACTA1 ACTA | sIVGRPRHQGVMVGMGQKDsyVGDEAQsKRGILTLKyPIEH |
| P68363 | S439 | Sugiyama | TUBA1B | SEAREDMAALEKDyEEVGVDsVEGEGEEEGEEy________ |
| P68363 | S48 | Sugiyama | TUBA1B | HGIQPDGQMPSDKtIGGGDDsFNtFFsEtGAGKHVPRAVFV |
| P78371 | S144 | Sugiyama | CCT2 99D8.1 CCTB | QTIIAGWREATKAAREALLssAVDHGsDEVKFRQDLMNIAG |
| P78417 | S23 | Sugiyama | GSTO1 GSTTLP28 | GESARsLGKGsAPPGPVPEGsIRIySMRFCPFAERTRLVLK |
| P84077 | S147 | Sugiyama | ARF1 | KQDLPNAMNAAEITDKLGLHsLRHRNWYIQATCATSGDGLY |
| P99999 | S48 | Sugiyama | CYCS CYC | KTGPNLHGLFGRKtGQAPGysytAANKNKGIIWGEDTLMEY |
| Q00613 | S363 | Sugiyama | HSF1 HSTF1 | AsVTALtDARGHTDtEGRPPsPPPtstPEKCLsVACLDKNE |
| Q01105 | S168 | Sugiyama | SET | ENKVLSKEFHLNEsGDPssKstEIKWKSGKDLTKRssQTQN |
| Q02790 | S258 | Sugiyama | FKBP4 FKBP52 | PPNAELKYELHLKSFEKAKEsWEMNsEEKLEQSTIVKERGt |
| Q04446 | S75 | Sugiyama | GBE1 | ILKNIGENEGGIDKFSRGyEsFGVHRCADGGLYCKEWAPGA |
| Q04726 | S205 | Sugiyama | TLE3 KIAA1547 | NHHELDHREREssANNsVsPsEsLRAsEKHRGsADYsMEAK |
| Q05639 | T432 | Sugiyama | EEF1A2 EEF1AL STN | VESFSQYPPLGRFAVRDMRQtVAVGVIKNVEKKSGGAGKVT |
| Q06124 | S28 | Sugiyama | PTPN11 PTP2C SHPTP2 | HPNITGVEAENLLLTRGVDGsFLARPSKSNPGDFTLSVRRN |
| Q06323 | S31 | Sugiyama | PSME1 IFI5111 | QAKVDVFREDLCTKtENLLGsyFPKKIsELDAFLKEPALNE |
| Q06830 | S126 | Sugiyama | PRDX1 PAGA PAGB TDPX2 | SDPKRtIAQDyGVLKADEGIsFRGLFIIDDKGILRQItVND |
| Q06830 | T183 | Sugiyama | PRDX1 PAGA PAGB TDPX2 | FQFtDKHGEVCPAGWKPGsDtIKPDVQKSKEyFSKQK____ |
| Q07866 | S524 | Sugiyama | KLC1 KLC KNS2 | QRVAEVLNDPENMEKRRsREsLNVDVVKYESGPDGGEEVSM |
| Q12792 | S142 | Sugiyama | TWF1 PTK9 | FGTVKEDVSLHGYKKyLLsQssPAPLtAAEEELRQIKINEV |
| Q12906 | S20 | Sugiyama | ILF3 DRBF MPHOSPH4 NF90 | _MRPMRIFVNDDRHVMAKHssVyPTQEELEAVQNMVsHtER |
| Q13247 | S303 | Sugiyama | SRSF6 SFRS6 SRP55 | ENGKGDIKsKSRsRsQsRsNsPLPVPPsKARsVsPPPKRAT |
| Q13283 | S232 | Sugiyama | G3BP1 G3BP | EEKPEPVLEETAPEDAQKsssPAPADIAQtVQEDLRtFsWA |
| Q13347 | S217 | Sugiyama | EIF3I EIF3S2 TRIP1 | sRDMtMFVtASKDNTAKLFDsttLEHQKTFRTERPVNSAAL |
| Q13409 | S92 | Sugiyama | DYNC1I2 DNCI2 DNCIC2 | ESPIVFSEYWVPPPMsPSSKsVStPsEAGsQDsGDGAVGsR |
| Q13509 | S115 | Sugiyama | TUBB3 TUBB4 | SGAGNNWAKGHytEGAELVDsVLDVVRKECENCDCLQGFQL |
| Q13509 | S75 | Sugiyama | TUBB3 TUBB4 | SSHKYVPRAILVDLEPGtMDsVRSGAFGHLFRPDNFIFGQS |
| Q13561 | T315 | Sugiyama | DCTN2 DCTN50 | KHKASVEDADTQSKVHQLyEtIQRWsPIASTLPELVQRLVT |
| Q13885 | S115 | Sugiyama | TUBB2A TUBB2 | sGAGNNWAKGHytEGAELVDsVLDVVRKESESCDCLQGFQL |
| Q13885 | S75 | Sugiyama | TUBB2A TUBB2 | AGNKYVPRAILVDLEPGtMDsVRsGPFGQIFRPDNFVFGQs |
| Q14152 | S1028 | Sugiyama | EIF3A EIF3S10 KIAA0139 | NWRHADDDRPPRRGLDEDRGsWRtADEDRGPRRGMDDDRGP |
| Q14152 | S584 | Sugiyama | EIF3A EIF3S10 KIAA0139 | EHQRILARRQtIEERKERLEsLNIQREKEELEQREAELQKV |
| Q14498 | S337 | Sugiyama | RBM39 HCC1 RNPC2 | AGRPMKVGHVTERtDAssAssFLDsDELERtGIDLGtTGRL |
| Q14566 | S324 | Sugiyama | MCM6 | APTNPRFGGKELRDEEQtAEsIKNQMTVKEWEKVFEMsQDK |
| Q14568 | S165 | Sugiyama | HSP90AA2P HSP90AA2 HSPC2 HSPCAL3 | AEKVTVITKHNDDEQyAWEssAGGsFtVRTDTGERMGRGTK |
| Q14568 | S169 | Sugiyama | HSP90AA2P HSP90AA2 HSPC2 HSPCAL3 | TVITKHNDDEQyAWEssAGGsFtVRTDTGERMGRGTKVILH |
| Q14568 | T171 | Sugiyama | HSP90AA2P HSP90AA2 HSPC2 HSPCAL3 | ITKHNDDEQyAWEssAGGsFtVRTDTGERMGRGTKVILHLK |
| Q14677 | S166 | Sugiyama | CLINT1 ENTH EPN4 EPNR KIAA0171 | REERKKAKKNKDKyVGVssDsVGGFRysERYDPEPKSKWDE |
| Q14694 | S253 | Sugiyama | USP10 KIAA0190 | GSDTRTAGQPEGGPGADFGQsCFPAEAGRDtLsRTAGAQPC |
| Q14980 | S1149 | Sugiyama | NUMA1 NMP22 NUMA | VSKLEQQCQKQQEQADsLERsLEAERASRAERDsALEtLQG |
| Q14980 | S1181 | Sugiyama | NUMA1 NMP22 NUMA | DsALEtLQGQLEEKAQELGHsQsALAsAQRELAAFRTKVQD |
| Q14980 | S1183 | Sugiyama | NUMA1 NMP22 NUMA | ALEtLQGQLEEKAQELGHsQsALAsAQRELAAFRTKVQDHS |
| Q14980 | S1229 | Sugiyama | NUMA1 NMP22 NUMA | WKAQVARGRQEAERKNsLIssLEEEVSILNRQVLEKEGESK |
| Q15005 | S218 | Sugiyama | SPCS2 KIAA0102 SPC25 | DHSGTLVMDAYEPEISRLHDsLAIERKIK____________ |
| Q15029 | T500 | Sugiyama | EFTUD2 KIAA0031 SNRP116 | KMYSTDDGVQFHAFGRVLSGtIHAGQPVKVLGENYTLEDEE |
| Q15185 | S72 | Sugiyama | PTGES3 P23 TEBP | EIDLFHCIDPNDsKHKRtDRsILCCLRKGEsGQsWPRLTKE |
| Q15758 | T532 | Sugiyama | SLC1A5 ASCT2 M7V1 RDR RDRC | VPTEEGNPLLKHyRGPAGDAtVAsEKEsVM___________ |
| Q16401 | S98 | Sugiyama | PSMD5 KIAA0072 | VHVARNLRVDLQRGLIHPDDsVKILTLSQIGRIVENSDAVT |
| Q16658 | S259 | Sugiyama | FSCN1 FAN1 HSN SNL | tLKAGKATKVGKDELFALEQsCAQVVLQAANERNVsTRQGM |
| Q16658 | T239 | Sugiyama | FSCN1 FAN1 HSN SNL | GKVAFRDCEGRyLAPsGPsGtLKAGKATKVGKDELFALEQs |
| Q16719 | S456 | Sugiyama | KYNU | APVPLyNsFHDVyKFTNLLtsILDsAETKN___________ |
| Q16719 | S460 | Sugiyama | KYNU | LyNsFHDVyKFTNLLtsILDsAETKN_______________ |
| Q3ZCM7 | S75 | Sugiyama | TUBB8 | SGGRYVPRAVLVDLEPGtMDsVRSGPFGQVFRPDNFIFGQC |
| Q4G0X9 | S553 | Sugiyama | CCDC40 KIAA1640 | EIEAYKKSIMKEEEKNEKLAsILNRTETEATLLQKLTTQCL |
| Q4V328 | S666 | Sugiyama | GRIPAP1 KIAA1167 | EELVLsEMNsPSRtQtGDsssIssFsYREILREKEssAVPA |
| Q562R1 | S240 | Sugiyama | ACTBL2 | VALDFEQEMVRAAAssSPERsyELPDGQVItIGNERFRCPE |
| Q58FF7 | S370 | Sugiyama | HSP90AB3P HSP90BC | KETQKSTYYITGESKEQVANsAFVERVRKQGFEVVYMTEPI |
| Q5VTE0 | T432 | Sugiyama | EEF1A1P5 EEF1AL3 | VEsFSDyPPLGRFAVRDMRQtVAVGVIKAVDKKAAGAGKVT |
| Q658Y4 | S332 | Sugiyama | FAM91A1 | KNVPSVNRLKSTLDPQKMLLsWDGGESRsPVQEAssAtDtD |
| Q6IBS0 | S140 | Sugiyama | TWF2 PTK9L MSTP011 | ELFGTVKDDLSFAGyQKHLssCAAPAPLtsAERELQQIRIN |
| Q6PEY2 | S48 | Sugiyama | TUBA3E | HGIQPDGQMPSDKtIGGGDDsFNtFFsEtGAGKHVPRAVFV |
| Q6PHR2 | S300 | GPS6|SIGNOR|EPSD|PSP | ULK3 | SLGRATALVVQAVKKDQEGDsAAALsLYCKALDFFVPALHY |
| Q6PHR2 | S305 | Sugiyama | ULK3 | TALVVQAVKKDQEGDsAAALsLYCKALDFFVPALHYEVDAQ |
| Q6PHR2 | S339 | Sugiyama | ULK3 | HYEVDAQRKEAIKAKVGQYVsRAEELKAIVSssNQALLRQG |
| Q6PHR2 | S350 | GPS6|SIGNOR|EPSD|PSP | ULK3 | IKAKVGQYVsRAEELKAIVSssNQALLRQGTSARDLLREMA |
| Q6PHR2 | S351 | Sugiyama | ULK3 | KAKVGQYVsRAEELKAIVSssNQALLRQGTSARDLLREMAR |
| Q6PHR2 | S384 | GPS6|SIGNOR|EPSD|PSP | ULK3 | DLLREMARDKPRLLAALEVAsAAMAKEEAAGGEQDALDLYQ |
| Q6PHR2 | S464 | GPS6|SIGNOR|EPSD|PSP|Sugiyama | ULK3 | VKMRESRWEADTLDKEGLsEsVRSSCTLQ____________ |
| Q6PJT7 | S330 | Sugiyama | ZC3H14 | HDGEEEEEDDDYGSRtGsISsSVSVPAKPERRPsLPPSKQA |
| Q6PKG0 | S548 | Sugiyama | LARP1 KIAA0731 LARP | VPtKTEEVSNLKTLPKGLsAsLPDLDsENWIEVKKRPRPSP |
| Q6S8J3 | S1068 | Sugiyama | POTEE A26C1A POTE2 | SLSTFQQMWISKQEyDEsGPsIVHRKCF_____________ |
| Q6S8J3 | S939 | Sugiyama | POTEE A26C1A POTE2 | VALDFEQEMAtAAssssLEKsyELPDGQVItIGNERFRCPE |
| Q71RC2 | S394 | Sugiyama | LARP4 PP13296 | RVKPQFRssGGsEHstEGsVsLGDGQLNRYSSRNFPAERHN |
| Q71U36 | S439 | Sugiyama | TUBA1A TUBA3 | SEAREDMAALEKDyEEVGVDsVEGEGEEEGEEy________ |
| Q71U36 | S48 | Sugiyama | TUBA1A TUBA3 | HGIQPDGQMPSDKtIGGGDDsFNtFFsEtGAGKHVPRAVFV |
| Q7KZF4 | S126 | Sugiyama | SND1 TDRD11 | GREyGMIyLGKDTNGENIAEsLVAEGLAtRREGMRANNPEQ |
| Q7Z417 | S592 | Sugiyama | NUFIP2 KIAA1321 PIG1 | sPQVLGSILKsGttsEsGALsLEPsHIGDLQKADtssQGAL |
| Q7Z5K2 | S231 | Sugiyama | WAPL FOE KIAA0261 WAPAL | WNSQFGKRPEsPsEIsPIKGsVRTGLFEWDNDFEDIRSEDC |
| Q86UP2 | S1181 | Sugiyama | KTN1 CG1 KIAA0004 | ENKWKVKVDESHKTIKQMQssFTSsEQELERLRSENKDIEN |
| Q86V81 | S145 | Sugiyama | ALYREF ALY BEF THOC4 | LFAEFGtLKKAAVHYDRsGRsLGtADVHFERKADALKAMKQ |
| Q8N684 | T203 | Sugiyama | CPSF7 | GGIPPRAHsRDssDsADGRAtPsENLVPSSARVDKPPSVLP |
| Q8N6T3 | S246 | Sugiyama | ARFGAP1 ARF1GAP | KEGATKFGSQASQKASELGHsLNENVLKPAQEKVKEGKIFD |
| Q8N6T3 | S348 | Sugiyama | ARFGAP1 ARF1GAP | FWETFGSAEPTKtRKsPssDsWtCADtstERRssDsWEVWG |
| Q8NBJ7 | S256 | Sugiyama | SUMF2 PSEC0171 UNQ1968/PRO4500 | EWTASPYQAAEQDMRVLRGAsWIDtADGsANHRARVttRMG |
| Q8NE71 | S105 | Sugiyama | ABCF1 ABC50 | KKDVDDDGEEKELMERLKKLsVPtsDEEDEVPAPKPRGGKK |
| Q8NEB9 | S249 | PSP | PIK3C3 VPS34 | KEyGIVYYEKDGDEssPILTsFELVKVPDPQMSMENLVESK |
| Q8TAM6 | S280 | Sugiyama | ERMN KIAA1189 | TISYRKIRKGNTKQRIDEFEsMMHL________________ |
| Q8TEW0 | S962 | Sugiyama | PARD3 PAR3 PAR3A | DEGMEtLEEDTEESSRsGREsVstAsDQPsHsLERQMNGNQ |
| Q8WUM4 | S454 | Sugiyama | PDCD6IP AIP1 ALIX KIAA1375 | DQLIKELPELLQRNREILDEsLRLLDEEEAtDNDLRAKFKE |
| Q8WVV9 | S86 | Sugiyama | HNRNPLL HNRPLL SRRF BLOCK24 | GGsHHKVsVsPVVHVRGLCEsVVEADLVEALEKFGTICYVM |
| Q96D46 | S462 | Sugiyama | NMD3 CGI-07 | FLEDLEEDEAIRKNVNIyRDsAIPVEsDtDDEGAPRISLAE |
| Q96HE7 | S143 | Sugiyama | ERO1A ERO1L UNQ434/PRO865 | EANNLIEECEQAERLGAVDEsLsEEtQKAVLQWTKHDDSSD |
| Q96IR7 | S360 | Sugiyama | HPDL GLOXD1 | LIQRQGATGFGQGNIRALWQsVQEQsARSQEA_________ |
| Q99496 | S143 | Sugiyama | RNF2 BAP1 DING HIPI3 RING1B | HQERVLARINKHNNQQALSHsIEEGLKIQAMNRLQRGKKQQ |
| Q99613 | S754 | Sugiyama | EIF3C EIF3S8 | REHVVAASKAMKMGDWKTCHsFIINEKMNGKVWDLFPEADK |
| Q99613 | S865 | Sugiyama | EIF3C EIF3S8 | HRTEPTAQQNLALQLAEKLGsLVENNERVFDHKQGtyGGyF |
| Q9BQE3 | S439 | Sugiyama | TUBA1C TUBA6 | SEAREDMAALEKDyEEVGADsADGEDEGEEy__________ |
| Q9BQE3 | S48 | Sugiyama | TUBA1C TUBA6 | HGIQPDGQMPSDKtIGGGDDsFNtFFsEtGAGKHVPRAVFV |
| Q9BVA1 | S115 | Sugiyama | TUBB2B | sGAGNNWAKGHytEGAELVDsVLDVVRKESESCDCLQGFQL |
| Q9BVA1 | S75 | Sugiyama | TUBB2B | tGNKYVPRAILVDLEPGtMDsVRsGPFGQIFRPDNFVFGQs |
| Q9BXS6 | S363 | Sugiyama | NUSAP1 ANKT BM-037 PRO0310 | TtEAtQtPVsNKKPVFDLKAsLsRPLNyEPHKGKLKPWGQS |
| Q9BYX7 | S239 | Sugiyama | POTEKP ACTBL3 FKSG30 | VALDSEQEMAMAASSSSVEKsyELPDGQVItIGNERFRCPE |
| Q9BYX7 | S368 | Sugiyama | POTEKP ACTBL3 FKSG30 | SLSTFQQMWISKQEyDEsGPsIVHRKCF_____________ |
| Q9H2U2 | S313 | Sugiyama | PPA2 HSPC124 | VQISDSPFRCtQEEARsLVEsVsssPNKEsNEEEQVWHFLG |
| Q9H3P7 | S316 | Sugiyama | ACBD3 GCP60 GOCAP1 GOLPH1 | QLAQQQAALQKQQEVVVAGssLPtssKVNATVPSNMMSVNG |
| Q9H3P7 | S393 | Sugiyama | ACBD3 GCP60 GOCAP1 GOLPH1 | SMWTRPQIKDFKEKIQQDADsVItVGRGEVVTVRVPTHEEG |
| Q9H788 | S124 | Sugiyama | SH2D4A PPP1R38 SH2A | LKAEQEAEEPRKTHsEEFTNsLKTKsQyHDLQAPDNQQtKD |
| Q9H8Y5 | S75 | Sugiyama | ANKZF1 ZNF744 | EsPERKLLQGPMDISEKLFCsTCDQTFQNHQEQREHYKLDW |
| Q9NPQ8 | S452 | Sugiyama | RIC8A | EGQysEDEDtDtDEyKEAKAsINPVTGRVEEKPPNPMEGMT |
| Q9NQ39 | S157 | Sugiyama | RPS10P5 RPS10L | TYRRCSVPPGADKKAEAGAGsAtEFQFRGRCGRGRGQPPQ_ |
| Q9NR30 | S706 | Sugiyama | DDX21 | PTASVTEIQEKWHDSRRWQLsVATEQPELEGPREGYGGFRG |
| Q9NVR5 | S773 | Sugiyama | DNAAF2 C14orf104 KTU | EFIKEKSATCSNEEKDNLNEsVITEEKETDGDHLsSLLNKT |
| Q9P2E9 | S872 | Sugiyama | RRBP1 KIAA1398 | RKALEAKAAAFEKQVLQLQAsHRESEEALQKRLDEVSRELC |
| Q9UBC2 | S374 | Sugiyama | EPS15L1 EPS15R | LsPDMVPPsERGtPGPDssGsLGsGEFTGVKELDDISQEIA |
| Q9UBC2 | S479 | Sugiyama | EPS15L1 EPS15R | LRDMLSDVRQKCQDETQMISsLKTQIQSQESDLKsQEDDLN |
| Q9UGV2 | S335 | Sugiyama | NDRG3 | YIPSASMTRLARsRtHstsssLGsGEsPFsRsVtsNQsDGt |
| Q9UII2 | S39 | Sugiyama | ATP5IF1 ATPI ATPIF1 | TMQARGFGsDQSENVDRGAGsIREAGGAFGKREQAEEERyF |
| Q9UKV3 | S388 | Sugiyama | ACIN1 ACINUS KIAA0670 | EEEEREIKssQGLKEKsKsPsPPRLtEDRKKAsLVALPEQt |
| Q9UNF0 | S273 | Sugiyama | PACSIN2 | KHLDLSNVAGYKAIyHDLEQsIRAADAVEDLRWFRANHGPG |
| Q9UNW1 | S468 | Sugiyama | MINPP1 MIPP UNQ900/PRO1917 | SQETVSFYEDLKNHYKDILQsCQTSEECELARANSTSDEL_ |
| Q9Y2B0 | S65 | Sugiyama | CNPY2 MSAP TMEM4 ZSIG9 UNQ1943/PRO4426 | VDPKKTIQMGsFRINPDGsQsVVEVPyARsEAHLtELLEEI |
| Q9Y4L1 | S461 | Sugiyama | HYOU1 GRP170 HSPH4 ORP150 | VVYPILVEFTREVEEEPGIHsLKHNKRVLFSRMGPYPQRKV |
| Q9Y5S9 | S56 | Sugiyama | RBM8A RBM8 HSPC114 MDS014 | KGRGFGsEEGsRARMREDyDsVEQDGDEPGPQRSVEGWILF |
| Q9Y6D6 | S1575 | Sugiyama | ARFGEF1 ARFGEP1 BIG1 | sPVsEKPLDtIsQKsVDIHDsIQPRsVDNRPQAPLVSASAV |
Site Promiscuity
Motif of predicted substrate sequence
Reactome pathways of predicted substrates
Download
| name | reactome_id | p | -log10p | ref_path | ref_path_lowest |
|---|---|---|---|---|---|
| M Phase | R-HSA-68886 | 1.110223e-16 | 15.955 | 0 | 0 |
| Cell Cycle | R-HSA-1640170 | 7.771561e-16 | 15.109 | 0 | 0 |
| Cell Cycle, Mitotic | R-HSA-69278 | 6.661338e-16 | 15.176 | 0 | 0 |
| Mitotic Prometaphase | R-HSA-68877 | 2.740030e-13 | 12.562 | 0 | 0 |
| Recruitment of NuMA to mitotic centrosomes | R-HSA-380320 | 1.424083e-12 | 11.846 | 0 | 0 |
| Cell-Cell communication | R-HSA-1500931 | 7.349121e-12 | 11.134 | 0 | 0 |
| Prefoldin mediated transfer of substrate to CCT/TriC | R-HSA-389957 | 7.514256e-11 | 10.124 | 0 | 0 |
| Cooperation of Prefoldin and TriC/CCT in actin and tubulin folding | R-HSA-389958 | 1.026792e-10 | 9.989 | 0 | 0 |
| Nervous system development | R-HSA-9675108 | 2.137307e-10 | 9.670 | 0 | 0 |
| Processing of Capped Intron-Containing Pre-mRNA | R-HSA-72203 | 5.219917e-10 | 9.282 | 0 | 0 |
| Axon guidance | R-HSA-422475 | 5.238445e-10 | 9.281 | 0 | 0 |
| Nuclear Envelope (NE) Reassembly | R-HSA-2995410 | 5.914106e-10 | 9.228 | 0 | 0 |
| Cellular responses to stimuli | R-HSA-8953897 | 6.617437e-10 | 9.179 | 0 | 0 |
| Formation of tubulin folding intermediates by CCT/TriC | R-HSA-389960 | 9.213895e-10 | 9.036 | 0 | 0 |
| G2/M Transition | R-HSA-69275 | 1.424437e-09 | 8.846 | 0 | 0 |
| Mitotic G2-G2/M phases | R-HSA-453274 | 1.943749e-09 | 8.711 | 0 | 0 |
| EML4 and NUDC in mitotic spindle formation | R-HSA-9648025 | 2.146682e-09 | 8.668 | 0 | 0 |
| Mitotic Anaphase | R-HSA-68882 | 2.786370e-09 | 8.555 | 0 | 0 |
| Cell junction organization | R-HSA-446728 | 2.726264e-09 | 8.564 | 0 | 0 |
| Mitotic Metaphase and Anaphase | R-HSA-2555396 | 3.208309e-09 | 8.494 | 0 | 0 |
| Resolution of Sister Chromatid Cohesion | R-HSA-2500257 | 3.385513e-09 | 8.470 | 0 | 0 |
| Recycling pathway of L1 | R-HSA-437239 | 4.355104e-09 | 8.361 | 0 | 0 |
| COPI-dependent Golgi-to-ER retrograde traffic | R-HSA-6811434 | 4.232210e-09 | 8.373 | 0 | 0 |
| Golgi-to-ER retrograde transport | R-HSA-8856688 | 4.023233e-09 | 8.395 | 0 | 0 |
| Microtubule-dependent trafficking of connexons from Golgi to the plasma membrane | R-HSA-190840 | 4.274658e-09 | 8.369 | 0 | 0 |
| Translocation of SLC2A4 (GLUT4) to the plasma membrane | R-HSA-1445148 | 5.849596e-09 | 8.233 | 0 | 0 |
| HSP90 chaperone cycle for steroid hormone receptors (SHR) in the presence of ligand | R-HSA-3371497 | 6.220640e-09 | 8.206 | 0 | 0 |
| Aggrephagy | R-HSA-9646399 | 6.604279e-09 | 8.180 | 0 | 0 |
| Cellular responses to stress | R-HSA-2262752 | 6.811123e-09 | 8.167 | 0 | 0 |
| Transport of connexons to the plasma membrane | R-HSA-190872 | 7.650222e-09 | 8.116 | 0 | 0 |
| Kinesins | R-HSA-983189 | 1.161936e-08 | 7.935 | 0 | 0 |
| Chromatin organization | R-HSA-4839726 | 1.427367e-08 | 7.845 | 0 | 0 |
| Separation of Sister Chromatids | R-HSA-2467813 | 1.735620e-08 | 7.761 | 0 | 0 |
| Mitotic Prophase | R-HSA-68875 | 2.729948e-08 | 7.564 | 0 | 0 |
| Regulation of endogenous retroelements by Piwi-interacting RNAs (piRNAs) | R-HSA-9845323 | 4.759292e-08 | 7.322 | 0 | 0 |
| COPI-mediated anterograde transport | R-HSA-6807878 | 4.872808e-08 | 7.312 | 0 | 0 |
| Metabolism of RNA | R-HSA-8953854 | 5.131293e-08 | 7.290 | 0 | 0 |
| AURKA Activation by TPX2 | R-HSA-8854518 | 5.733096e-08 | 7.242 | 0 | 0 |
| Assembly and cell surface presentation of NMDA receptors | R-HSA-9609736 | 6.359149e-08 | 7.197 | 0 | 0 |
| Selective autophagy | R-HSA-9663891 | 6.827335e-08 | 7.166 | 0 | 0 |
| Chromatin modifying enzymes | R-HSA-3247509 | 7.323824e-08 | 7.135 | 0 | 0 |
| The role of GTSE1 in G2/M progression after G2 checkpoint | R-HSA-8852276 | 8.032485e-08 | 7.095 | 0 | 0 |
| Cell Cycle Checkpoints | R-HSA-69620 | 9.793950e-08 | 7.009 | 0 | 0 |
| Loss of proteins required for interphase microtubule organization from the centrosome | R-HSA-380284 | 1.035836e-07 | 6.985 | 0 | 0 |
| Loss of Nlp from mitotic centrosomes | R-HSA-380259 | 1.035836e-07 | 6.985 | 0 | 0 |
| L1CAM interactions | R-HSA-373760 | 1.211952e-07 | 6.917 | 0 | 0 |
| Post-chaperonin tubulin folding pathway | R-HSA-389977 | 1.499590e-07 | 6.824 | 0 | 0 |
| Positive epigenetic regulation of rRNA expression | R-HSA-5250913 | 1.910057e-07 | 6.719 | 0 | 0 |
| COPI-independent Golgi-to-ER retrograde traffic | R-HSA-6811436 | 2.021232e-07 | 6.694 | 0 | 0 |
| Antiviral mechanism by IFN-stimulated genes | R-HSA-1169410 | 2.030930e-07 | 6.692 | 0 | 0 |
| mRNA Splicing - Major Pathway | R-HSA-72163 | 2.051372e-07 | 6.688 | 0 | 0 |
| Sealing of the nuclear envelope (NE) by ESCRT-III | R-HSA-9668328 | 2.463153e-07 | 6.609 | 0 | 0 |
| HCMV Early Events | R-HSA-9609690 | 2.648801e-07 | 6.577 | 0 | 0 |
| Recruitment of mitotic centrosome proteins and complexes | R-HSA-380270 | 3.003626e-07 | 6.522 | 0 | 0 |
| mRNA Splicing | R-HSA-72172 | 3.382999e-07 | 6.471 | 0 | 0 |
| Centrosome maturation | R-HSA-380287 | 4.652098e-07 | 6.332 | 0 | 0 |
| Regulation of endogenous retroelements | R-HSA-9842860 | 4.823584e-07 | 6.317 | 0 | 0 |
| Nonhomologous End-Joining (NHEJ) | R-HSA-5693571 | 5.047559e-07 | 6.297 | 0 | 0 |
| Transport of Mature Transcript to Cytoplasm | R-HSA-72202 | 5.970337e-07 | 6.224 | 0 | 0 |
| Chaperonin-mediated protein folding | R-HSA-390466 | 6.062166e-07 | 6.217 | 0 | 0 |
| Signal Transduction | R-HSA-162582 | 6.665382e-07 | 6.176 | 1 | 0 |
| Autophagy | R-HSA-9612973 | 6.987060e-07 | 6.156 | 0 | 0 |
| Cilium Assembly | R-HSA-5617833 | 7.262112e-07 | 6.139 | 0 | 0 |
| Adherens junctions interactions | R-HSA-418990 | 7.612005e-07 | 6.119 | 0 | 0 |
| Regulation of PLK1 Activity at G2/M Transition | R-HSA-2565942 | 8.898394e-07 | 6.051 | 0 | 0 |
| Transport of Mature mRNA derived from an Intron-Containing Transcript | R-HSA-159236 | 1.035216e-06 | 5.985 | 0 | 0 |
| Intra-Golgi and retrograde Golgi-to-ER traffic | R-HSA-6811442 | 1.029791e-06 | 5.987 | 0 | 0 |
| Activation of AMPK downstream of NMDARs | R-HSA-9619483 | 1.061688e-06 | 5.974 | 0 | 0 |
| Cell-cell junction organization | R-HSA-421270 | 1.132608e-06 | 5.946 | 0 | 0 |
| Regulation of CDH1 Expression and Function | R-HSA-9764265 | 1.212129e-06 | 5.916 | 0 | 0 |
| Regulation of Expression and Function of Type I Classical Cadherins | R-HSA-9764274 | 1.212129e-06 | 5.916 | 0 | 0 |
| Regulation of Homotypic Cell-Cell Adhesion | R-HSA-9759476 | 1.496444e-06 | 5.825 | 0 | 0 |
| B-WICH complex positively regulates rRNA expression | R-HSA-5250924 | 1.821245e-06 | 5.740 | 0 | 0 |
| Protein folding | R-HSA-391251 | 1.856770e-06 | 5.731 | 0 | 0 |
| HCMV Infection | R-HSA-9609646 | 2.209393e-06 | 5.656 | 0 | 0 |
| G2/M Checkpoints | R-HSA-69481 | 2.310609e-06 | 5.636 | 0 | 0 |
| Gap junction trafficking and regulation | R-HSA-157858 | 2.583323e-06 | 5.588 | 0 | 0 |
| Transcriptional regulation by small RNAs | R-HSA-5578749 | 2.806653e-06 | 5.552 | 0 | 0 |
| Gap junction trafficking | R-HSA-190828 | 2.815984e-06 | 5.550 | 0 | 0 |
| HDACs deacetylate histones | R-HSA-3214815 | 2.927055e-06 | 5.534 | 0 | 0 |
| MHC class II antigen presentation | R-HSA-2132295 | 2.946852e-06 | 5.531 | 0 | 0 |
| Macroautophagy | R-HSA-1632852 | 3.266243e-06 | 5.486 | 0 | 0 |
| Anchoring of the basal body to the plasma membrane | R-HSA-5620912 | 3.277254e-06 | 5.484 | 0 | 0 |
| Deposition of new CENPA-containing nucleosomes at the centromere | R-HSA-606279 | 3.644433e-06 | 5.438 | 0 | 0 |
| Nucleosome assembly | R-HSA-774815 | 3.644433e-06 | 5.438 | 0 | 0 |
| Apoptotic cleavage of cellular proteins | R-HSA-111465 | 4.018996e-06 | 5.396 | 0 | 0 |
| PKR-mediated signaling | R-HSA-9833482 | 4.147648e-06 | 5.382 | 0 | 0 |
| Apoptotic execution phase | R-HSA-75153 | 4.686602e-06 | 5.329 | 0 | 0 |
| Activation of the mRNA upon binding of the cap-binding complex and eIFs, and subsequent binding to 43S | R-HSA-72662 | 5.745742e-06 | 5.241 | 0 | 0 |
| Regulation of CDH1 Gene Transcription | R-HSA-9764560 | 6.135266e-06 | 5.212 | 0 | 0 |
| Replacement of protamines by nucleosomes in the male pronucleus | R-HSA-9821993 | 6.559898e-06 | 5.183 | 0 | 0 |
| Membrane Trafficking | R-HSA-199991 | 6.875708e-06 | 5.163 | 0 | 0 |
| Recruitment and ATM-mediated phosphorylation of repair and signaling proteins at DNA double strand breaks | R-HSA-5693565 | 7.127434e-06 | 5.147 | 0 | 0 |
| Translation initiation complex formation | R-HSA-72649 | 8.339650e-06 | 5.079 | 0 | 0 |
| Factors involved in megakaryocyte development and platelet production | R-HSA-983231 | 8.563505e-06 | 5.067 | 0 | 0 |
| Negative Regulation of CDH1 Gene Transcription | R-HSA-9764725 | 8.802287e-06 | 5.055 | 0 | 0 |
| Regulation of endogenous retroelements by the Human Silencing Hub (HUSH) complex | R-HSA-9843970 | 9.759970e-06 | 5.011 | 0 | 0 |
| Gap junction assembly | R-HSA-190861 | 9.759970e-06 | 5.011 | 0 | 0 |
| ERCC6 (CSB) and EHMT2 (G9a) positively regulate rRNA expression | R-HSA-427389 | 1.202178e-05 | 4.920 | 0 | 0 |
| Ribosomal scanning and start codon recognition | R-HSA-72702 | 1.286067e-05 | 4.891 | 0 | 0 |
| G2/M DNA damage checkpoint | R-HSA-69473 | 1.309437e-05 | 4.883 | 0 | 0 |
| Viral Infection Pathways | R-HSA-9824446 | 1.300617e-05 | 4.886 | 0 | 0 |
| Nuclear Envelope Breakdown | R-HSA-2980766 | 1.585932e-05 | 4.800 | 0 | 0 |
| Formation of the beta-catenin:TCF transactivating complex | R-HSA-201722 | 1.946991e-05 | 4.711 | 0 | 0 |
| Cap-dependent Translation Initiation | R-HSA-72737 | 1.924542e-05 | 4.716 | 0 | 0 |
| Eukaryotic Translation Initiation | R-HSA-72613 | 1.924542e-05 | 4.716 | 0 | 0 |
| ER to Golgi Anterograde Transport | R-HSA-199977 | 1.934489e-05 | 4.713 | 0 | 0 |
| Epigenetic regulation of gene expression | R-HSA-212165 | 2.320719e-05 | 4.634 | 0 | 0 |
| Meiotic synapsis | R-HSA-1221632 | 2.321638e-05 | 4.634 | 0 | 0 |
| Cargo trafficking to the periciliary membrane | R-HSA-5620920 | 2.323816e-05 | 4.634 | 0 | 0 |
| Gene and protein expression by JAK-STAT signaling after Interleukin-12 stimulation | R-HSA-8950505 | 2.376488e-05 | 4.624 | 0 | 0 |
| TP53 Regulates Transcription of DNA Repair Genes | R-HSA-6796648 | 2.652911e-05 | 4.576 | 0 | 0 |
| GTP hydrolysis and joining of the 60S ribosomal subunit | R-HSA-72706 | 3.173487e-05 | 4.498 | 0 | 0 |
| DNA Double Strand Break Response | R-HSA-5693606 | 3.441956e-05 | 4.463 | 0 | 0 |
| DNA Damage/Telomere Stress Induced Senescence | R-HSA-2559586 | 4.240385e-05 | 4.373 | 0 | 0 |
| Interactions of Vpr with host cellular proteins | R-HSA-176033 | 4.573585e-05 | 4.340 | 0 | 0 |
| Post NMDA receptor activation events | R-HSA-438064 | 4.725444e-05 | 4.326 | 0 | 0 |
| HATs acetylate histones | R-HSA-3214847 | 5.225229e-05 | 4.282 | 0 | 0 |
| Diseases of programmed cell death | R-HSA-9645723 | 5.506151e-05 | 4.259 | 0 | 0 |
| Interleukin-12 signaling | R-HSA-9020591 | 5.506477e-05 | 4.259 | 0 | 0 |
| HIV Life Cycle | R-HSA-162587 | 6.025659e-05 | 4.220 | 0 | 0 |
| PRC2 methylates histones and DNA | R-HSA-212300 | 6.570749e-05 | 4.182 | 0 | 0 |
| Cell-extracellular matrix interactions | R-HSA-446353 | 8.666919e-05 | 4.062 | 0 | 0 |
| L13a-mediated translational silencing of Ceruloplasmin expression | R-HSA-156827 | 8.021169e-05 | 4.096 | 0 | 0 |
| DNA Double-Strand Break Repair | R-HSA-5693532 | 8.675489e-05 | 4.062 | 0 | 0 |
| Regulation of PD-L1(CD274) transcription | R-HSA-9909649 | 8.682742e-05 | 4.061 | 0 | 0 |
| Regulation of MITF-M-dependent genes involved in DNA replication, damage repair and senescence | R-HSA-9825895 | 8.846357e-05 | 4.053 | 0 | 0 |
| Transport of the SLBP independent Mature mRNA | R-HSA-159227 | 9.388413e-05 | 4.027 | 0 | 0 |
| Programmed Cell Death | R-HSA-5357801 | 9.440483e-05 | 4.025 | 0 | 0 |
| Deubiquitination | R-HSA-5688426 | 1.182886e-04 | 3.927 | 0 | 0 |
| Diseases of signal transduction by growth factor receptors and second messengers | R-HSA-5663202 | 1.193074e-04 | 3.923 | 0 | 0 |
| Transport of the SLBP Dependant Mature mRNA | R-HSA-159230 | 1.200782e-04 | 3.921 | 0 | 0 |
| Assembly of the pre-replicative complex | R-HSA-68867 | 1.311961e-04 | 3.882 | 0 | 0 |
| Transport of Mature mRNA Derived from an Intronless Transcript | R-HSA-159231 | 1.315085e-04 | 3.881 | 0 | 0 |
| Transcriptional Regulation by E2F6 | R-HSA-8953750 | 1.315085e-04 | 3.881 | 0 | 0 |
| Ub-specific processing proteases | R-HSA-5689880 | 1.581692e-04 | 3.801 | 0 | 0 |
| HIV Infection | R-HSA-162906 | 1.633736e-04 | 3.787 | 0 | 0 |
| Transport of Mature mRNAs Derived from Intronless Transcripts | R-HSA-159234 | 1.634997e-04 | 3.786 | 0 | 0 |
| Regulation of endogenous retroelements by KRAB-ZFP proteins | R-HSA-9843940 | 1.682559e-04 | 3.774 | 0 | 0 |
| Gene Silencing by RNA | R-HSA-211000 | 1.727575e-04 | 3.763 | 0 | 0 |
| SWI/SNF chromatin remodelers | R-HSA-9932451 | 1.869498e-04 | 3.728 | 0 | 0 |
| ATP-dependent chromatin remodelers | R-HSA-9932444 | 1.869498e-04 | 3.728 | 0 | 0 |
| mRNA 3'-end processing | R-HSA-72187 | 2.003670e-04 | 3.698 | 0 | 0 |
| Condensation of Prophase Chromosomes | R-HSA-2299718 | 2.042235e-04 | 3.690 | 0 | 0 |
| Cellular response to heat stress | R-HSA-3371556 | 2.106939e-04 | 3.676 | 0 | 0 |
| Apoptosis | R-HSA-109581 | 2.169779e-04 | 3.664 | 0 | 0 |
| Formation of Senescence-Associated Heterochromatin Foci (SAHF) | R-HSA-2559584 | 2.208188e-04 | 3.656 | 0 | 0 |
| Carboxyterminal post-translational modifications of tubulin | R-HSA-8955332 | 2.473680e-04 | 3.607 | 0 | 0 |
| Influenza Infection | R-HSA-168255 | 2.767050e-04 | 3.558 | 0 | 0 |
| Signaling by ROBO receptors | R-HSA-376176 | 2.877834e-04 | 3.541 | 0 | 0 |
| Signaling by high-kinase activity BRAF mutants | R-HSA-6802948 | 2.975243e-04 | 3.526 | 0 | 0 |
| Vpr-mediated nuclear import of PICs | R-HSA-180910 | 2.975243e-04 | 3.526 | 0 | 0 |
| Estrogen-dependent gene expression | R-HSA-9018519 | 2.999780e-04 | 3.523 | 0 | 0 |
| Developmental Biology | R-HSA-1266738 | 3.046434e-04 | 3.516 | 0 | 0 |
| Packaging Of Telomere Ends | R-HSA-171306 | 3.156653e-04 | 3.501 | 0 | 0 |
| RNA Polymerase I Promoter Opening | R-HSA-73728 | 3.156653e-04 | 3.501 | 0 | 0 |
| Formation of the polybromo-BAF (pBAF) complex | R-HSA-9933939 | 3.220959e-04 | 3.492 | 0 | 0 |
| Interleukin-12 family signaling | R-HSA-447115 | 3.279333e-04 | 3.484 | 0 | 0 |
| Transcriptional Regulation by TP53 | R-HSA-3700989 | 3.619021e-04 | 3.441 | 0 | 0 |
| Organelle biogenesis and maintenance | R-HSA-1852241 | 3.692484e-04 | 3.433 | 0 | 0 |
| Hedgehog 'off' state | R-HSA-5610787 | 3.707544e-04 | 3.431 | 0 | 0 |
| SARS-CoV-1-host interactions | R-HSA-9692914 | 3.636257e-04 | 3.439 | 0 | 0 |
| ChREBP activates metabolic gene expression | R-HSA-163765 | 3.778338e-04 | 3.423 | 0 | 0 |
| SARS-CoV-1 Infection | R-HSA-9678108 | 3.892008e-04 | 3.410 | 0 | 0 |
| NS1 Mediated Effects on Host Pathways | R-HSA-168276 | 4.493710e-04 | 3.347 | 0 | 0 |
| Formation of the embryonic stem cell BAF (esBAF) complex | R-HSA-9933946 | 4.583932e-04 | 3.339 | 0 | 0 |
| Activation of NMDA receptors and postsynaptic events | R-HSA-442755 | 4.715936e-04 | 3.326 | 0 | 0 |
| Regulation of CDH1 Function | R-HSA-9764561 | 4.743341e-04 | 3.324 | 0 | 0 |
| Influenza Viral RNA Transcription and Replication | R-HSA-168273 | 4.804235e-04 | 3.318 | 0 | 0 |
| RUNX1 regulates transcription of genes involved in differentiation of HSCs | R-HSA-8939236 | 4.843242e-04 | 3.315 | 0 | 0 |
| Drug resistance in ERBB2 KD mutants | R-HSA-9665230 | 5.677720e-04 | 3.246 | 0 | 0 |
| Drug-mediated inhibition of ERBB2 signaling | R-HSA-9652282 | 5.677720e-04 | 3.246 | 0 | 0 |
| Resistance of ERBB2 KD mutants to neratinib | R-HSA-9665246 | 5.677720e-04 | 3.246 | 0 | 0 |
| Resistance of ERBB2 KD mutants to AEE788 | R-HSA-9665250 | 5.677720e-04 | 3.246 | 0 | 0 |
| Resistance of ERBB2 KD mutants to trastuzumab | R-HSA-9665233 | 5.677720e-04 | 3.246 | 0 | 0 |
| Resistance of ERBB2 KD mutants to afatinib | R-HSA-9665249 | 5.677720e-04 | 3.246 | 0 | 0 |
| Resistance of ERBB2 KD mutants to lapatinib | R-HSA-9665251 | 5.677720e-04 | 3.246 | 0 | 0 |
| Drug resistance in ERBB2 TMD/JMD mutants | R-HSA-9665737 | 5.677720e-04 | 3.246 | 0 | 0 |
| Resistance of ERBB2 KD mutants to tesevatinib | R-HSA-9665245 | 5.677720e-04 | 3.246 | 0 | 0 |
| Resistance of ERBB2 KD mutants to sapitinib | R-HSA-9665244 | 5.677720e-04 | 3.246 | 0 | 0 |
| Resistance of ERBB2 KD mutants to osimertinib | R-HSA-9665247 | 5.677720e-04 | 3.246 | 0 | 0 |
| DNA methylation | R-HSA-5334118 | 5.119946e-04 | 3.291 | 0 | 0 |
| Inhibition of DNA recombination at telomere | R-HSA-9670095 | 5.471657e-04 | 3.262 | 0 | 0 |
| Meiosis | R-HSA-1500620 | 5.524833e-04 | 3.258 | 0 | 0 |
| Nuclear import of Rev protein | R-HSA-180746 | 5.422956e-04 | 3.266 | 0 | 0 |
| RNA Polymerase I Transcription | R-HSA-73864 | 5.471910e-04 | 3.262 | 0 | 0 |
| DNA Replication Pre-Initiation | R-HSA-69002 | 5.144344e-04 | 3.289 | 0 | 0 |
| Transcriptional regulation by RUNX1 | R-HSA-8878171 | 5.444431e-04 | 3.264 | 0 | 0 |
| Recognition and association of DNA glycosylase with site containing an affected pyrimidine | R-HSA-110328 | 5.422956e-04 | 3.266 | 0 | 0 |
| Signaling by BRAF and RAF1 fusions | R-HSA-6802952 | 5.922395e-04 | 3.228 | 0 | 0 |
| Late Phase of HIV Life Cycle | R-HSA-162599 | 6.023836e-04 | 3.220 | 0 | 0 |
| Apoptotic cleavage of cell adhesion proteins | R-HSA-351906 | 6.264543e-04 | 3.203 | 0 | 0 |
| Amplification of signal from unattached kinetochores via a MAD2 inhibitory signal | R-HSA-141444 | 6.287985e-04 | 3.201 | 0 | 0 |
| Amplification of signal from the kinetochores | R-HSA-141424 | 6.287985e-04 | 3.201 | 0 | 0 |
| Nephrin family interactions | R-HSA-373753 | 6.315713e-04 | 3.200 | 0 | 0 |
| Formation of the ternary complex, and subsequently, the 43S complex | R-HSA-72695 | 6.380644e-04 | 3.195 | 0 | 0 |
| Defective TPR may confer susceptibility towards thyroid papillary carcinoma (TPC) | R-HSA-5619107 | 6.432217e-04 | 3.192 | 0 | 0 |
| Activated PKN1 stimulates transcription of AR (androgen receptor) regulated genes KLK2 and KLK3 | R-HSA-5625886 | 6.623696e-04 | 3.179 | 0 | 0 |
| Nuclear Pore Complex (NPC) Disassembly | R-HSA-3301854 | 6.670003e-04 | 3.176 | 0 | 0 |
| Eukaryotic Translation Elongation | R-HSA-156842 | 7.045094e-04 | 3.152 | 0 | 0 |
| IP3 and IP4 transport between cytosol and nucleus | R-HSA-1855196 | 8.013064e-04 | 3.096 | 0 | 0 |
| IP6 and IP7 transport between cytosol and nucleus | R-HSA-1855229 | 8.013064e-04 | 3.096 | 0 | 0 |
| Signaling by RAF1 mutants | R-HSA-9656223 | 7.973619e-04 | 3.098 | 0 | 0 |
| Nonsense-Mediated Decay (NMD) | R-HSA-927802 | 7.172857e-04 | 3.144 | 0 | 0 |
| Nonsense Mediated Decay (NMD) enhanced by the Exon Junction Complex (EJC) | R-HSA-975957 | 7.172857e-04 | 3.144 | 0 | 0 |
| MAP2K and MAPK activation | R-HSA-5674135 | 7.973619e-04 | 3.098 | 0 | 0 |
| Homology Directed Repair | R-HSA-5693538 | 7.607396e-04 | 3.119 | 0 | 0 |
| Processing of DNA double-strand break ends | R-HSA-5693607 | 8.151790e-04 | 3.089 | 0 | 0 |
| Glycolysis | R-HSA-70171 | 8.669787e-04 | 3.062 | 0 | 0 |
| RNA Polymerase II Transcription Termination | R-HSA-73856 | 8.827462e-04 | 3.054 | 0 | 0 |
| HDR through Homologous Recombination (HRR) or Single Strand Annealing (SSA) | R-HSA-5693567 | 8.883414e-04 | 3.051 | 0 | 0 |
| Intraflagellar transport | R-HSA-5620924 | 8.994005e-04 | 3.046 | 0 | 0 |
| Gene expression (Transcription) | R-HSA-74160 | 9.254966e-04 | 3.034 | 0 | 0 |
| Recognition and association of DNA glycosylase with site containing an affected purine | R-HSA-110330 | 9.903216e-04 | 3.004 | 0 | 0 |
| RNA Polymerase I Promoter Clearance | R-HSA-73854 | 1.057333e-03 | 2.976 | 0 | 0 |
| Defective pyroptosis | R-HSA-9710421 | 1.137307e-03 | 2.944 | 0 | 0 |
| IPs transport between nucleus and cytosol | R-HSA-1855170 | 1.214718e-03 | 2.916 | 0 | 0 |
| Regulation of TP53 Activity through Acetylation | R-HSA-6804758 | 1.214718e-03 | 2.916 | 0 | 0 |
| Assembly of the ORC complex at the origin of replication | R-HSA-68616 | 1.214718e-03 | 2.916 | 0 | 0 |
| MITF-M-regulated melanocyte development | R-HSA-9730414 | 1.289789e-03 | 2.889 | 0 | 0 |
| mTORC1-mediated signalling | R-HSA-166208 | 1.376707e-03 | 2.861 | 0 | 0 |
| Meiotic recombination | R-HSA-912446 | 1.456712e-03 | 2.837 | 0 | 0 |
| Regulation of Glucokinase by Glucokinase Regulatory Protein | R-HSA-170822 | 1.479327e-03 | 2.830 | 0 | 0 |
| Regulation of TP53 Activity | R-HSA-5633007 | 1.490151e-03 | 2.827 | 0 | 0 |
| Chaperone Mediated Autophagy | R-HSA-9613829 | 1.538501e-03 | 2.813 | 0 | 0 |
| Interactions of Rev with host cellular proteins | R-HSA-177243 | 1.707049e-03 | 2.768 | 0 | 0 |
| SARS-CoV-1 modulates host translation machinery | R-HSA-9735869 | 1.789361e-03 | 2.747 | 0 | 0 |
| Signaling by RAS mutants | R-HSA-6802949 | 1.867729e-03 | 2.729 | 0 | 0 |
| Signaling downstream of RAS mutants | R-HSA-9649948 | 1.867729e-03 | 2.729 | 0 | 0 |
| Paradoxical activation of RAF signaling by kinase inactive BRAF | R-HSA-6802955 | 1.867729e-03 | 2.729 | 0 | 0 |
| Signaling by moderate kinase activity BRAF mutants | R-HSA-6802946 | 1.867729e-03 | 2.729 | 0 | 0 |
| Major pathway of rRNA processing in the nucleolus and cytosol | R-HSA-6791226 | 1.891122e-03 | 2.723 | 0 | 0 |
| rRNA processing in the nucleus and cytosol | R-HSA-8868773 | 2.145909e-03 | 2.668 | 0 | 0 |
| Mitotic Spindle Checkpoint | R-HSA-69618 | 1.944256e-03 | 2.711 | 0 | 0 |
| PKMTs methylate histone lysines | R-HSA-3214841 | 2.025066e-03 | 2.694 | 0 | 0 |
| Vesicle-mediated transport | R-HSA-5653656 | 2.186387e-03 | 2.660 | 0 | 0 |
| Protein ubiquitination | R-HSA-8852135 | 2.274746e-03 | 2.643 | 0 | 0 |
| Formation of a pool of free 40S subunits | R-HSA-72689 | 2.527734e-03 | 2.597 | 0 | 0 |
| Formation of neuronal progenitor and neuronal BAF (npBAF and nBAF) | R-HSA-9934037 | 2.559215e-03 | 2.592 | 0 | 0 |
| Cleavage of the damaged pyrimidine | R-HSA-110329 | 2.806840e-03 | 2.552 | 0 | 0 |
| Depyrimidination | R-HSA-73928 | 2.806840e-03 | 2.552 | 0 | 0 |
| Semaphorin interactions | R-HSA-373755 | 3.011588e-03 | 2.521 | 0 | 0 |
| SIRT1 negatively regulates rRNA expression | R-HSA-427359 | 3.049744e-03 | 2.516 | 0 | 0 |
| Cleavage of the damaged purine | R-HSA-110331 | 3.049744e-03 | 2.516 | 0 | 0 |
| Glucose metabolism | R-HSA-70326 | 3.069668e-03 | 2.513 | 0 | 0 |
| Oncogenic MAPK signaling | R-HSA-6802957 | 3.107600e-03 | 2.508 | 0 | 0 |
| Signaling by Hedgehog | R-HSA-5358351 | 3.138824e-03 | 2.503 | 1 | 0 |
| Transport to the Golgi and subsequent modification | R-HSA-948021 | 3.211653e-03 | 2.493 | 0 | 0 |
| Interferon Signaling | R-HSA-913531 | 3.244251e-03 | 2.489 | 0 | 0 |
| Nonsense Mediated Decay (NMD) independent of the Exon Junction Complex (EJC) | R-HSA-975956 | 3.288984e-03 | 2.483 | 0 | 0 |
| NoRC negatively regulates rRNA expression | R-HSA-427413 | 3.346610e-03 | 2.475 | 0 | 0 |
| Depurination | R-HSA-73927 | 3.601009e-03 | 2.444 | 0 | 0 |
| Rev-mediated nuclear export of HIV RNA | R-HSA-165054 | 3.601009e-03 | 2.444 | 0 | 0 |
| ESR-mediated signaling | R-HSA-8939211 | 3.674008e-03 | 2.435 | 0 | 0 |
| Defective Intrinsic Pathway for Apoptosis | R-HSA-9734009 | 4.051561e-03 | 2.392 | 0 | 0 |
| SRP-dependent cotranslational protein targeting to membrane | R-HSA-1799339 | 4.273920e-03 | 2.369 | 0 | 0 |
| Signaling by ALK fusions and activated point mutants | R-HSA-9725370 | 4.273920e-03 | 2.369 | 0 | 0 |
| Signaling by ALK in cancer | R-HSA-9700206 | 4.273920e-03 | 2.369 | 0 | 0 |
| snRNP Assembly | R-HSA-191859 | 4.465633e-03 | 2.350 | 0 | 0 |
| Metabolism of non-coding RNA | R-HSA-194441 | 4.465633e-03 | 2.350 | 0 | 0 |
| RNA Polymerase I Promoter Escape | R-HSA-73772 | 4.490970e-03 | 2.348 | 0 | 0 |
| E3 ubiquitin ligases ubiquitinate target proteins | R-HSA-8866654 | 4.490970e-03 | 2.348 | 0 | 0 |
| Striated Muscle Contraction | R-HSA-390522 | 4.606981e-03 | 2.337 | 0 | 0 |
| Formation of the non-canonical BAF (ncBAF) complex | R-HSA-9933947 | 5.391374e-03 | 2.268 | 0 | 0 |
| Peptide chain elongation | R-HSA-156902 | 4.748530e-03 | 2.323 | 0 | 0 |
| MITF-M-dependent gene expression | R-HSA-9856651 | 4.625999e-03 | 2.335 | 0 | 0 |
| VEGFA-VEGFR2 Pathway | R-HSA-4420097 | 5.169805e-03 | 2.287 | 0 | 0 |
| RUNX1 regulates genes involved in megakaryocyte differentiation and platelet function | R-HSA-8936459 | 5.529206e-03 | 2.257 | 0 | 0 |
| TCF dependent signaling in response to WNT | R-HSA-201681 | 4.895693e-03 | 2.310 | 0 | 0 |
| Maternal to zygotic transition (MZT) | R-HSA-9816359 | 5.180693e-03 | 2.286 | 0 | 0 |
| Unwinding of DNA | R-HSA-176974 | 5.487559e-03 | 2.261 | 0 | 0 |
| ISG15 antiviral mechanism | R-HSA-1169408 | 5.293429e-03 | 2.276 | 0 | 0 |
| Cytokine Signaling in Immune system | R-HSA-1280215 | 4.922719e-03 | 2.308 | 0 | 0 |
| Regulation of expression of SLITs and ROBOs | R-HSA-9010553 | 5.373202e-03 | 2.270 | 0 | 0 |
| Host Interactions of HIV factors | R-HSA-162909 | 5.628730e-03 | 2.250 | 0 | 0 |
| Chromatin modifications during the maternal to zygotic transition (MZT) | R-HSA-9821002 | 5.745830e-03 | 2.241 | 0 | 0 |
| Transport of Ribonucleoproteins into the Host Nucleus | R-HSA-168271 | 5.745830e-03 | 2.241 | 0 | 0 |
| Late endosomal microautophagy | R-HSA-9615710 | 5.868661e-03 | 2.231 | 0 | 0 |
| Developmental Lineage of Mammary Gland Myoepithelial Cells | R-HSA-9927432 | 5.868661e-03 | 2.231 | 0 | 0 |
| Synaptic adhesion-like molecules | R-HSA-8849932 | 6.047205e-03 | 2.218 | 0 | 0 |
| Pre-NOTCH Transcription and Translation | R-HSA-1912408 | 6.398399e-03 | 2.194 | 0 | 0 |
| tRNA processing in the nucleus | R-HSA-6784531 | 6.443904e-03 | 2.191 | 0 | 0 |
| SARS-CoV Infections | R-HSA-9679506 | 6.477348e-03 | 2.189 | 0 | 0 |
| Regulation of cytoskeletal remodeling and cell spreading by IPP complex components | R-HSA-446388 | 6.811479e-03 | 2.167 | 0 | 0 |
| RUNX1 regulates expression of components of tight junctions | R-HSA-8935964 | 6.811479e-03 | 2.167 | 0 | 0 |
| Regulation of CDH19 Expression and Function | R-HSA-9764302 | 6.811479e-03 | 2.167 | 0 | 0 |
| Formation of the canonical BAF (cBAF) complex | R-HSA-9933937 | 7.040841e-03 | 2.152 | 0 | 0 |
| G alpha (12/13) signalling events | R-HSA-416482 | 7.288443e-03 | 2.137 | 0 | 0 |
| Neurodegenerative Diseases | R-HSA-8863678 | 7.424903e-03 | 2.129 | 0 | 0 |
| Deregulated CDK5 triggers multiple neurodegenerative pathways in Alzheimer's disease models | R-HSA-8862803 | 7.424903e-03 | 2.129 | 0 | 0 |
| Folding of actin by CCT/TriC | R-HSA-390450 | 7.603132e-03 | 2.119 | 0 | 0 |
| HCMV Late Events | R-HSA-9610379 | 7.691145e-03 | 2.114 | 0 | 0 |
| Transcriptional and post-translational regulation of MITF-M expression and activity | R-HSA-9856649 | 7.717534e-03 | 2.113 | 0 | 0 |
| Formation of the dystrophin-glycoprotein complex (DGC) | R-HSA-9913351 | 8.257520e-03 | 2.083 | 0 | 0 |
| Chromosome Maintenance | R-HSA-73886 | 8.487091e-03 | 2.071 | 0 | 0 |
| Developmental Lineages of the Mammary Gland | R-HSA-9924644 | 8.583739e-03 | 2.066 | 0 | 0 |
| Regulation of mRNA stability by proteins that bind AU-rich elements | R-HSA-450531 | 8.583739e-03 | 2.066 | 0 | 0 |
| Negative epigenetic regulation of rRNA expression | R-HSA-5250941 | 8.925092e-03 | 2.049 | 0 | 0 |
| SARS-CoV-1 targets host intracellular signalling and regulatory pathways | R-HSA-9735871 | 9.027458e-03 | 2.044 | 0 | 0 |
| Ribosome-associated quality control | R-HSA-9948299 | 1.101168e-02 | 1.958 | 0 | 0 |
| Epigenetic regulation by WDR5-containing histone modifying complexes | R-HSA-9917777 | 1.113159e-02 | 1.953 | 0 | 0 |
| RUNX1 interacts with co-factors whose precise effect on RUNX1 targets is not known | R-HSA-8939243 | 1.132154e-02 | 1.946 | 0 | 0 |
| Regulation of MITF-M-dependent genes involved in pigmentation | R-HSA-9824585 | 1.142348e-02 | 1.942 | 0 | 0 |
| NEP/NS2 Interacts with the Cellular Export Machinery | R-HSA-168333 | 1.142348e-02 | 1.942 | 0 | 0 |
| Signaling by VEGF | R-HSA-194138 | 1.241953e-02 | 1.906 | 0 | 0 |
| Smooth Muscle Contraction | R-HSA-445355 | 1.248655e-02 | 1.904 | 0 | 0 |
| Regulation of PD-L1(CD274) expression | R-HSA-9909648 | 1.258732e-02 | 1.900 | 0 | 0 |
| Export of Viral Ribonucleoproteins from Nucleus | R-HSA-168274 | 1.294848e-02 | 1.888 | 0 | 0 |
| PELO:HBS1L and ABCE1 dissociate a ribosome on a non-stop mRNA | R-HSA-9954714 | 1.316288e-02 | 1.881 | 0 | 0 |
| MAPK1/MAPK3 signaling | R-HSA-5684996 | 1.324069e-02 | 1.878 | 0 | 0 |
| Mitotic Telophase/Cytokinesis | R-HSA-68884 | 1.341524e-02 | 1.872 | 0 | 0 |
| Integration of provirus | R-HSA-162592 | 1.341524e-02 | 1.872 | 0 | 0 |
| NFE2L2 regulates pentose phosphate pathway genes | R-HSA-9818028 | 1.341524e-02 | 1.872 | 0 | 0 |
| Initiation of Nuclear Envelope (NE) Reformation | R-HSA-2995383 | 1.364512e-02 | 1.865 | 0 | 0 |
| Base-Excision Repair, AP Site Formation | R-HSA-73929 | 1.399914e-02 | 1.854 | 0 | 0 |
| SHOC2 M1731 mutant abolishes MRAS complex function | R-HSA-9726840 | 1.442118e-02 | 1.841 | 0 | 0 |
| RAF/MAP kinase cascade | R-HSA-5673001 | 1.459572e-02 | 1.836 | 0 | 0 |
| Transcriptional regulation of granulopoiesis | R-HSA-9616222 | 1.474294e-02 | 1.831 | 0 | 0 |
| Diseases of Telomere Maintenance | R-HSA-9673013 | 1.497120e-02 | 1.825 | 0 | 0 |
| Defective Inhibition of DNA Recombination at Telomere | R-HSA-9670621 | 1.497120e-02 | 1.825 | 0 | 0 |
| Alternative Lengthening of Telomeres (ALT) | R-HSA-9006821 | 1.497120e-02 | 1.825 | 0 | 0 |
| Defective Inhibition of DNA Recombination at Telomere Due to ATRX Mutations | R-HSA-9670615 | 1.497120e-02 | 1.825 | 0 | 0 |
| Defective Inhibition of DNA Recombination at Telomere Due to DAXX Mutations | R-HSA-9670613 | 1.497120e-02 | 1.825 | 0 | 0 |
| Constitutive Signaling by Overexpressed ERBB2 | R-HSA-9634285 | 1.721109e-02 | 1.764 | 0 | 0 |
| Z-decay: degradation of maternal mRNAs by zygotically expressed factors | R-HSA-9820865 | 1.721109e-02 | 1.764 | 0 | 0 |
| Formation of WDR5-containing histone-modifying complexes | R-HSA-9772755 | 1.741229e-02 | 1.759 | 0 | 0 |
| EPH-Ephrin signaling | R-HSA-2682334 | 1.562514e-02 | 1.806 | 0 | 0 |
| Nuclear events mediated by NFE2L2 | R-HSA-9759194 | 1.581970e-02 | 1.801 | 0 | 0 |
| KEAP1-NFE2L2 pathway | R-HSA-9755511 | 1.596224e-02 | 1.797 | 0 | 0 |
| RNA Polymerase II Transcription | R-HSA-73857 | 1.646904e-02 | 1.783 | 0 | 0 |
| Signaling by Hippo | R-HSA-2028269 | 1.734515e-02 | 1.761 | 0 | 0 |
| DNA Replication | R-HSA-69306 | 1.810470e-02 | 1.742 | 0 | 0 |
| Reproduction | R-HSA-1474165 | 1.892613e-02 | 1.723 | 0 | 0 |
| Regulation of HSF1-mediated heat shock response | R-HSA-3371453 | 1.963568e-02 | 1.707 | 0 | 0 |
| Oxidative Stress Induced Senescence | R-HSA-2559580 | 1.963568e-02 | 1.707 | 0 | 0 |
| Type I hemidesmosome assembly | R-HSA-446107 | 1.966973e-02 | 1.706 | 0 | 0 |
| Signaling by MRAS-complex mutants | R-HSA-9660537 | 1.966973e-02 | 1.706 | 0 | 0 |
| Gain-of-function MRAS complexes activate RAF signaling | R-HSA-9726842 | 1.966973e-02 | 1.706 | 0 | 0 |
| Adrenoceptors | R-HSA-390696 | 1.966973e-02 | 1.706 | 0 | 0 |
| Amyloid fiber formation | R-HSA-977225 | 2.030732e-02 | 1.692 | 0 | 0 |
| Signaling by ERBB2 ECD mutants | R-HSA-9665348 | 2.100667e-02 | 1.678 | 0 | 0 |
| Depolymerization of the Nuclear Lamina | R-HSA-4419969 | 2.100667e-02 | 1.678 | 0 | 0 |
| Eukaryotic Translation Termination | R-HSA-72764 | 2.160965e-02 | 1.665 | 0 | 0 |
| RNA Polymerase II Pre-transcription Events | R-HSA-674695 | 2.215333e-02 | 1.655 | 0 | 0 |
| Deactivation of the beta-catenin transactivating complex | R-HSA-3769402 | 2.261804e-02 | 1.646 | 0 | 0 |
| Response of endothelial cells to shear stress | R-HSA-9860931 | 2.282752e-02 | 1.642 | 0 | 0 |
| Response of EIF2AK4 (GCN2) to amino acid deficiency | R-HSA-9633012 | 2.282752e-02 | 1.642 | 0 | 0 |
| Co-inhibition by PD-1 | R-HSA-389948 | 2.284557e-02 | 1.641 | 0 | 0 |
| EPHB-mediated forward signaling | R-HSA-3928662 | 2.440165e-02 | 1.613 | 0 | 0 |
| Transcriptional regulation by the AP-2 (TFAP2) family of transcription factors | R-HSA-8864260 | 2.440165e-02 | 1.613 | 0 | 0 |
| MAPK family signaling cascades | R-HSA-5683057 | 2.441891e-02 | 1.612 | 0 | 0 |
| SARS-CoV-2-host interactions | R-HSA-9705683 | 2.528026e-02 | 1.597 | 0 | 0 |
| Orc1 removal from chromatin | R-HSA-68949 | 2.553334e-02 | 1.593 | 0 | 0 |
| Signaling by Interleukins | R-HSA-449147 | 2.595402e-02 | 1.586 | 0 | 0 |
| GP1b-IX-V activation signalling | R-HSA-430116 | 2.595932e-02 | 1.586 | 0 | 0 |
| Regulation of PTEN gene transcription | R-HSA-8943724 | 2.616694e-02 | 1.582 | 0 | 0 |
| SARS-CoV-2 Infection | R-HSA-9694516 | 2.641466e-02 | 1.578 | 0 | 0 |
| Sensory processing of sound by inner hair cells of the cochlea | R-HSA-9662360 | 2.642155e-02 | 1.578 | 0 | 0 |
| Cellular responses to mechanical stimuli | R-HSA-9855142 | 2.742565e-02 | 1.562 | 0 | 0 |
| Nectin/Necl trans heterodimerization | R-HSA-420597 | 2.763010e-02 | 1.559 | 0 | 0 |
| LRR FLII-interacting protein 1 (LRRFIP1) activates type I IFN production | R-HSA-3134973 | 2.763010e-02 | 1.559 | 0 | 0 |
| IRS activation | R-HSA-74713 | 2.763010e-02 | 1.559 | 0 | 0 |
| Loss of Function of TGFBR1 in Cancer | R-HSA-3656534 | 2.763010e-02 | 1.559 | 0 | 0 |
| NrCAM interactions | R-HSA-447038 | 2.763010e-02 | 1.559 | 0 | 0 |
| Viral Messenger RNA Synthesis | R-HSA-168325 | 2.877426e-02 | 1.541 | 0 | 0 |
| Regulation of TP53 Expression and Degradation | R-HSA-6806003 | 2.885162e-02 | 1.540 | 0 | 0 |
| Sema4D induced cell migration and growth-cone collapse | R-HSA-416572 | 2.982330e-02 | 1.525 | 0 | 0 |
| Regulation of Expression and Function of Type II Classical Cadherins | R-HSA-9764260 | 3.006049e-02 | 1.522 | 0 | 0 |
| rRNA processing | R-HSA-72312 | 3.054018e-02 | 1.515 | 0 | 0 |
| Postmitotic nuclear pore complex (NPC) reformation | R-HSA-9615933 | 3.057461e-02 | 1.515 | 0 | 0 |
| Manipulation of host energy metabolism | R-HSA-9636667 | 3.172200e-02 | 1.499 | 0 | 0 |
| Loss of Function of SMAD4 in Cancer | R-HSA-3304347 | 3.172200e-02 | 1.499 | 0 | 0 |
| SMAD4 MH2 Domain Mutants in Cancer | R-HSA-3311021 | 3.172200e-02 | 1.499 | 0 | 0 |
| SMAD2/3 MH2 Domain Mutants in Cancer | R-HSA-3315487 | 3.172200e-02 | 1.499 | 0 | 0 |
| Breakdown of the nuclear lamina | R-HSA-352238 | 3.172200e-02 | 1.499 | 0 | 0 |
| Translation | R-HSA-72766 | 3.196862e-02 | 1.495 | 0 | 0 |
| Developmental Cell Lineages of the Integumentary System | R-HSA-9734779 | 3.252629e-02 | 1.488 | 0 | 0 |
| Cellular Senescence | R-HSA-2559583 | 3.263420e-02 | 1.486 | 0 | 0 |
| Erythropoietin activates RAS | R-HSA-9027284 | 3.263797e-02 | 1.486 | 0 | 0 |
| RIP-mediated NFkB activation via ZBP1 | R-HSA-1810476 | 3.263797e-02 | 1.486 | 0 | 0 |
| DCC mediated attractive signaling | R-HSA-418885 | 3.263797e-02 | 1.486 | 0 | 0 |
| 2-LTR circle formation | R-HSA-164843 | 3.332712e-02 | 1.477 | 0 | 0 |
| Regulation of CDH11 function | R-HSA-9762292 | 3.332712e-02 | 1.477 | 0 | 0 |
| Early Phase of HIV Life Cycle | R-HSA-162594 | 3.502156e-02 | 1.456 | 0 | 0 |
| Basigin interactions | R-HSA-210991 | 3.502156e-02 | 1.456 | 0 | 0 |
| Interaction between L1 and Ankyrins | R-HSA-445095 | 3.514653e-02 | 1.454 | 0 | 0 |
| VEGFR2 mediated vascular permeability | R-HSA-5218920 | 3.619891e-02 | 1.441 | 0 | 0 |
| High laminar flow shear stress activates signaling by PIEZO1 and PECAM1:CDH5:KDR in endothelial cells | R-HSA-9856530 | 3.660751e-02 | 1.436 | 0 | 0 |
| ZNF598 and the Ribosome-associated Quality Trigger (RQT) complex dissociate a ribosome stalled on a no-go mRNA | R-HSA-9954716 | 3.732034e-02 | 1.428 | 0 | 0 |
| Sensory processing of sound by outer hair cells of the cochlea | R-HSA-9662361 | 3.778109e-02 | 1.423 | 0 | 0 |
| CDH11 homotypic and heterotypic interactions | R-HSA-9833576 | 3.859583e-02 | 1.413 | 0 | 0 |
| Prolonged ERK activation events | R-HSA-169893 | 3.922304e-02 | 1.406 | 0 | 0 |
| Response to elevated platelet cytosolic Ca2+ | R-HSA-76005 | 3.922917e-02 | 1.406 | 0 | 0 |
| DNA Repair | R-HSA-73894 | 3.978738e-02 | 1.400 | 0 | 0 |
| Cellular response to starvation | R-HSA-9711097 | 4.000850e-02 | 1.398 | 0 | 0 |
| Ras activation upon Ca2+ influx through NMDA receptor | R-HSA-442982 | 4.076966e-02 | 1.390 | 0 | 0 |
| Regulation of TP53 Expression | R-HSA-6804754 | 5.313358e-02 | 1.275 | 0 | 0 |
| Activation, myristolyation of BID and translocation to mitochondria | R-HSA-75108 | 5.313358e-02 | 1.275 | 0 | 0 |
| Tandem of pore domain in a weak inwardly rectifying K+ channels (TWIK) | R-HSA-1299308 | 5.313358e-02 | 1.275 | 0 | 0 |
| TFAP2A acts as a transcriptional repressor during retinoic acid induced cell differentiation | R-HSA-8869496 | 5.144375e-02 | 1.289 | 0 | 0 |
| Signaling by GSK3beta mutants | R-HSA-5339716 | 5.136350e-02 | 1.289 | 0 | 0 |
| Signaling by EGFRvIII in Cancer | R-HSA-5637812 | 5.465955e-02 | 1.262 | 0 | 0 |
| Constitutive Signaling by EGFRvIII | R-HSA-5637810 | 5.465955e-02 | 1.262 | 0 | 0 |
| Activation of the pre-replicative complex | R-HSA-68962 | 5.149156e-02 | 1.288 | 0 | 0 |
| Formation of RNA Pol II elongation complex | R-HSA-112382 | 5.438753e-02 | 1.265 | 0 | 0 |
| Regulation of TP53 Degradation | R-HSA-6804757 | 4.824970e-02 | 1.317 | 0 | 0 |
| TP53 regulates transcription of additional cell cycle genes whose exact role in the p53 pathway remain uncertain | R-HSA-6804115 | 4.708065e-02 | 1.327 | 0 | 0 |
| AUF1 (hnRNP D0) binds and destabilizes mRNA | R-HSA-450408 | 4.824970e-02 | 1.317 | 0 | 0 |
| Activation of HOX genes during differentiation | R-HSA-5619507 | 4.406361e-02 | 1.356 | 0 | 0 |
| Activation of anterior HOX genes in hindbrain development during early embryogenesis | R-HSA-5617472 | 4.406361e-02 | 1.356 | 0 | 0 |
| Signaling by TGF-beta Receptor Complex in Cancer | R-HSA-3304351 | 5.144375e-02 | 1.289 | 0 | 0 |
| Pre-NOTCH Expression and Processing | R-HSA-1912422 | 4.498280e-02 | 1.347 | 0 | 0 |
| Turbulent (oscillatory, disturbed) flow shear stress activates signaling by PIEZO1 and integrins in endothelial cells | R-HSA-9860927 | 4.316024e-02 | 1.365 | 0 | 0 |
| Regulation of CDH11 Expression and Function | R-HSA-9759475 | 4.559466e-02 | 1.341 | 0 | 0 |
| MTOR signalling | R-HSA-165159 | 4.473428e-02 | 1.349 | 0 | 0 |
| Signaling by NOTCH | R-HSA-157118 | 4.354342e-02 | 1.361 | 0 | 0 |
| Vpr-mediated induction of apoptosis by mitochondrial outer membrane permeabilization | R-HSA-180897 | 5.313358e-02 | 1.275 | 0 | 0 |
| Platelet degranulation | R-HSA-114608 | 4.358351e-02 | 1.361 | 0 | 0 |
| Neurotransmitter receptors and postsynaptic signal transmission | R-HSA-112314 | 4.304070e-02 | 1.366 | 0 | 0 |
| Non-integrin membrane-ECM interactions | R-HSA-3000171 | 4.730254e-02 | 1.325 | 0 | 0 |
| TFAP2 (AP-2) family regulates transcription of growth factors and their receptors | R-HSA-8866910 | 4.656073e-02 | 1.332 | 0 | 0 |
| Mitotic G1 phase and G1/S transition | R-HSA-453279 | 5.469897e-02 | 1.262 | 0 | 0 |
| Regulation of T cell activation by CD28 family | R-HSA-388841 | 5.702142e-02 | 1.244 | 0 | 0 |
| Selenocysteine synthesis | R-HSA-2408557 | 5.932294e-02 | 1.227 | 0 | 0 |
| RNA Polymerase II Transcription Elongation | R-HSA-75955 | 5.933745e-02 | 1.227 | 0 | 0 |
| Signaling by Nuclear Receptors | R-HSA-9006931 | 6.098498e-02 | 1.215 | 0 | 0 |
| Signaling by ERBB2 TMD/JMD mutants | R-HSA-9665686 | 6.142536e-02 | 1.212 | 0 | 0 |
| Deadenylation of mRNA | R-HSA-429947 | 6.142536e-02 | 1.212 | 0 | 0 |
| TRAF6 mediated NF-kB activation | R-HSA-933542 | 6.142536e-02 | 1.212 | 0 | 0 |
| Signaling by CTNNB1 phospho-site mutants | R-HSA-4839743 | 6.202719e-02 | 1.207 | 0 | 0 |
| CTNNB1 S37 mutants aren't phosphorylated | R-HSA-5358749 | 6.202719e-02 | 1.207 | 0 | 0 |
| CTNNB1 T41 mutants aren't phosphorylated | R-HSA-5358752 | 6.202719e-02 | 1.207 | 0 | 0 |
| CTNNB1 S33 mutants aren't phosphorylated | R-HSA-5358747 | 6.202719e-02 | 1.207 | 0 | 0 |
| CTNNB1 S45 mutants aren't phosphorylated | R-HSA-5358751 | 6.202719e-02 | 1.207 | 0 | 0 |
| Sensory processing of sound | R-HSA-9659379 | 6.334475e-02 | 1.198 | 0 | 0 |
| Regulation of MITF-M-dependent genes involved in extracellular matrix, focal adhesion and epithelial-to-mesenchymal transition | R-HSA-9926550 | 6.352136e-02 | 1.197 | 0 | 0 |
| Platelet sensitization by LDL | R-HSA-432142 | 6.352136e-02 | 1.197 | 0 | 0 |
| ZBP1(DAI) mediated induction of type I IFNs | R-HSA-1606322 | 6.352136e-02 | 1.197 | 0 | 0 |
| Epigenetic regulation of adipogenesis genes by MLL3 and MLL4 complexes | R-HSA-9851695 | 6.417698e-02 | 1.193 | 0 | 0 |
| MLL4 and MLL3 complexes regulate expression of PPARG target genes in adipogenesis and hepatic steatosis | R-HSA-9841922 | 6.417698e-02 | 1.193 | 0 | 0 |
| Epigenetic regulation of gene expression by MLL3 and MLL4 complexes | R-HSA-9818564 | 6.417698e-02 | 1.193 | 0 | 0 |
| G1/S Transition | R-HSA-69206 | 6.417698e-02 | 1.193 | 0 | 0 |
| SARS-CoV-2 modulates host translation machinery | R-HSA-9754678 | 6.457163e-02 | 1.190 | 0 | 0 |
| Infectious disease | R-HSA-5663205 | 6.580919e-02 | 1.182 | 0 | 0 |
| Signaling by WNT | R-HSA-195721 | 6.598801e-02 | 1.181 | 0 | 0 |
| SOS-mediated signalling | R-HSA-112412 | 6.608376e-02 | 1.180 | 0 | 0 |
| Cohesin Loading onto Chromatin | R-HSA-2470946 | 6.608376e-02 | 1.180 | 0 | 0 |
| Uptake and function of diphtheria toxin | R-HSA-5336415 | 6.608376e-02 | 1.180 | 0 | 0 |
| Viral mRNA Translation | R-HSA-192823 | 6.696748e-02 | 1.174 | 0 | 0 |
| Signaling by PTK6 | R-HSA-8848021 | 6.808568e-02 | 1.167 | 0 | 0 |
| Signaling by Non-Receptor Tyrosine Kinases | R-HSA-9006927 | 6.808568e-02 | 1.167 | 0 | 0 |
| Sema4D in semaphorin signaling | R-HSA-400685 | 6.946703e-02 | 1.158 | 0 | 0 |
| Long-term potentiation | R-HSA-9620244 | 6.946703e-02 | 1.158 | 0 | 0 |
| Resolution of D-loop Structures through Holliday Junction Intermediates | R-HSA-5693568 | 7.195207e-02 | 1.143 | 0 | 0 |
| Maturation of nucleoprotein | R-HSA-9694631 | 7.314166e-02 | 1.136 | 0 | 0 |
| NFE2L2 regulating tumorigenic genes | R-HSA-9818030 | 7.376199e-02 | 1.132 | 0 | 0 |
| Frs2-mediated activation | R-HSA-170968 | 7.376199e-02 | 1.132 | 0 | 0 |
| Switching of origins to a post-replicative state | R-HSA-69052 | 7.581544e-02 | 1.120 | 0 | 0 |
| Platelet activation, signaling and aggregation | R-HSA-76002 | 7.792169e-02 | 1.108 | 0 | 0 |
| Gluconeogenesis | R-HSA-70263 | 7.799831e-02 | 1.108 | 0 | 0 |
| Myogenesis | R-HSA-525793 | 7.808760e-02 | 1.107 | 0 | 0 |
| Base Excision Repair | R-HSA-73884 | 7.863477e-02 | 1.104 | 0 | 0 |
| Telomere Maintenance | R-HSA-157579 | 7.931305e-02 | 1.101 | 0 | 0 |
| Association of TriC/CCT with target proteins during biosynthesis | R-HSA-390471 | 7.970428e-02 | 1.099 | 0 | 0 |
| Resolution of D-Loop Structures | R-HSA-5693537 | 7.970428e-02 | 1.099 | 0 | 0 |
| Signaling by NOTCH4 | R-HSA-9013694 | 8.117144e-02 | 1.091 | 0 | 0 |
| ROBO receptors bind AKAP5 | R-HSA-9010642 | 8.239850e-02 | 1.084 | 0 | 0 |
| Formyl peptide receptors bind formyl peptides and many other ligands | R-HSA-444473 | 8.239850e-02 | 1.084 | 0 | 0 |
| Formation of definitive endoderm | R-HSA-9823730 | 8.350994e-02 | 1.078 | 0 | 0 |
| Degradation of CDH1 | R-HSA-9766229 | 8.469957e-02 | 1.072 | 0 | 0 |
| TP53 Regulates Transcription of Death Receptors and Ligands | R-HSA-6803211 | 8.653378e-02 | 1.063 | 0 | 0 |
| CRMPs in Sema3A signaling | R-HSA-399956 | 8.653378e-02 | 1.063 | 0 | 0 |
| Signal regulatory protein family interactions | R-HSA-391160 | 8.653378e-02 | 1.063 | 0 | 0 |
| Mitochondrial unfolded protein response (UPRmt) | R-HSA-9841251 | 8.728223e-02 | 1.059 | 0 | 0 |
| Loss of Function of TP53 in Cancer | R-HSA-9723907 | 8.787049e-02 | 1.056 | 0 | 0 |
| APC truncation mutants are not K63 polyubiquitinated | R-HSA-5467333 | 8.787049e-02 | 1.056 | 0 | 0 |
| Loss of function of TP53 in cancer due to loss of tetramerization ability | R-HSA-9723905 | 8.787049e-02 | 1.056 | 0 | 0 |
| RAF activation | R-HSA-5673000 | 8.792133e-02 | 1.056 | 0 | 0 |
| Cooperation of PDCL (PhLP1) and TRiC/CCT in G-protein beta folding | R-HSA-6814122 | 8.792133e-02 | 1.056 | 0 | 0 |
| NPAS4 regulates expression of target genes | R-HSA-9768919 | 8.792133e-02 | 1.056 | 0 | 0 |
| Hemostasis | R-HSA-109582 | 8.803709e-02 | 1.055 | 0 | 0 |
| Cellular response to chemical stress | R-HSA-9711123 | 8.827965e-02 | 1.054 | 0 | 0 |
| PTEN Regulation | R-HSA-6807070 | 9.054370e-02 | 1.043 | 0 | 0 |
| Regulation of RAS by GAPs | R-HSA-5658442 | 9.173464e-02 | 1.037 | 0 | 0 |
| SARS-CoV-2 targets PDZ proteins in cell-cell junction | R-HSA-9705677 | 1.062800e-01 | 0.974 | 0 | 0 |
| TLR3-mediated TICAM1-dependent programmed cell death | R-HSA-9013957 | 1.062800e-01 | 0.974 | 0 | 0 |
| PLCG1 events in ERBB2 signaling | R-HSA-1251932 | 1.062800e-01 | 0.974 | 0 | 0 |
| TGFBR1 KD Mutants in Cancer | R-HSA-3656532 | 1.062800e-01 | 0.974 | 0 | 0 |
| Signaling by membrane-tethered fusions of PDGFRA or PDGFRB | R-HSA-9673768 | 1.364956e-01 | 0.865 | 0 | 0 |
| SMAD2/3 Phosphorylation Motif Mutants in Cancer | R-HSA-3304356 | 1.364956e-01 | 0.865 | 0 | 0 |
| ARMS-mediated activation | R-HSA-170984 | 1.002514e-01 | 0.999 | 0 | 0 |
| Gap junction degradation | R-HSA-190873 | 1.002514e-01 | 0.999 | 0 | 0 |
| Establishment of Sister Chromatid Cohesion | R-HSA-2468052 | 1.194933e-01 | 0.923 | 0 | 0 |
| Activation of Ca-permeable Kainate Receptor | R-HSA-451308 | 1.194933e-01 | 0.923 | 0 | 0 |
| PECAM1 interactions | R-HSA-210990 | 1.399675e-01 | 0.854 | 0 | 0 |
| Signaling by APC mutants | R-HSA-4839744 | 1.399675e-01 | 0.854 | 0 | 0 |
| AXIN missense mutants destabilize the destruction complex | R-HSA-5467340 | 1.399675e-01 | 0.854 | 0 | 0 |
| APC truncation mutants have impaired AXIN binding | R-HSA-5467337 | 1.399675e-01 | 0.854 | 0 | 0 |
| Truncations of AMER1 destabilize the destruction complex | R-HSA-5467348 | 1.399675e-01 | 0.854 | 0 | 0 |
| Spry regulation of FGF signaling | R-HSA-1295596 | 1.002985e-01 | 0.999 | 0 | 0 |
| Beta-catenin phosphorylation cascade | R-HSA-196299 | 1.002985e-01 | 0.999 | 0 | 0 |
| KSRP (KHSRP) binds and destabilizes mRNA | R-HSA-450604 | 1.150037e-01 | 0.939 | 0 | 0 |
| GRB2:SOS provides linkage to MAPK signaling for Integrins | R-HSA-354194 | 1.150037e-01 | 0.939 | 0 | 0 |
| Signaling by Ligand-Responsive EGFR Variants in Cancer | R-HSA-5637815 | 9.461005e-02 | 1.024 | 0 | 0 |
| Constitutive Signaling by Ligand-Responsive EGFR Cancer Variants | R-HSA-1236382 | 9.461005e-02 | 1.024 | 0 | 0 |
| Regulation of MITF-M-dependent genes involved in apoptosis | R-HSA-9824594 | 9.461005e-02 | 1.024 | 0 | 0 |
| Unblocking of NMDA receptors, glutamate binding and activation | R-HSA-438066 | 1.064207e-01 | 0.973 | 0 | 0 |
| HIV elongation arrest and recovery | R-HSA-167287 | 9.704279e-02 | 1.013 | 0 | 0 |
| Pausing and recovery of HIV elongation | R-HSA-167290 | 9.704279e-02 | 1.013 | 0 | 0 |
| Signaling by ERBB2 KD Mutants | R-HSA-9664565 | 1.073580e-01 | 0.969 | 0 | 0 |
| Signaling by ERBB2 in Cancer | R-HSA-1227990 | 1.182136e-01 | 0.927 | 0 | 0 |
| Developmental Lineage of Mammary Gland Luminal Epithelial Cells | R-HSA-9927418 | 9.459814e-02 | 1.024 | 0 | 0 |
| EPH-ephrin mediated repulsion of cells | R-HSA-3928665 | 1.391841e-01 | 0.856 | 0 | 0 |
| Transcription of the HIV genome | R-HSA-167172 | 9.729175e-02 | 1.012 | 0 | 0 |
| Nuclear Receptor transcription pathway | R-HSA-383280 | 1.049218e-01 | 0.979 | 0 | 0 |
| Activation of IRF3, IRF7 mediated by TBK1, IKKε (IKBKE) | R-HSA-936964 | 1.305899e-01 | 0.884 | 0 | 0 |
| Ribosome Quality Control (RQC) complex extracts and degrades nascent peptide | R-HSA-9954709 | 1.171993e-01 | 0.931 | 0 | 0 |
| EGFR Transactivation by Gastrin | R-HSA-2179392 | 1.194933e-01 | 0.923 | 0 | 0 |
| Sema3A PAK dependent Axon repulsion | R-HSA-399954 | 1.002985e-01 | 0.999 | 0 | 0 |
| SMAD2/SMAD3:SMAD4 heterotrimer regulates transcription | R-HSA-2173796 | 1.153114e-01 | 0.938 | 0 | 0 |
| Stabilization of p53 | R-HSA-69541 | 1.357684e-01 | 0.867 | 0 | 0 |
| Downregulation of ERBB2 signaling | R-HSA-8863795 | 1.182136e-01 | 0.927 | 0 | 0 |
| Budding and maturation of HIV virion | R-HSA-162588 | 1.295926e-01 | 0.887 | 0 | 0 |
| Trafficking of AMPA receptors | R-HSA-399719 | 1.295926e-01 | 0.887 | 0 | 0 |
| HSF1-dependent transactivation | R-HSA-3371571 | 9.910225e-02 | 1.004 | 0 | 0 |
| Proteasome assembly | R-HSA-9907900 | 1.113183e-01 | 0.953 | 0 | 0 |
| Deadenylation-dependent mRNA decay | R-HSA-429914 | 9.508832e-02 | 1.022 | 0 | 0 |
| Protein-protein interactions at synapses | R-HSA-6794362 | 9.355347e-02 | 1.029 | 0 | 0 |
| Pyrophosphate hydrolysis | R-HSA-71737 | 1.364956e-01 | 0.865 | 0 | 0 |
| Regulation of localization of FOXO transcription factors | R-HSA-9614399 | 1.399675e-01 | 0.854 | 0 | 0 |
| Activation of BAD and translocation to mitochondria | R-HSA-111447 | 1.002985e-01 | 0.999 | 0 | 0 |
| Somitogenesis | R-HSA-9824272 | 1.202428e-01 | 0.920 | 0 | 0 |
| PTK6 Regulates Proteins Involved in RNA Processing | R-HSA-8849468 | 1.364956e-01 | 0.865 | 0 | 0 |
| Signal attenuation | R-HSA-74749 | 1.194933e-01 | 0.923 | 0 | 0 |
| Protein methylation | R-HSA-8876725 | 1.002985e-01 | 0.999 | 0 | 0 |
| Transcriptional regulation by RUNX3 | R-HSA-8878159 | 1.299485e-01 | 0.886 | 0 | 0 |
| Regulated Necrosis | R-HSA-5218859 | 9.729175e-02 | 1.012 | 0 | 0 |
| MTF1 activates gene expression | R-HSA-5660489 | 1.062800e-01 | 0.974 | 0 | 0 |
| Caspase-mediated cleavage of cytoskeletal proteins | R-HSA-264870 | 1.002514e-01 | 0.999 | 0 | 0 |
| Ionotropic activity of kainate receptors | R-HSA-451306 | 1.399675e-01 | 0.854 | 0 | 0 |
| Receptor-type tyrosine-protein phosphatases | R-HSA-388844 | 1.150037e-01 | 0.939 | 0 | 0 |
| PIP3 activates AKT signaling | R-HSA-1257604 | 1.125882e-01 | 0.949 | 0 | 0 |
| S Phase | R-HSA-69242 | 1.390428e-01 | 0.857 | 0 | 0 |
| Suppression of apoptosis | R-HSA-9635465 | 1.399675e-01 | 0.854 | 0 | 0 |
| TAK1-dependent IKK and NF-kappa-B activation | R-HSA-445989 | 1.391841e-01 | 0.856 | 0 | 0 |
| FLT3 signaling in disease | R-HSA-9682385 | 1.057320e-01 | 0.976 | 0 | 0 |
| SARS-CoV-2 targets host intracellular signalling and regulatory pathways | R-HSA-9755779 | 1.002985e-01 | 0.999 | 0 | 0 |
| Interleukin-3, Interleukin-5 and GM-CSF signaling | R-HSA-512988 | 9.459814e-02 | 1.024 | 0 | 0 |
| Activation of BH3-only proteins | R-HSA-114452 | 1.182136e-01 | 0.927 | 0 | 0 |
| Senescence-Associated Secretory Phenotype (SASP) | R-HSA-2559582 | 1.323689e-01 | 0.878 | 0 | 0 |
| Muscle contraction | R-HSA-397014 | 1.315257e-01 | 0.881 | 0 | 0 |
| Downstream signal transduction | R-HSA-186763 | 1.295926e-01 | 0.887 | 0 | 0 |
| Potential therapeutics for SARS | R-HSA-9679191 | 1.021089e-01 | 0.991 | 0 | 0 |
| RMTs methylate histone arginines | R-HSA-3214858 | 1.113183e-01 | 0.953 | 0 | 0 |
| Transcriptional Regulation by NPAS4 | R-HSA-9634815 | 1.068001e-01 | 0.971 | 0 | 0 |
| Cytosolic sensors of pathogen-associated DNA | R-HSA-1834949 | 1.107841e-01 | 0.956 | 0 | 0 |
| Co-inhibition by BTLA | R-HSA-9927353 | 1.364956e-01 | 0.865 | 0 | 0 |
| Apoptosis induced DNA fragmentation | R-HSA-140342 | 1.194933e-01 | 0.923 | 0 | 0 |
| Negative regulation of NMDA receptor-mediated neuronal transmission | R-HSA-9617324 | 1.064207e-01 | 0.973 | 0 | 0 |
| Cell death signalling via NRAGE, NRIF and NADE | R-HSA-204998 | 1.329301e-01 | 0.876 | 0 | 0 |
| NOTCH4 Intracellular Domain Regulates Transcription | R-HSA-9013695 | 9.461005e-02 | 1.024 | 0 | 0 |
| Signaling by Leptin | R-HSA-2586552 | 1.194933e-01 | 0.923 | 0 | 0 |
| Constitutive Signaling by AKT1 E17K in Cancer | R-HSA-5674400 | 1.320654e-01 | 0.879 | 0 | 0 |
| NRAGE signals death through JNK | R-HSA-193648 | 1.408101e-01 | 0.851 | 0 | 0 |
| Regulation of ornithine decarboxylase (ODC) | R-HSA-350562 | 1.414754e-01 | 0.849 | 0 | 0 |
| DNA strand elongation | R-HSA-69190 | 1.414754e-01 | 0.849 | 0 | 0 |
| p75 NTR receptor-mediated signalling | R-HSA-193704 | 1.434495e-01 | 0.843 | 0 | 0 |
| Thromboxane signalling through TP receptor | R-HSA-428930 | 1.458356e-01 | 0.836 | 0 | 0 |
| Formation of HIV elongation complex in the absence of HIV Tat | R-HSA-167152 | 1.466207e-01 | 0.834 | 0 | 0 |
| Attenuation phase | R-HSA-3371568 | 1.466207e-01 | 0.834 | 0 | 0 |
| p130Cas linkage to MAPK signaling for integrins | R-HSA-372708 | 1.469924e-01 | 0.833 | 0 | 0 |
| Generic Transcription Pathway | R-HSA-212436 | 1.503677e-01 | 0.823 | 0 | 0 |
| Regulation of necroptotic cell death | R-HSA-5675482 | 1.538404e-01 | 0.813 | 0 | 0 |
| Glutamate binding, activation of AMPA receptors and synaptic plasticity | R-HSA-399721 | 1.538404e-01 | 0.813 | 0 | 0 |
| CREB1 phosphorylation through NMDA receptor-mediated activation of RAS signaling | R-HSA-442742 | 1.538404e-01 | 0.813 | 0 | 0 |
| Activation of ATR in response to replication stress | R-HSA-176187 | 1.538404e-01 | 0.813 | 0 | 0 |
| UCH proteinases | R-HSA-5689603 | 1.572855e-01 | 0.803 | 0 | 0 |
| Interleukin-1 signaling | R-HSA-9020702 | 1.576840e-01 | 0.802 | 0 | 0 |
| M-decay: degradation of maternal mRNAs by maternally stored factors | R-HSA-9820841 | 1.578692e-01 | 0.802 | 0 | 0 |
| APOBEC3G mediated resistance to HIV-1 infection | R-HSA-180689 | 1.615145e-01 | 0.792 | 0 | 0 |
| Regulation of gene expression by Hypoxia-inducible Factor | R-HSA-1234158 | 1.615145e-01 | 0.792 | 0 | 0 |
| Signaling by AMER1 mutants | R-HSA-4839748 | 1.615145e-01 | 0.792 | 0 | 0 |
| Signaling by AXIN mutants | R-HSA-4839735 | 1.615145e-01 | 0.792 | 0 | 0 |
| MyD88-independent TLR4 cascade | R-HSA-166166 | 1.616510e-01 | 0.791 | 0 | 0 |
| TRIF (TICAM1)-mediated TLR4 signaling | R-HSA-937061 | 1.616510e-01 | 0.791 | 0 | 0 |
| Signaling by cytosolic FGFR1 fusion mutants | R-HSA-1839117 | 1.641419e-01 | 0.785 | 0 | 0 |
| Ephrin signaling | R-HSA-3928664 | 1.641419e-01 | 0.785 | 0 | 0 |
| GAB1 signalosome | R-HSA-180292 | 1.641419e-01 | 0.785 | 0 | 0 |
| Clathrin-mediated endocytosis | R-HSA-8856828 | 1.660926e-01 | 0.780 | 0 | 0 |
| EGR2 and SOX10-mediated initiation of Schwann cell myelination | R-HSA-9619665 | 1.666636e-01 | 0.778 | 0 | 0 |
| NFE2L2 regulating anti-oxidant/detoxification enzymes | R-HSA-9818027 | 1.666636e-01 | 0.778 | 0 | 0 |
| TICAM1 deficiency - HSE | R-HSA-5602566 | 1.680245e-01 | 0.775 | 0 | 0 |
| SARS-CoV-1 targets PDZ proteins in cell-cell junction | R-HSA-9692912 | 1.680245e-01 | 0.775 | 0 | 0 |
| Defective DNA double strand break response due to BRCA1 loss of function | R-HSA-9663199 | 1.680245e-01 | 0.775 | 0 | 0 |
| Defective DNA double strand break response due to BARD1 loss of function | R-HSA-9699150 | 1.680245e-01 | 0.775 | 0 | 0 |
| Defective F8 binding to von Willebrand factor | R-HSA-9672393 | 1.680245e-01 | 0.775 | 0 | 0 |
| Activation and oligomerization of BAK protein | R-HSA-111452 | 1.680245e-01 | 0.775 | 0 | 0 |
| Activation, translocation and oligomerization of BAX | R-HSA-114294 | 1.680245e-01 | 0.775 | 0 | 0 |
| Inhibition of PKR | R-HSA-169131 | 1.680245e-01 | 0.775 | 0 | 0 |
| IkBA variant leads to EDA-ID | R-HSA-5603029 | 1.683040e-01 | 0.774 | 0 | 0 |
| Loss of Function of SMAD2/3 in Cancer | R-HSA-3304349 | 1.683040e-01 | 0.774 | 0 | 0 |
| Noncanonical activation of NOTCH3 | R-HSA-9017802 | 1.683040e-01 | 0.774 | 0 | 0 |
| RUNX3 regulates CDKN1A transcription | R-HSA-8941855 | 1.683040e-01 | 0.774 | 0 | 0 |
| Negative feedback regulation of MAPK pathway | R-HSA-5674499 | 1.683040e-01 | 0.774 | 0 | 0 |
| Aryl hydrocarbon receptor signalling | R-HSA-8937144 | 1.683040e-01 | 0.774 | 0 | 0 |
| TYSND1 cleaves peroxisomal proteins | R-HSA-9033500 | 1.683040e-01 | 0.774 | 0 | 0 |
| Negative regulation of MAPK pathway | R-HSA-5675221 | 1.694973e-01 | 0.771 | 0 | 0 |
| RNA polymerase II transcribes snRNA genes | R-HSA-6807505 | 1.716524e-01 | 0.765 | 0 | 0 |
| Regulation of TP53 Activity through Phosphorylation | R-HSA-6804756 | 1.716524e-01 | 0.765 | 0 | 0 |
| Death Receptor Signaling | R-HSA-73887 | 1.741566e-01 | 0.759 | 0 | 0 |
| Signaling by NTRK1 (TRKA) | R-HSA-187037 | 1.746602e-01 | 0.758 | 0 | 0 |
| Signaling by EGFR in Cancer | R-HSA-1643713 | 1.750873e-01 | 0.757 | 0 | 0 |
| Signaling by FLT3 fusion proteins | R-HSA-9703465 | 1.750873e-01 | 0.757 | 0 | 0 |
| Developmental Lineage of Mammary Gland Alveolar Cells | R-HSA-9927426 | 1.799193e-01 | 0.745 | 0 | 0 |
| Signal amplification | R-HSA-392518 | 1.799193e-01 | 0.745 | 0 | 0 |
| Ubiquitin-dependent degradation of Cyclin D | R-HSA-75815 | 1.799193e-01 | 0.745 | 0 | 0 |
| Autodegradation of the E3 ubiquitin ligase COP1 | R-HSA-349425 | 1.799193e-01 | 0.745 | 0 | 0 |
| RNA Polymerase I Transcription Initiation | R-HSA-73762 | 1.814871e-01 | 0.741 | 0 | 0 |
| Regulation of signaling by CBL | R-HSA-912631 | 1.819664e-01 | 0.740 | 0 | 0 |
| Impaired BRCA2 binding to PALB2 | R-HSA-9709603 | 1.819664e-01 | 0.740 | 0 | 0 |
| The NLRP3 inflammasome | R-HSA-844456 | 1.819664e-01 | 0.740 | 0 | 0 |
| Rap1 signalling | R-HSA-392517 | 1.819664e-01 | 0.740 | 0 | 0 |
| Scavenging by Class F Receptors | R-HSA-3000484 | 1.839752e-01 | 0.735 | 0 | 0 |
| Regulation of IFNG signaling | R-HSA-877312 | 1.839752e-01 | 0.735 | 0 | 0 |
| Advanced glycosylation endproduct receptor signaling | R-HSA-879415 | 1.839752e-01 | 0.735 | 0 | 0 |
| AKT phosphorylates targets in the cytosol | R-HSA-198323 | 1.839752e-01 | 0.735 | 0 | 0 |
| Degradation of beta-catenin by the destruction complex | R-HSA-195253 | 1.870734e-01 | 0.728 | 0 | 0 |
| Downstream signaling events of B Cell Receptor (BCR) | R-HSA-1168372 | 1.870734e-01 | 0.728 | 0 | 0 |
| Formation of paraxial mesoderm | R-HSA-9793380 | 1.900529e-01 | 0.721 | 0 | 0 |
| Disassembly of the destruction complex and recruitment of AXIN to the membrane | R-HSA-4641262 | 1.904876e-01 | 0.720 | 0 | 0 |
| Tat-mediated HIV elongation arrest and recovery | R-HSA-167243 | 1.904876e-01 | 0.720 | 0 | 0 |
| Pausing and recovery of Tat-mediated HIV elongation | R-HSA-167238 | 1.904876e-01 | 0.720 | 0 | 0 |
| TP53 Regulates Transcription of Genes Involved in Cytochrome C Release | R-HSA-6803204 | 1.904876e-01 | 0.720 | 0 | 0 |
| Insulin processing | R-HSA-264876 | 1.904876e-01 | 0.720 | 0 | 0 |
| Signalling to ERKs | R-HSA-187687 | 1.935805e-01 | 0.713 | 0 | 0 |
| Signaling by SCF-KIT | R-HSA-1433557 | 1.938196e-01 | 0.713 | 0 | 0 |
| Toll Like Receptor 3 (TLR3) Cascade | R-HSA-168164 | 1.963114e-01 | 0.707 | 0 | 0 |
| Signaling by NTRKs | R-HSA-166520 | 1.988288e-01 | 0.702 | 0 | 0 |
| Insertion of tail-anchored proteins into the endoplasmic reticulum membrane | R-HSA-9609523 | 2.003920e-01 | 0.698 | 0 | 0 |
| Defective homologous recombination repair (HRR) due to PALB2 loss of function | R-HSA-9701193 | 2.003920e-01 | 0.698 | 0 | 0 |
| Defective HDR through Homologous Recombination Repair (HRR) due to PALB2 loss of BRCA2/RAD51/RAD51C binding function | R-HSA-9704646 | 2.003920e-01 | 0.698 | 0 | 0 |
| Defective homologous recombination repair (HRR) due to BRCA1 loss of function | R-HSA-9701192 | 2.003920e-01 | 0.698 | 0 | 0 |
| Defective HDR through Homologous Recombination Repair (HRR) due to PALB2 loss of BRCA1 binding function | R-HSA-9704331 | 2.003920e-01 | 0.698 | 0 | 0 |
| VxPx cargo-targeting to cilium | R-HSA-5620916 | 2.003920e-01 | 0.698 | 0 | 0 |
| Signaling by NODAL | R-HSA-1181150 | 2.003920e-01 | 0.698 | 0 | 0 |
| PTK6 promotes HIF1A stabilization | R-HSA-8857538 | 2.011924e-01 | 0.696 | 0 | 0 |
| Autointegration results in viral DNA circles | R-HSA-177539 | 2.011924e-01 | 0.696 | 0 | 0 |
| RAS signaling downstream of NF1 loss-of-function variants | R-HSA-6802953 | 2.011924e-01 | 0.696 | 0 | 0 |
| Regulation of NFE2L2 gene expression | R-HSA-9818749 | 2.011924e-01 | 0.696 | 0 | 0 |
| Integration of viral DNA into host genomic DNA | R-HSA-175567 | 2.011924e-01 | 0.696 | 0 | 0 |
| Golgi Associated Vesicle Biogenesis | R-HSA-432722 | 2.039830e-01 | 0.690 | 0 | 0 |
| PINK1-PRKN Mediated Mitophagy | R-HSA-5205685 | 2.063469e-01 | 0.685 | 0 | 0 |
| Activation of kainate receptors upon glutamate binding | R-HSA-451326 | 2.063469e-01 | 0.685 | 0 | 0 |
| Pyroptosis | R-HSA-5620971 | 2.063469e-01 | 0.685 | 0 | 0 |
| Netrin-1 signaling | R-HSA-373752 | 2.064748e-01 | 0.685 | 0 | 0 |
| trans-Golgi Network Vesicle Budding | R-HSA-199992 | 2.070837e-01 | 0.684 | 0 | 0 |
| Formation of axial mesoderm | R-HSA-9796292 | 2.071938e-01 | 0.684 | 0 | 0 |
| PI5P Regulates TP53 Acetylation | R-HSA-6811555 | 2.071938e-01 | 0.684 | 0 | 0 |
| Maturation of nucleoprotein | R-HSA-9683610 | 2.071938e-01 | 0.684 | 0 | 0 |
| Chk1/Chk2(Cds1) mediated inactivation of Cyclin B:Cdk1 complex | R-HSA-75035 | 2.071938e-01 | 0.684 | 0 | 0 |
| Replication of the SARS-CoV-1 genome | R-HSA-9682706 | 2.071938e-01 | 0.684 | 0 | 0 |
| HSF1 activation | R-HSA-3371511 | 2.076186e-01 | 0.683 | 0 | 0 |
| Interactions of Tat with host cellular proteins | R-HSA-176034 | 2.411393e-01 | 0.618 | 0 | 0 |
| Defective SLC6A3 causes Parkinsonism-dystonia infantile (PKDYS) | R-HSA-5619081 | 2.411393e-01 | 0.618 | 0 | 0 |
| Defective SLC4A4 causes renal tubular acidosis, proximal, with ocular abnormalities and mental retardation (pRTA-OA) | R-HSA-5619054 | 2.411393e-01 | 0.618 | 0 | 0 |
| TRAF3 deficiency - HSE | R-HSA-5602571 | 2.411393e-01 | 0.618 | 0 | 0 |
| Defective SLC6A3 causes Parkinsonism-dystonia infantile (PKDYS) | R-HSA-5660724 | 2.411393e-01 | 0.618 | 0 | 0 |
| Defective VWF binding to collagen type I | R-HSA-9845622 | 2.411393e-01 | 0.618 | 0 | 0 |
| Enhanced cleavage of VWF variant by ADAMTS13 | R-HSA-9845619 | 3.078326e-01 | 0.512 | 0 | 0 |
| Signaling by RAS GAP mutants | R-HSA-9753510 | 3.078326e-01 | 0.512 | 0 | 0 |
| Defective VWF cleavage by ADAMTS13 variant | R-HSA-9845621 | 3.078326e-01 | 0.512 | 0 | 0 |
| TGFBR1 LBD Mutants in Cancer | R-HSA-3656535 | 3.078326e-01 | 0.512 | 0 | 0 |
| Defective F8 cleavage by thrombin | R-HSA-9672391 | 3.078326e-01 | 0.512 | 0 | 0 |
| Defective AHCY causes HMAHCHD | R-HSA-5578997 | 3.078326e-01 | 0.512 | 0 | 0 |
| Activated NTRK2 signals through CDK5 | R-HSA-9032845 | 2.347259e-01 | 0.629 | 0 | 0 |
| NOSTRIN mediated eNOS trafficking | R-HSA-203641 | 2.347259e-01 | 0.629 | 0 | 0 |
| TRIF-mediated programmed cell death | R-HSA-2562578 | 2.347259e-01 | 0.629 | 0 | 0 |
| Regulation of MITF-M dependent genes involved in metabolism | R-HSA-9854907 | 3.686681e-01 | 0.433 | 0 | 0 |
| Signaling by cytosolic PDGFRA and PDGFRB fusion proteins | R-HSA-9673766 | 3.686681e-01 | 0.433 | 0 | 0 |
| Axonal growth stimulation | R-HSA-209563 | 3.686681e-01 | 0.433 | 0 | 0 |
| Adrenaline signalling through Alpha-2 adrenergic receptor | R-HSA-392023 | 3.686681e-01 | 0.433 | 0 | 0 |
| Loss of Function of KMT2D in MLL4 Complex Formation in Kabuki Syndrome | R-HSA-9944997 | 3.686681e-01 | 0.433 | 0 | 0 |
| Defective SLC7A7 causes lysinuric protein intolerance (LPI) | R-HSA-5660862 | 3.686681e-01 | 0.433 | 0 | 0 |
| Loss of Function of KMT2D in Kabuki Syndrome | R-HSA-9944971 | 3.686681e-01 | 0.433 | 0 | 0 |
| MET activates PTPN11 | R-HSA-8865999 | 3.686681e-01 | 0.433 | 0 | 0 |
| Regulation of TBK1, IKKε-mediated activation of IRF3, IRF7 upon TLR3 ligation | R-HSA-9828211 | 2.685374e-01 | 0.571 | 0 | 0 |
| Formation of annular gap junctions | R-HSA-196025 | 2.685374e-01 | 0.571 | 0 | 0 |
| Lipophagy | R-HSA-9613354 | 3.023194e-01 | 0.520 | 0 | 0 |
| Hypusine synthesis from eIF5A-lysine | R-HSA-204626 | 3.023194e-01 | 0.520 | 0 | 0 |
| 5-Phosphoribose 1-diphosphate biosynthesis | R-HSA-73843 | 3.023194e-01 | 0.520 | 0 | 0 |
| ALK mutants bind TKIs | R-HSA-9700645 | 3.023194e-01 | 0.520 | 0 | 0 |
| Binding and entry of HIV virion | R-HSA-173107 | 3.358161e-01 | 0.474 | 0 | 0 |
| MET activates RAP1 and RAC1 | R-HSA-8875555 | 3.358161e-01 | 0.474 | 0 | 0 |
| Signaling by Erythropoietin | R-HSA-9006335 | 2.226208e-01 | 0.652 | 0 | 0 |
| FGFR2 alternative splicing | R-HSA-6803529 | 2.585269e-01 | 0.587 | 0 | 0 |
| G beta:gamma signalling through CDC42 | R-HSA-8964616 | 3.047452e-01 | 0.516 | 0 | 0 |
| Processing of Intronless Pre-mRNAs | R-HSA-77595 | 3.047452e-01 | 0.516 | 0 | 0 |
| GRB2 events in ERBB2 signaling | R-HSA-1963640 | 3.047452e-01 | 0.516 | 0 | 0 |
| Antigen processing: Ub, ATP-independent proteasomal degradation | R-HSA-9912633 | 3.047452e-01 | 0.516 | 0 | 0 |
| InlA-mediated entry of Listeria monocytogenes into host cells | R-HSA-8876493 | 3.688169e-01 | 0.433 | 0 | 0 |
| Condensation of Prometaphase Chromosomes | R-HSA-2514853 | 4.011505e-01 | 0.397 | 0 | 0 |
| Activation of RAC1 | R-HSA-428540 | 4.011505e-01 | 0.397 | 0 | 0 |
| Regulation of TBK1, IKKε (IKBKE)-mediated activation of IRF3, IRF7 | R-HSA-9824878 | 4.011505e-01 | 0.397 | 0 | 0 |
| Phosphorylation of CLOCK, acetylation of BMAL1 (ARNTL) at target gene promoters | R-HSA-9931512 | 4.011505e-01 | 0.397 | 0 | 0 |
| Formation of HIV-1 elongation complex containing HIV-1 Tat | R-HSA-167200 | 2.516946e-01 | 0.599 | 0 | 0 |
| Tight junction interactions | R-HSA-420029 | 3.194146e-01 | 0.496 | 0 | 0 |
| Resolution of D-loop Structures through Synthesis-Dependent Strand Annealing (SDSA) | R-HSA-5693554 | 3.194146e-01 | 0.496 | 0 | 0 |
| HIV Transcription Elongation | R-HSA-167169 | 2.669374e-01 | 0.574 | 0 | 0 |
| Tat-mediated elongation of the HIV-1 transcript | R-HSA-167246 | 2.669374e-01 | 0.574 | 0 | 0 |
| RNA Polymerase II Transcription Pre-Initiation And Promoter Opening | R-HSA-73779 | 2.669374e-01 | 0.574 | 0 | 0 |
| DNA Damage Recognition in GG-NER | R-HSA-5696394 | 3.086175e-01 | 0.511 | 0 | 0 |
| IKK complex recruitment mediated by RIP1 | R-HSA-937041 | 3.792819e-01 | 0.421 | 0 | 0 |
| RNA Polymerase II HIV Promoter Escape | R-HSA-167162 | 2.980604e-01 | 0.526 | 0 | 0 |
| HIV Transcription Initiation | R-HSA-167161 | 2.980604e-01 | 0.526 | 0 | 0 |
| RNA Polymerase II Transcription Initiation | R-HSA-75953 | 2.980604e-01 | 0.526 | 0 | 0 |
| EPHA-mediated growth cone collapse | R-HSA-3928663 | 3.606225e-01 | 0.443 | 0 | 0 |
| Transcription of E2F targets under negative control by DREAM complex | R-HSA-1362277 | 4.038268e-01 | 0.394 | 0 | 0 |
| RNA Polymerase II Promoter Escape | R-HSA-73776 | 3.298238e-01 | 0.482 | 0 | 0 |
| RET signaling | R-HSA-8853659 | 3.623074e-01 | 0.441 | 0 | 0 |
| Endosomal Sorting Complex Required For Transport (ESCRT) | R-HSA-917729 | 4.017526e-01 | 0.396 | 0 | 0 |
| Impaired BRCA2 binding to RAD51 | R-HSA-9709570 | 4.017526e-01 | 0.396 | 0 | 0 |
| RNA Polymerase II Transcription Initiation And Promoter Clearance | R-HSA-76042 | 3.619818e-01 | 0.441 | 0 | 0 |
| mRNA Splicing - Minor Pathway | R-HSA-72165 | 3.781345e-01 | 0.422 | 0 | 0 |
| Autodegradation of Cdh1 by Cdh1:APC/C | R-HSA-174084 | 3.781345e-01 | 0.422 | 0 | 0 |
| APC/C:Cdc20 mediated degradation of Securin | R-HSA-174154 | 3.942983e-01 | 0.404 | 0 | 0 |
| Neutrophil degranulation | R-HSA-6798695 | 2.396705e-01 | 0.620 | 0 | 0 |
| Transcriptional regulation of brown and beige adipocyte differentiation by EBF2 | R-HSA-9844594 | 2.669374e-01 | 0.574 | 0 | 0 |
| Transcriptional regulation of brown and beige adipocyte differentiation | R-HSA-9843743 | 2.669374e-01 | 0.574 | 0 | 0 |
| Negative regulation of FGFR3 signaling | R-HSA-5654732 | 3.812253e-01 | 0.419 | 0 | 0 |
| Mitochondrial protein import | R-HSA-1268020 | 3.180096e-01 | 0.498 | 0 | 0 |
| Negative regulation of FGFR4 signaling | R-HSA-5654733 | 4.017526e-01 | 0.396 | 0 | 0 |
| Signaling by EGFR | R-HSA-177929 | 2.401947e-01 | 0.619 | 0 | 0 |
| Signaling by ERBB2 | R-HSA-1227986 | 2.914399e-01 | 0.535 | 0 | 0 |
| TGFBR3 expression | R-HSA-9839394 | 3.194146e-01 | 0.496 | 0 | 0 |
| TICAM1-dependent activation of IRF3/IRF7 | R-HSA-9013973 | 4.011505e-01 | 0.397 | 0 | 0 |
| Insulin receptor recycling | R-HSA-77387 | 3.812253e-01 | 0.419 | 0 | 0 |
| SHC1 events in ERBB2 signaling | R-HSA-1250196 | 4.221532e-01 | 0.375 | 0 | 0 |
| ER-Phagosome pathway | R-HSA-1236974 | 2.952080e-01 | 0.530 | 0 | 0 |
| PI3K/AKT activation | R-HSA-198203 | 3.358161e-01 | 0.474 | 0 | 0 |
| Nuclear RNA decay | R-HSA-9930044 | 2.909525e-01 | 0.536 | 0 | 0 |
| RIPK1-mediated regulated necrosis | R-HSA-5213460 | 2.367063e-01 | 0.626 | 0 | 0 |
| Transcriptional activity of SMAD2/SMAD3:SMAD4 heterotrimer | R-HSA-2173793 | 2.401947e-01 | 0.619 | 0 | 0 |
| Dectin-1 mediated noncanonical NF-kB signaling | R-HSA-5607761 | 3.619818e-01 | 0.441 | 0 | 0 |
| TP53 Regulates Transcription of Cell Death Genes | R-HSA-5633008 | 3.563153e-01 | 0.448 | 0 | 0 |
| Protein localization | R-HSA-9609507 | 4.068214e-01 | 0.391 | 0 | 0 |
| The CRY:PER:kinase complex represses transactivation by the BMAL:CLOCK (ARNTL:CLOCK) complex | R-HSA-9931521 | 3.047452e-01 | 0.516 | 0 | 0 |
| NF-kB is activated and signals survival | R-HSA-209560 | 4.011505e-01 | 0.397 | 0 | 0 |
| TP53 regulates transcription of several additional cell death genes whose specific roles in p53-dependent apoptosis remain uncertain | R-HSA-6803205 | 2.585269e-01 | 0.587 | 0 | 0 |
| Germ layer formation at gastrulation | R-HSA-9754189 | 3.792819e-01 | 0.421 | 0 | 0 |
| HDR through Homologous Recombination (HRR) | R-HSA-5685942 | 3.860235e-01 | 0.413 | 0 | 0 |
| p53-Dependent G1 DNA Damage Response | R-HSA-69563 | 2.738319e-01 | 0.563 | 0 | 0 |
| p53-Dependent G1/S DNA damage checkpoint | R-HSA-69580 | 2.738319e-01 | 0.563 | 0 | 0 |
| PTK6 Expression | R-HSA-8849473 | 2.347259e-01 | 0.629 | 0 | 0 |
| Calcineurin activates NFAT | R-HSA-2025928 | 3.023194e-01 | 0.520 | 0 | 0 |
| Insulin-like Growth Factor-2 mRNA Binding Proteins (IGF2BPs/IMPs/VICKZs) bind RNA | R-HSA-428359 | 3.358161e-01 | 0.474 | 0 | 0 |
| NIK-->noncanonical NF-kB signaling | R-HSA-5676590 | 2.824032e-01 | 0.549 | 0 | 0 |
| Hh mutants are degraded by ERAD | R-HSA-5362768 | 2.824032e-01 | 0.549 | 0 | 0 |
| Degradation of GLI1 by the proteasome | R-HSA-5610780 | 2.980604e-01 | 0.526 | 0 | 0 |
| Fanconi Anemia Pathway | R-HSA-6783310 | 3.619818e-01 | 0.441 | 0 | 0 |
| Cellular response to hypoxia | R-HSA-1234174 | 2.340709e-01 | 0.631 | 0 | 0 |
| Signaling by TGF-beta Receptor Complex | R-HSA-170834 | 2.952012e-01 | 0.530 | 0 | 0 |
| TBC/RABGAPs | R-HSA-8854214 | 3.298238e-01 | 0.482 | 0 | 0 |
| Developmental Cell Lineages | R-HSA-9734767 | 3.744194e-01 | 0.427 | 0 | 0 |
| Hh mutants abrogate ligand secretion | R-HSA-5387390 | 3.298238e-01 | 0.482 | 0 | 0 |
| Nuclear events stimulated by ALK signaling in cancer | R-HSA-9725371 | 2.598914e-01 | 0.585 | 0 | 0 |
| Gastrin-CREB signalling pathway via PKC and MAPK | R-HSA-881907 | 3.792819e-01 | 0.421 | 0 | 0 |
| Synthesis of DNA | R-HSA-69239 | 3.048162e-01 | 0.516 | 0 | 0 |
| Signal transduction by L1 | R-HSA-445144 | 4.038268e-01 | 0.394 | 0 | 0 |
| Signaling by FGFR2 | R-HSA-5654738 | 4.205229e-01 | 0.376 | 0 | 0 |
| p75NTR signals via NF-kB | R-HSA-193639 | 2.553091e-01 | 0.593 | 0 | 0 |
| Activation of gene expression by SREBF (SREBP) | R-HSA-2426168 | 2.116028e-01 | 0.674 | 0 | 0 |
| Mitophagy | R-HSA-5205647 | 3.264265e-01 | 0.486 | 0 | 0 |
| G1/S DNA Damage Checkpoints | R-HSA-69615 | 3.314671e-01 | 0.480 | 0 | 0 |
| Inhibition of Host mRNA Processing and RNA Silencing | R-HSA-168315 | 2.411393e-01 | 0.618 | 0 | 0 |
| Localization of the PINCH-ILK-PARVIN complex to focal adhesions | R-HSA-446343 | 3.078326e-01 | 0.512 | 0 | 0 |
| Regulation of cortical dendrite branching | R-HSA-8985801 | 3.078326e-01 | 0.512 | 0 | 0 |
| Influenza Virus Induced Apoptosis | R-HSA-168277 | 3.078326e-01 | 0.512 | 0 | 0 |
| Signalling to ERK5 | R-HSA-198765 | 3.078326e-01 | 0.512 | 0 | 0 |
| Neurophilin interactions with VEGF and VEGFR | R-HSA-194306 | 3.078326e-01 | 0.512 | 0 | 0 |
| Defective HLCS causes multiple carboxylase deficiency | R-HSA-3371599 | 2.347259e-01 | 0.629 | 0 | 0 |
| Inactivation of CDC42 and RAC1 | R-HSA-428543 | 3.023194e-01 | 0.520 | 0 | 0 |
| Butyrate Response Factor 1 (BRF1) binds and destabilizes mRNA | R-HSA-450385 | 2.553091e-01 | 0.593 | 0 | 0 |
| Tristetraprolin (TTP, ZFP36) binds and destabilizes mRNA | R-HSA-450513 | 2.553091e-01 | 0.593 | 0 | 0 |
| Bicarbonate transporters | R-HSA-425381 | 3.688169e-01 | 0.433 | 0 | 0 |
| vRNP Assembly | R-HSA-192905 | 3.688169e-01 | 0.433 | 0 | 0 |
| GSK3B and BTRC:CUL1-mediated-degradation of NFE2L2 | R-HSA-9762114 | 2.220040e-01 | 0.654 | 0 | 0 |
| Regulation of activated PAK-2p34 by proteasome mediated degradation | R-HSA-211733 | 2.562307e-01 | 0.591 | 0 | 0 |
| SPOP-mediated proteasomal degradation of PD-L1(CD274) | R-HSA-9929491 | 2.824032e-01 | 0.549 | 0 | 0 |
| Defective CFTR causes cystic fibrosis | R-HSA-5678895 | 3.619818e-01 | 0.441 | 0 | 0 |
| rRNA modification in the nucleus and cytosol | R-HSA-6790901 | 3.314671e-01 | 0.480 | 0 | 0 |
| Interconversion of nucleotide di- and triphosphates | R-HSA-499943 | 3.183662e-01 | 0.497 | 0 | 0 |
| Intrinsic Pathway for Apoptosis | R-HSA-109606 | 2.401947e-01 | 0.619 | 0 | 0 |
| Biotin transport and metabolism | R-HSA-196780 | 2.553091e-01 | 0.593 | 0 | 0 |
| Pexophagy | R-HSA-9664873 | 3.358161e-01 | 0.474 | 0 | 0 |
| Signaling by Receptor Tyrosine Kinases | R-HSA-9006934 | 2.829859e-01 | 0.548 | 0 | 0 |
| Regulation of CDH11 gene transcription | R-HSA-9762293 | 3.023194e-01 | 0.520 | 0 | 0 |
| Asymmetric localization of PCP proteins | R-HSA-4608870 | 3.619818e-01 | 0.441 | 0 | 0 |
| Regulation of cholesterol biosynthesis by SREBP (SREBF) | R-HSA-1655829 | 4.076522e-01 | 0.390 | 0 | 0 |
| Metabolism of proteins | R-HSA-392499 | 2.324584e-01 | 0.634 | 0 | 0 |
| Adaptive Immune System | R-HSA-1280218 | 3.968654e-01 | 0.401 | 0 | 0 |
| Intracellular signaling by second messengers | R-HSA-9006925 | 2.265133e-01 | 0.645 | 0 | 0 |
| Activation of PUMA and translocation to mitochondria | R-HSA-139915 | 2.347259e-01 | 0.629 | 0 | 0 |
| NOTCH4 Activation and Transmission of Signal to the Nucleus | R-HSA-9013700 | 3.023194e-01 | 0.520 | 0 | 0 |
| Signaling by Activin | R-HSA-1502540 | 2.553091e-01 | 0.593 | 0 | 0 |
| LGI-ADAM interactions | R-HSA-5682910 | 3.688169e-01 | 0.433 | 0 | 0 |
| Degradation of GLI2 by the proteasome | R-HSA-5610783 | 2.980604e-01 | 0.526 | 0 | 0 |
| GLI3 is processed to GLI3R by the proteasome | R-HSA-5610785 | 2.980604e-01 | 0.526 | 0 | 0 |
| Hedgehog ligand biogenesis | R-HSA-5358346 | 3.022538e-01 | 0.520 | 0 | 0 |
| Activation of NF-kappaB in B cells | R-HSA-1169091 | 3.022538e-01 | 0.520 | 0 | 0 |
| Integration of energy metabolism | R-HSA-163685 | 2.494934e-01 | 0.603 | 0 | 0 |
| Regulation of KIT signaling | R-HSA-1433559 | 2.310196e-01 | 0.636 | 0 | 0 |
| FOXO-mediated transcription of cell cycle genes | R-HSA-9617828 | 2.387467e-01 | 0.622 | 0 | 0 |
| Neuronal System | R-HSA-112316 | 3.435734e-01 | 0.464 | 0 | 0 |
| Synthesis of PIPs in the nucleus | R-HSA-8847453 | 2.347259e-01 | 0.629 | 0 | 0 |
| Intracellular oxygen transport | R-HSA-8981607 | 3.686681e-01 | 0.433 | 0 | 0 |
| Defects in biotin (Btn) metabolism | R-HSA-3323169 | 3.023194e-01 | 0.520 | 0 | 0 |
| Cellular response to mitochondrial stress | R-HSA-9840373 | 3.023194e-01 | 0.520 | 0 | 0 |
| Zinc influx into cells by the SLC39 gene family | R-HSA-442380 | 3.023194e-01 | 0.520 | 0 | 0 |
| RHOBTB3 ATPase cycle | R-HSA-9706019 | 3.688169e-01 | 0.433 | 0 | 0 |
| Regulation of RUNX3 expression and activity | R-HSA-8941858 | 2.669374e-01 | 0.574 | 0 | 0 |
| Negative regulation of NOTCH4 signaling | R-HSA-9604323 | 2.669374e-01 | 0.574 | 0 | 0 |
| FBXL7 down-regulates AURKA during mitotic entry and in early mitosis | R-HSA-8854050 | 3.443370e-01 | 0.463 | 0 | 0 |
| SCF-beta-TrCP mediated degradation of Emi1 | R-HSA-174113 | 3.443370e-01 | 0.463 | 0 | 0 |
| DDX58/IFIH1-mediated induction of interferon-alpha/beta | R-HSA-168928 | 3.739798e-01 | 0.427 | 0 | 0 |
| Expression of BMAL (ARNTL), CLOCK, and NPAS2 | R-HSA-9931509 | 4.161896e-01 | 0.381 | 0 | 0 |
| Transmission across Chemical Synapses | R-HSA-112315 | 2.339131e-01 | 0.631 | 0 | 0 |
| Positive Regulation of CDH1 Gene Transcription | R-HSA-9764790 | 3.358161e-01 | 0.474 | 0 | 0 |
| Interleukin-37 signaling | R-HSA-9008059 | 2.392640e-01 | 0.621 | 0 | 0 |
| Cross-presentation of soluble exogenous antigens (endosomes) | R-HSA-1236978 | 2.516946e-01 | 0.599 | 0 | 0 |
| GSK3B-mediated proteasomal degradation of PD-L1(CD274) | R-HSA-9929356 | 2.516946e-01 | 0.599 | 0 | 0 |
| Inflammasomes | R-HSA-622312 | 3.812253e-01 | 0.419 | 0 | 0 |
| Degradation of DVL | R-HSA-4641258 | 3.802981e-01 | 0.420 | 0 | 0 |
| Hedgehog 'on' state | R-HSA-5632684 | 3.059003e-01 | 0.514 | 1 | 1 |
| NGF-stimulated transcription | R-HSA-9031628 | 4.104461e-01 | 0.387 | 0 | 0 |
| Assembly and release of respiratory syncytial virus (RSV) virions | R-HSA-9820962 | 3.358161e-01 | 0.474 | 0 | 0 |
| Signaling by PDGFR in disease | R-HSA-9671555 | 2.387467e-01 | 0.622 | 0 | 0 |
| Synthesis of active ubiquitin: roles of E1 and E2 enzymes | R-HSA-8866652 | 3.606225e-01 | 0.443 | 0 | 0 |
| Vif-mediated degradation of APOBEC3G | R-HSA-180585 | 3.623074e-01 | 0.441 | 0 | 0 |
| Degradation of AXIN | R-HSA-4641257 | 3.802981e-01 | 0.420 | 0 | 0 |
| Signaling by NTRK2 (TRKB) | R-HSA-9006115 | 3.606225e-01 | 0.443 | 0 | 0 |
| Response of Mtb to phagocytosis | R-HSA-9637690 | 3.298238e-01 | 0.482 | 0 | 0 |
| Zinc transporters | R-HSA-435354 | 2.310196e-01 | 0.636 | 0 | 0 |
| G1/S-Specific Transcription | R-HSA-69205 | 3.623074e-01 | 0.441 | 0 | 0 |
| RUNX3 Regulates Immune Response and Cell Migration | R-HSA-8949275 | 2.347259e-01 | 0.629 | 0 | 0 |
| Respiratory syncytial virus genome replication | R-HSA-9834752 | 3.023194e-01 | 0.520 | 0 | 0 |
| ATF6 (ATF6-alpha) activates chaperone genes | R-HSA-381183 | 4.011505e-01 | 0.397 | 0 | 0 |
| Vpu mediated degradation of CD4 | R-HSA-180534 | 3.086175e-01 | 0.511 | 0 | 0 |
| Regulation of Apoptosis | R-HSA-169911 | 3.443370e-01 | 0.463 | 0 | 0 |
| Interleukin-1 family signaling | R-HSA-446652 | 2.270856e-01 | 0.644 | 0 | 0 |
| Ubiquitin-Mediated Degradation of Phosphorylated Cdc25A | R-HSA-69601 | 3.619818e-01 | 0.441 | 0 | 0 |
| p53-Independent G1/S DNA Damage Checkpoint | R-HSA-69613 | 3.619818e-01 | 0.441 | 0 | 0 |
| SARS-CoV-2 activates/modulates innate and adaptive immune responses | R-HSA-9705671 | 3.082123e-01 | 0.511 | 0 | 0 |
| Tandem pore domain potassium channels | R-HSA-1296346 | 3.358161e-01 | 0.474 | 0 | 0 |
| Selenoamino acid metabolism | R-HSA-2408522 | 3.208282e-01 | 0.494 | 0 | 0 |
| Early SARS-CoV-2 Infection Events | R-HSA-9772572 | 4.049701e-01 | 0.393 | 0 | 0 |
| Replication of the SARS-CoV-2 genome | R-HSA-9694686 | 3.296477e-01 | 0.482 | 0 | 0 |
| XBP1(S) activates chaperone genes | R-HSA-381038 | 2.629131e-01 | 0.580 | 0 | 0 |
| SARS-CoV-1 Genome Replication and Transcription | R-HSA-9679514 | 2.310196e-01 | 0.636 | 0 | 0 |
| IRE1alpha activates chaperones | R-HSA-381070 | 3.285066e-01 | 0.483 | 0 | 0 |
| SARS-CoV-2 Genome Replication and Transcription | R-HSA-9694682 | 3.792819e-01 | 0.421 | 0 | 0 |
| Unfolded Protein Response (UPR) | R-HSA-381119 | 2.741291e-01 | 0.562 | 0 | 0 |
| Regulation of gene expression in beta cells | R-HSA-210745 | 4.017526e-01 | 0.396 | 0 | 0 |
| HCN channels | R-HSA-1296061 | 4.241600e-01 | 0.372 | 0 | 0 |
| NFE2L2 regulating ER-stress associated genes | R-HSA-9818035 | 4.241600e-01 | 0.372 | 0 | 0 |
| RUNX3 regulates BCL2L11 (BIM) transcription | R-HSA-8952158 | 4.241600e-01 | 0.372 | 0 | 0 |
| Loss of Function of FBXW7 in Cancer and NOTCH1 Signaling | R-HSA-2644607 | 4.241600e-01 | 0.372 | 0 | 0 |
| FBXW7 Mutants and NOTCH1 in Cancer | R-HSA-2644605 | 4.241600e-01 | 0.372 | 0 | 0 |
| GRB7 events in ERBB2 signaling | R-HSA-1306955 | 4.241600e-01 | 0.372 | 0 | 0 |
| Defective LFNG causes SCDO3 | R-HSA-5083630 | 4.241600e-01 | 0.372 | 0 | 0 |
| Regulation of gap junction activity | R-HSA-191650 | 4.241600e-01 | 0.372 | 0 | 0 |
| Transcriptional activation of cell cycle inhibitor p21 | R-HSA-69895 | 4.241600e-01 | 0.372 | 0 | 0 |
| Transcriptional activation of p53 responsive genes | R-HSA-69560 | 4.241600e-01 | 0.372 | 0 | 0 |
| SARS-CoV-1-mediated effects on programmed cell death | R-HSA-9692913 | 4.241600e-01 | 0.372 | 0 | 0 |
| Activation of NOXA and translocation to mitochondria | R-HSA-111448 | 4.241600e-01 | 0.372 | 0 | 0 |
| TNFR1-mediated ceramide production | R-HSA-5626978 | 4.241600e-01 | 0.372 | 0 | 0 |
| Cyclin E associated events during G1/S transition | R-HSA-69202 | 4.272112e-01 | 0.369 | 0 | 0 |
| TNFR1-induced proapoptotic signaling | R-HSA-5357786 | 4.280813e-01 | 0.368 | 0 | 0 |
| Post-translational protein modification | R-HSA-597592 | 4.285751e-01 | 0.368 | 0 | 0 |
| Phosphorylation and nuclear translocation of the CRY:PER:kinase complex | R-HSA-9931530 | 4.326792e-01 | 0.364 | 0 | 0 |
| RUNX3 regulates NOTCH signaling | R-HSA-8941856 | 4.326792e-01 | 0.364 | 0 | 0 |
| GRB2 events in EGFR signaling | R-HSA-179812 | 4.326792e-01 | 0.364 | 0 | 0 |
| Downregulation of ERBB2:ERBB3 signaling | R-HSA-1358803 | 4.326792e-01 | 0.364 | 0 | 0 |
| p75NTR recruits signalling complexes | R-HSA-209543 | 4.326792e-01 | 0.364 | 0 | 0 |
| Signaling by LTK | R-HSA-9842663 | 4.326792e-01 | 0.364 | 0 | 0 |
| Activated NTRK2 signals through FRS2 and FRS3 | R-HSA-9028731 | 4.326792e-01 | 0.364 | 0 | 0 |
| Diseases of Immune System | R-HSA-5260271 | 4.340196e-01 | 0.362 | 0 | 0 |
| Diseases associated with the TLR signaling cascade | R-HSA-5602358 | 4.340196e-01 | 0.362 | 0 | 0 |
| EGFR downregulation | R-HSA-182971 | 4.423794e-01 | 0.354 | 0 | 0 |
| Regulation of RUNX2 expression and activity | R-HSA-8939902 | 4.492054e-01 | 0.348 | 0 | 0 |
| Regulation of MITF-M-dependent genes involved in cell cycle and proliferation | R-HSA-9825892 | 4.519751e-01 | 0.345 | 0 | 0 |
| Listeria monocytogenes entry into host cells | R-HSA-8876384 | 4.519751e-01 | 0.345 | 0 | 0 |
| Ribavirin ADME | R-HSA-9755088 | 4.519751e-01 | 0.345 | 0 | 0 |
| Serine metabolism | R-HSA-977347 | 4.519751e-01 | 0.345 | 0 | 0 |
| Mitochondrial calcium ion transport | R-HSA-8949215 | 4.519751e-01 | 0.345 | 0 | 0 |
| Assembly Of The HIV Virion | R-HSA-175474 | 4.519751e-01 | 0.345 | 0 | 0 |
| Nuclear Events (kinase and transcription factor activation) | R-HSA-198725 | 4.545484e-01 | 0.342 | 0 | 0 |
| Cyclin A:Cdk2-associated events at S phase entry | R-HSA-69656 | 4.545484e-01 | 0.342 | 0 | 0 |
| Oxygen-dependent proline hydroxylation of Hypoxia-inducible Factor Alpha | R-HSA-1234176 | 4.585359e-01 | 0.339 | 0 | 0 |
| Toll Like Receptor 4 (TLR4) Cascade | R-HSA-166016 | 4.593897e-01 | 0.338 | 0 | 0 |
| Downregulation of SMAD2/3:SMAD4 transcriptional activity | R-HSA-2173795 | 4.623876e-01 | 0.335 | 0 | 0 |
| Signaling by WNT in cancer | R-HSA-4791275 | 4.623876e-01 | 0.335 | 0 | 0 |
| G0 and Early G1 | R-HSA-1538133 | 4.623876e-01 | 0.335 | 0 | 0 |
| PDH complex synthesizes acetyl-CoA from PYR | R-HSA-9861559 | 4.632949e-01 | 0.334 | 0 | 0 |
| Regulation of TP53 Activity through Association with Co-factors | R-HSA-6804759 | 4.632949e-01 | 0.334 | 0 | 0 |
| Membrane binding and targetting of GAG proteins | R-HSA-174490 | 4.632949e-01 | 0.334 | 0 | 0 |
| NR1H2 & NR1H3 regulate gene expression linked to lipogenesis | R-HSA-9029558 | 4.632949e-01 | 0.334 | 0 | 0 |
| Interleukin-6 signaling | R-HSA-1059683 | 4.632949e-01 | 0.334 | 0 | 0 |
| ATF6 (ATF6-alpha) activates chaperones | R-HSA-381033 | 4.632949e-01 | 0.334 | 0 | 0 |
| Signaling by PDGF | R-HSA-186797 | 4.638299e-01 | 0.334 | 0 | 0 |
| Inositol phosphate metabolism | R-HSA-1483249 | 4.690698e-01 | 0.329 | 0 | 0 |
| Signaling by FGFR1 in disease | R-HSA-5655302 | 4.692859e-01 | 0.329 | 0 | 0 |
| Degradation of CRY and PER proteins | R-HSA-9932298 | 4.692859e-01 | 0.329 | 0 | 0 |
| Signaling by TGFB family members | R-HSA-9006936 | 4.709725e-01 | 0.327 | 0 | 0 |
| Cdc20:Phospho-APC/C mediated degradation of Cyclin A | R-HSA-174184 | 4.743682e-01 | 0.324 | 0 | 0 |
| AMPK-induced ERAD and lysosome mediated degradation of PD-L1(CD274) | R-HSA-9931269 | 4.743682e-01 | 0.324 | 0 | 0 |
| Regulation of MITF-M dependent genes involved in invasion | R-HSA-9854909 | 4.747774e-01 | 0.324 | 0 | 0 |
| NFE2L2 regulating inflammation associated genes | R-HSA-9818026 | 4.747774e-01 | 0.324 | 0 | 0 |
| Enhanced binding of GP1BA variant to VWF multimer:collagen | R-HSA-9845620 | 4.747774e-01 | 0.324 | 0 | 0 |
| FLT3 signaling by CBL mutants | R-HSA-9706377 | 4.747774e-01 | 0.324 | 0 | 0 |
| Defective binding of VWF variant to GPIb:IX:V | R-HSA-9846298 | 4.747774e-01 | 0.324 | 0 | 0 |
| Post-transcriptional silencing by small RNAs | R-HSA-426496 | 4.747774e-01 | 0.324 | 0 | 0 |
| RUNX1 regulates transcription of genes involved in interleukin signaling | R-HSA-8939247 | 4.747774e-01 | 0.324 | 0 | 0 |
| RUNX1 regulates transcription of genes involved in BCR signaling | R-HSA-8939245 | 4.747774e-01 | 0.324 | 0 | 0 |
| Suppression of autophagy | R-HSA-9636569 | 4.747774e-01 | 0.324 | 0 | 0 |
| Muscarinic acetylcholine receptors | R-HSA-390648 | 4.747774e-01 | 0.324 | 0 | 0 |
| SMAC(DIABLO)-mediated dissociation of IAP:caspase complexes | R-HSA-111464 | 4.747774e-01 | 0.324 | 0 | 0 |
| SMAC (DIABLO) binds to IAPs | R-HSA-111463 | 4.747774e-01 | 0.324 | 0 | 0 |
| Phosphorylation and nuclear translocation of BMAL1 (ARNTL) and CLOCK | R-HSA-9931529 | 4.747774e-01 | 0.324 | 0 | 0 |
| DEx/H-box helicases activate type I IFN and inflammatory cytokines production | R-HSA-3134963 | 4.747774e-01 | 0.324 | 0 | 0 |
| Toxicity of botulinum toxin type C (botC) | R-HSA-5250971 | 4.747774e-01 | 0.324 | 0 | 0 |
| Zinc efflux and compartmentalization by the SLC30 family | R-HSA-435368 | 4.747774e-01 | 0.324 | 0 | 0 |
| Assembly of Viral Components at the Budding Site | R-HSA-168316 | 4.747774e-01 | 0.324 | 0 | 0 |
| Regulation of MITF-M-dependent genes involved in lysosome biogenesis and autophagy | R-HSA-9857377 | 4.754462e-01 | 0.323 | 0 | 0 |
| Notch-HLH transcription pathway | R-HSA-350054 | 4.754462e-01 | 0.323 | 0 | 0 |
| NOTCH3 Activation and Transmission of Signal to the Nucleus | R-HSA-9013507 | 4.754462e-01 | 0.323 | 0 | 0 |
| Interleukin-4 and Interleukin-13 signaling | R-HSA-6785807 | 4.765565e-01 | 0.322 | 0 | 0 |
| Negative regulation of FGFR1 signaling | R-HSA-5654726 | 4.821378e-01 | 0.317 | 0 | 0 |
| Integrin signaling | R-HSA-354192 | 4.821378e-01 | 0.317 | 0 | 0 |
| HDR through Single Strand Annealing (SSA) | R-HSA-5685938 | 4.821378e-01 | 0.317 | 0 | 0 |
| FGFR1 mutant receptor activation | R-HSA-1839124 | 4.821378e-01 | 0.317 | 0 | 0 |
| Cyclin A/B1/B2 associated events during G2/M transition | R-HSA-69273 | 4.821378e-01 | 0.317 | 0 | 0 |
| MAPK6/MAPK4 signaling | R-HSA-5687128 | 4.844251e-01 | 0.315 | 0 | 0 |
| Mitochondrial protein degradation | R-HSA-9837999 | 4.868365e-01 | 0.313 | 0 | 0 |
| APC/C:Cdh1 mediated degradation of Cdc20 and other APC/C:Cdh1 targeted proteins in late mitosis/early G1 | R-HSA-174178 | 4.900649e-01 | 0.310 | 0 | 0 |
| APC:Cdc20 mediated degradation of cell cycle proteins prior to satisfation of the cell cycle checkpoint | R-HSA-179419 | 4.900649e-01 | 0.310 | 0 | 0 |
| Amino acids regulate mTORC1 | R-HSA-9639288 | 4.900649e-01 | 0.310 | 0 | 0 |
| Regulation of PTEN stability and activity | R-HSA-8948751 | 4.900649e-01 | 0.310 | 0 | 0 |
| ERBB2 Activates PTK6 Signaling | R-HSA-8847993 | 4.929145e-01 | 0.307 | 0 | 0 |
| Beta oxidation of hexanoyl-CoA to butanoyl-CoA | R-HSA-77350 | 4.929145e-01 | 0.307 | 0 | 0 |
| Beta oxidation of lauroyl-CoA to decanoyl-CoA-CoA | R-HSA-77310 | 4.929145e-01 | 0.307 | 0 | 0 |
| Beta oxidation of octanoyl-CoA to hexanoyl-CoA | R-HSA-77348 | 4.929145e-01 | 0.307 | 0 | 0 |
| NRIF signals cell death from the nucleus | R-HSA-205043 | 4.929145e-01 | 0.307 | 0 | 0 |
| Synthesis And Processing Of GAG, GAGPOL Polyproteins | R-HSA-174495 | 4.929145e-01 | 0.307 | 0 | 0 |
| Malate-aspartate shuttle | R-HSA-9856872 | 4.929145e-01 | 0.307 | 0 | 0 |
| Acyl chain remodeling of CL | R-HSA-1482798 | 4.929145e-01 | 0.307 | 0 | 0 |
| Circadian clock | R-HSA-9909396 | 4.941897e-01 | 0.306 | 0 | 0 |
| Syndecan interactions | R-HSA-3000170 | 4.984412e-01 | 0.302 | 0 | 0 |
| Growth hormone receptor signaling | R-HSA-982772 | 4.984412e-01 | 0.302 | 0 | 0 |
| Regulation of CDH1 posttranslational processing and trafficking to plasma membrane | R-HSA-9768727 | 5.015937e-01 | 0.300 | 0 | 0 |
| Signaling by FGFR4 | R-HSA-5654743 | 5.038346e-01 | 0.298 | 0 | 0 |
| TGF-beta receptor signaling activates SMADs | R-HSA-2173789 | 5.038346e-01 | 0.298 | 0 | 0 |
| CDK-mediated phosphorylation and removal of Cdc6 | R-HSA-69017 | 5.056059e-01 | 0.296 | 0 | 0 |
| Toll Like Receptor 9 (TLR9) Cascade | R-HSA-168138 | 5.124788e-01 | 0.290 | 0 | 0 |
| Negative regulation of FGFR2 signaling | R-HSA-5654727 | 5.207227e-01 | 0.283 | 0 | 0 |
| Diseases of DNA Double-Strand Break Repair | R-HSA-9675136 | 5.207227e-01 | 0.283 | 0 | 0 |
| Defective homologous recombination repair (HRR) due to BRCA2 loss of function | R-HSA-9701190 | 5.207227e-01 | 0.283 | 0 | 0 |
| Amine ligand-binding receptors | R-HSA-375280 | 5.207754e-01 | 0.283 | 0 | 0 |
| SCF(Skp2)-mediated degradation of p27/p21 | R-HSA-187577 | 5.207754e-01 | 0.283 | 0 | 0 |
| ADP signalling through P2Y purinoceptor 1 | R-HSA-418592 | 5.209141e-01 | 0.283 | 0 | 0 |
| CD209 (DC-SIGN) signaling | R-HSA-5621575 | 5.209141e-01 | 0.283 | 0 | 0 |
| Processing of Capped Intronless Pre-mRNA | R-HSA-75067 | 5.209141e-01 | 0.283 | 0 | 0 |
| Signaling by NOTCH1 t(7;9)(NOTCH1:M1580_K2555) Translocation Mutant | R-HSA-2660825 | 5.209481e-01 | 0.283 | 0 | 0 |
| Defects of platelet adhesion to exposed collagen | R-HSA-9823587 | 5.209481e-01 | 0.283 | 0 | 0 |
| Constitutive Signaling by NOTCH1 t(7;9)(NOTCH1:M1580_K2555) Translocation Mutant | R-HSA-2660826 | 5.209481e-01 | 0.283 | 0 | 0 |
| Plus-strand DNA synthesis | R-HSA-164525 | 5.209481e-01 | 0.283 | 0 | 0 |
| Activation of caspases through apoptosome-mediated cleavage | R-HSA-111459 | 5.209481e-01 | 0.283 | 0 | 0 |
| Inhibition of Signaling by Overexpressed EGFR | R-HSA-5638303 | 5.209481e-01 | 0.283 | 0 | 0 |
| SLIT2:ROBO1 increases RHOA activity | R-HSA-8985586 | 5.209481e-01 | 0.283 | 0 | 0 |
| Signaling by Overexpressed Wild-Type EGFR in Cancer | R-HSA-5638302 | 5.209481e-01 | 0.283 | 0 | 0 |
| Loss of MECP2 binding ability to the NCoR/SMRT complex | R-HSA-9022537 | 5.209481e-01 | 0.283 | 0 | 0 |
| Signalling to p38 via RIT and RIN | R-HSA-187706 | 5.209481e-01 | 0.283 | 0 | 0 |
| VEGF binds to VEGFR leading to receptor dimerization | R-HSA-195399 | 5.209481e-01 | 0.283 | 0 | 0 |
| Release of apoptotic factors from the mitochondria | R-HSA-111457 | 5.209481e-01 | 0.283 | 0 | 0 |
| VEGF ligand-receptor interactions | R-HSA-194313 | 5.209481e-01 | 0.283 | 0 | 0 |
| SMAC, XIAP-regulated apoptotic response | R-HSA-111469 | 5.209481e-01 | 0.283 | 0 | 0 |
| Epithelial-Mesenchymal Transition (EMT) during gastrulation | R-HSA-9758919 | 5.209481e-01 | 0.283 | 0 | 0 |
| TRAIL signaling | R-HSA-75158 | 5.209481e-01 | 0.283 | 0 | 0 |
| APC/C:Cdc20 mediated degradation of mitotic proteins | R-HSA-176409 | 5.209721e-01 | 0.283 | 0 | 0 |
| Competing endogenous RNAs (ceRNAs) regulate PTEN translation | R-HSA-8948700 | 5.214765e-01 | 0.283 | 0 | 0 |
| TRAF6-mediated induction of TAK1 complex within TLR4 complex | R-HSA-937072 | 5.214765e-01 | 0.283 | 0 | 0 |
| TGF-beta receptor signaling in EMT (epithelial to mesenchymal transition) | R-HSA-2173791 | 5.214765e-01 | 0.283 | 0 | 0 |
| SHC1 events in EGFR signaling | R-HSA-180336 | 5.214765e-01 | 0.283 | 0 | 0 |
| TICAM1, RIP1-mediated IKK complex recruitment | R-HSA-168927 | 5.214765e-01 | 0.283 | 0 | 0 |
| G beta:gamma signalling through BTK | R-HSA-8964315 | 5.214765e-01 | 0.283 | 0 | 0 |
| ERBB2 Regulates Cell Motility | R-HSA-6785631 | 5.214765e-01 | 0.283 | 0 | 0 |
| IRF3-mediated induction of type I IFN | R-HSA-3270619 | 5.214765e-01 | 0.283 | 0 | 0 |
| PCP/CE pathway | R-HSA-4086400 | 5.346746e-01 | 0.272 | 0 | 0 |
| Activation of APC/C and APC/C:Cdc20 mediated degradation of mitotic proteins | R-HSA-176814 | 5.361462e-01 | 0.271 | 0 | 0 |
| Detoxification of Reactive Oxygen Species | R-HSA-3299685 | 5.361462e-01 | 0.271 | 0 | 0 |
| Platelet Aggregation (Plug Formation) | R-HSA-76009 | 5.374635e-01 | 0.270 | 0 | 0 |
| Signaling by FGFR3 | R-HSA-5654741 | 5.374635e-01 | 0.270 | 0 | 0 |
| Presynaptic phase of homologous DNA pairing and strand exchange | R-HSA-5693616 | 5.394960e-01 | 0.268 | 0 | 0 |
| PERK regulates gene expression | R-HSA-381042 | 5.394960e-01 | 0.268 | 0 | 0 |
| G protein gated Potassium channels | R-HSA-1296059 | 5.428262e-01 | 0.265 | 0 | 0 |
| Inhibition of voltage gated Ca2+ channels via Gbeta/gamma subunits | R-HSA-997272 | 5.428262e-01 | 0.265 | 0 | 0 |
| Activation of G protein gated Potassium channels | R-HSA-1296041 | 5.428262e-01 | 0.265 | 0 | 0 |
| VEGFR2 mediated cell proliferation | R-HSA-5218921 | 5.428262e-01 | 0.265 | 0 | 0 |
| HDMs demethylate histones | R-HSA-3214842 | 5.428262e-01 | 0.265 | 0 | 0 |
| Formation of the nephric duct | R-HSA-9830364 | 5.428262e-01 | 0.265 | 0 | 0 |
| Interleukin-7 signaling | R-HSA-1266695 | 5.428262e-01 | 0.265 | 0 | 0 |
| Antigen processing-Cross presentation | R-HSA-1236975 | 5.449171e-01 | 0.264 | 0 | 0 |
| TRAF6 mediated induction of NFkB and MAP kinases upon TLR7/8 or 9 activation | R-HSA-975138 | 5.449171e-01 | 0.264 | 0 | 0 |
| MyD88 cascade initiated on plasma membrane | R-HSA-975871 | 5.456009e-01 | 0.263 | 0 | 0 |
| Toll Like Receptor 10 (TLR10) Cascade | R-HSA-168142 | 5.456009e-01 | 0.263 | 0 | 0 |
| Toll Like Receptor 5 (TLR5) Cascade | R-HSA-168176 | 5.456009e-01 | 0.263 | 0 | 0 |
| TP53 Regulates Transcription of Caspase Activators and Caspases | R-HSA-6803207 | 5.489382e-01 | 0.260 | 0 | 0 |
| Attachment and Entry | R-HSA-9678110 | 5.489382e-01 | 0.260 | 0 | 0 |
| Caspase activation via Death Receptors in the presence of ligand | R-HSA-140534 | 5.489382e-01 | 0.260 | 0 | 0 |
| Class I peroxisomal membrane protein import | R-HSA-9603798 | 5.489382e-01 | 0.260 | 0 | 0 |
| Phase 4 - resting membrane potential | R-HSA-5576886 | 5.489382e-01 | 0.260 | 0 | 0 |
| Regulation of NF-kappa B signaling | R-HSA-9758274 | 5.489382e-01 | 0.260 | 0 | 0 |
| Regulation of gene expression in late stage (branching morphogenesis) pancreatic bud precursor cells | R-HSA-210744 | 5.489382e-01 | 0.260 | 0 | 0 |
| TP53 Regulates Transcription of Cell Cycle Genes | R-HSA-6791312 | 5.511118e-01 | 0.259 | 0 | 0 |
| Regulation of pyruvate metabolism | R-HSA-9861718 | 5.538787e-01 | 0.257 | 0 | 0 |
| Signaling by TGFBR3 | R-HSA-9839373 | 5.538787e-01 | 0.257 | 0 | 0 |
| PI3K/AKT Signaling in Cancer | R-HSA-2219528 | 5.548586e-01 | 0.256 | 0 | 0 |
| MyD88 dependent cascade initiated on endosome | R-HSA-975155 | 5.558517e-01 | 0.255 | 0 | 0 |
| RNA Polymerase III Abortive And Retractive Initiation | R-HSA-749476 | 5.578879e-01 | 0.253 | 0 | 0 |
| RNA Polymerase III Transcription | R-HSA-74158 | 5.578879e-01 | 0.253 | 0 | 0 |
| GPVI-mediated activation cascade | R-HSA-114604 | 5.578879e-01 | 0.253 | 0 | 0 |
| Small interfering RNA (siRNA) biogenesis | R-HSA-426486 | 5.630626e-01 | 0.249 | 0 | 0 |
| Signaling by LTK in cancer | R-HSA-9842640 | 5.630626e-01 | 0.249 | 0 | 0 |
| Activation of NIMA Kinases NEK9, NEK6, NEK7 | R-HSA-2980767 | 5.630626e-01 | 0.249 | 0 | 0 |
| STAT5 Activation | R-HSA-9645135 | 5.630626e-01 | 0.249 | 0 | 0 |
| Erythropoietin activates STAT5 | R-HSA-9027283 | 5.630626e-01 | 0.249 | 0 | 0 |
| Uncoating of the HIV Virion | R-HSA-162585 | 5.630626e-01 | 0.249 | 0 | 0 |
| Abacavir transmembrane transport | R-HSA-2161517 | 5.630626e-01 | 0.249 | 0 | 0 |
| Defective factor VIII causes hemophilia A | R-HSA-9662001 | 5.630626e-01 | 0.249 | 0 | 0 |
| Chylomicron clearance | R-HSA-8964026 | 5.630626e-01 | 0.249 | 0 | 0 |
| VLDL assembly | R-HSA-8866423 | 5.630626e-01 | 0.249 | 0 | 0 |
| Activated NOTCH1 Transmits Signal to the Nucleus | R-HSA-2122948 | 5.641455e-01 | 0.249 | 0 | 0 |
| Phosphorylated BMAL1:CLOCK (ARNTL:CLOCK) activates expression of core clock genes | R-HSA-9931510 | 5.641455e-01 | 0.249 | 0 | 0 |
| Adrenaline,noradrenaline inhibits insulin secretion | R-HSA-400042 | 5.641455e-01 | 0.249 | 0 | 0 |
| TRP channels | R-HSA-3295583 | 5.641455e-01 | 0.249 | 0 | 0 |
| Glutamate Neurotransmitter Release Cycle | R-HSA-210500 | 5.641455e-01 | 0.249 | 0 | 0 |
| Metalloprotease DUBs | R-HSA-5689901 | 5.641455e-01 | 0.249 | 0 | 0 |
| TCR signaling | R-HSA-202403 | 5.666848e-01 | 0.247 | 0 | 0 |
| Retrograde transport at the Trans-Golgi-Network | R-HSA-6811440 | 5.700030e-01 | 0.244 | 0 | 0 |
| mRNA decay by 5' to 3' exoribonuclease | R-HSA-430039 | 5.752722e-01 | 0.240 | 0 | 0 |
| Beta oxidation of decanoyl-CoA to octanoyl-CoA-CoA | R-HSA-77346 | 5.752722e-01 | 0.240 | 0 | 0 |
| Disorders of Developmental Biology | R-HSA-9675151 | 5.752722e-01 | 0.240 | 0 | 0 |
| Acetylcholine regulates insulin secretion | R-HSA-399997 | 5.752722e-01 | 0.240 | 0 | 0 |
| Response to metal ions | R-HSA-5660526 | 5.752722e-01 | 0.240 | 0 | 0 |
| Ovarian tumor domain proteases | R-HSA-5689896 | 5.758762e-01 | 0.240 | 0 | 0 |
| Extra-nuclear estrogen signaling | R-HSA-9009391 | 5.796297e-01 | 0.237 | 0 | 0 |
| Regulation of beta-cell development | R-HSA-186712 | 5.803591e-01 | 0.236 | 0 | 0 |
| TNFR1-induced NF-kappa-B signaling pathway | R-HSA-5357956 | 5.848460e-01 | 0.233 | 0 | 0 |
| RNA Polymerase I Transcription Termination | R-HSA-73863 | 5.848460e-01 | 0.233 | 0 | 0 |
| Transport of nucleosides and free purine and pyrimidine bases across the plasma membrane | R-HSA-83936 | 5.848460e-01 | 0.233 | 0 | 0 |
| Regulation of actin dynamics for phagocytic cup formation | R-HSA-2029482 | 5.914093e-01 | 0.228 | 0 | 0 |
| Metabolism of nitric oxide: NOS3 activation and regulation | R-HSA-202131 | 5.934417e-01 | 0.227 | 0 | 0 |
| Homologous DNA Pairing and Strand Exchange | R-HSA-5693579 | 5.934417e-01 | 0.227 | 0 | 0 |
| Metabolism of polyamines | R-HSA-351202 | 5.946147e-01 | 0.226 | 0 | 0 |
| Toll Like Receptor 7/8 (TLR7/8) Cascade | R-HSA-168181 | 5.985122e-01 | 0.223 | 0 | 0 |
| PI3K events in ERBB2 signaling | R-HSA-1963642 | 6.004645e-01 | 0.222 | 0 | 0 |
| Regulation of NPAS4 gene expression | R-HSA-9768759 | 6.004645e-01 | 0.222 | 0 | 0 |
| Specification of primordial germ cells | R-HSA-9827857 | 6.004645e-01 | 0.222 | 0 | 0 |
| RUNX3 regulates WNT signaling | R-HSA-8951430 | 6.014770e-01 | 0.221 | 0 | 0 |
| Binding of TCF/LEF:CTNNB1 to target gene promoters | R-HSA-4411364 | 6.014770e-01 | 0.221 | 0 | 0 |
| PP2A-mediated dephosphorylation of key metabolic factors | R-HSA-163767 | 6.014770e-01 | 0.221 | 0 | 0 |
| IFNG signaling activates MAPKs | R-HSA-9732724 | 6.014770e-01 | 0.221 | 0 | 0 |
| Recycling of eIF2:GDP | R-HSA-72731 | 6.014770e-01 | 0.221 | 0 | 0 |
| Pre-NOTCH Processing in the Endoplasmic Reticulum | R-HSA-1912399 | 6.014770e-01 | 0.221 | 0 | 0 |
| Disinhibition of SNARE formation | R-HSA-114516 | 6.014770e-01 | 0.221 | 0 | 0 |
| Insulin effects increased synthesis of Xylulose-5-Phosphate | R-HSA-163754 | 6.014770e-01 | 0.221 | 0 | 0 |
| Microbial modulation of RIPK1-mediated regulated necrosis | R-HSA-9686347 | 6.014770e-01 | 0.221 | 0 | 0 |
| Activated NTRK3 signals through PI3K | R-HSA-9603381 | 6.014770e-01 | 0.221 | 0 | 0 |
| LDL remodeling | R-HSA-8964041 | 6.014770e-01 | 0.221 | 0 | 0 |
| Netrin mediated repulsion signals | R-HSA-418886 | 6.014770e-01 | 0.221 | 0 | 0 |
| Phase 3 - rapid repolarisation | R-HSA-5576890 | 6.014770e-01 | 0.221 | 0 | 0 |
| Role of ABL in ROBO-SLIT signaling | R-HSA-428890 | 6.014770e-01 | 0.221 | 0 | 0 |
| CHL1 interactions | R-HSA-447041 | 6.014770e-01 | 0.221 | 0 | 0 |
| Displacement of DNA glycosylase by APEX1 | R-HSA-110357 | 6.014770e-01 | 0.221 | 0 | 0 |
| Formation of the HIV-1 Early Elongation Complex | R-HSA-167158 | 6.049075e-01 | 0.218 | 0 | 0 |
| Formation of the Early Elongation Complex | R-HSA-113418 | 6.049075e-01 | 0.218 | 0 | 0 |
| ATF4 activates genes in response to endoplasmic reticulum stress | R-HSA-380994 | 6.049075e-01 | 0.218 | 0 | 0 |
| Global Genome Nucleotide Excision Repair (GG-NER) | R-HSA-5696399 | 6.099205e-01 | 0.215 | 0 | 0 |
| Pentose phosphate pathway | R-HSA-71336 | 6.105683e-01 | 0.214 | 0 | 0 |
| Respiratory syncytial virus (RSV) genome replication, transcription and translation | R-HSA-9820965 | 6.105683e-01 | 0.214 | 0 | 0 |
| Cargo recognition for clathrin-mediated endocytosis | R-HSA-8856825 | 6.124930e-01 | 0.213 | 0 | 0 |
| Extracellular matrix organization | R-HSA-1474244 | 6.145537e-01 | 0.211 | 0 | 0 |
| Azathioprine ADME | R-HSA-9748787 | 6.164764e-01 | 0.210 | 0 | 0 |
| NCAM signaling for neurite out-growth | R-HSA-375165 | 6.223341e-01 | 0.206 | 0 | 0 |
| Regulation of APC/C activators between G1/S and early anaphase | R-HSA-176408 | 6.223341e-01 | 0.206 | 0 | 0 |
| Heme signaling | R-HSA-9707616 | 6.223341e-01 | 0.206 | 0 | 0 |
| DARPP-32 events | R-HSA-180024 | 6.243151e-01 | 0.205 | 0 | 0 |
| G beta:gamma signalling through PLC beta | R-HSA-418217 | 6.245123e-01 | 0.204 | 0 | 0 |
| RNA Polymerase III Transcription Termination | R-HSA-73980 | 6.245123e-01 | 0.204 | 0 | 0 |
| Regulation of TP53 Activity through Methylation | R-HSA-6804760 | 6.245123e-01 | 0.204 | 0 | 0 |
| Serotonin Neurotransmitter Release Cycle | R-HSA-181429 | 6.245123e-01 | 0.204 | 0 | 0 |
| Presynaptic function of Kainate receptors | R-HSA-500657 | 6.245123e-01 | 0.204 | 0 | 0 |
| Tie2 Signaling | R-HSA-210993 | 6.245123e-01 | 0.204 | 0 | 0 |
| Nephron development | R-HSA-9831926 | 6.245123e-01 | 0.204 | 0 | 0 |
| Translation of Replicase and Assembly of the Replication Transcription Complex | R-HSA-9679504 | 6.245123e-01 | 0.204 | 0 | 0 |
| Formation of Incision Complex in GG-NER | R-HSA-5696395 | 6.272427e-01 | 0.203 | 0 | 0 |
| TP53 Regulates Metabolic Genes | R-HSA-5628897 | 6.292154e-01 | 0.201 | 0 | 0 |
| Regulation of PD-L1(CD274) Post-translational modification | R-HSA-9909615 | 6.335595e-01 | 0.198 | 0 | 0 |
| Reverse Transcription of HIV RNA | R-HSA-162589 | 6.365162e-01 | 0.196 | 0 | 0 |
| Minus-strand DNA synthesis | R-HSA-164516 | 6.365162e-01 | 0.196 | 0 | 0 |
| phospho-PLA2 pathway | R-HSA-111995 | 6.365162e-01 | 0.196 | 0 | 0 |
| EGFR interacts with phospholipase C-gamma | R-HSA-212718 | 6.365162e-01 | 0.196 | 0 | 0 |
| Regulation of NPAS4 mRNA translation | R-HSA-9768778 | 6.365162e-01 | 0.196 | 0 | 0 |
| MET receptor recycling | R-HSA-8875656 | 6.365162e-01 | 0.196 | 0 | 0 |
| Regulation by c-FLIP | R-HSA-3371378 | 6.365162e-01 | 0.196 | 0 | 0 |
| Activation of RAS in B cells | R-HSA-1169092 | 6.365162e-01 | 0.196 | 0 | 0 |
| RUNX1 regulates transcription of genes involved in differentiation of myeloid cells | R-HSA-8939246 | 6.365162e-01 | 0.196 | 0 | 0 |
| BH3-only proteins associate with and inactivate anti-apoptotic BCL-2 members | R-HSA-111453 | 6.365162e-01 | 0.196 | 0 | 0 |
| Axonal growth inhibition (RHOA activation) | R-HSA-193634 | 6.365162e-01 | 0.196 | 0 | 0 |
| Dimerization of procaspase-8 | R-HSA-69416 | 6.365162e-01 | 0.196 | 0 | 0 |
| TGFBR3 PTM regulation | R-HSA-9839383 | 6.365162e-01 | 0.196 | 0 | 0 |
| SLC-mediated bile acid transport | R-HSA-9958517 | 6.365162e-01 | 0.196 | 0 | 0 |
| PTK6 Regulates RTKs and Their Effectors AKT1 and DOK1 | R-HSA-8849469 | 6.365162e-01 | 0.196 | 0 | 0 |
| Interleukin-23 signaling | R-HSA-9020933 | 6.365162e-01 | 0.196 | 0 | 0 |
| DAP12 signaling | R-HSA-2424491 | 6.430584e-01 | 0.192 | 0 | 0 |
| RNA Polymerase III Transcription Initiation | R-HSA-76046 | 6.430584e-01 | 0.192 | 0 | 0 |
| Energy dependent regulation of mTOR by LKB1-AMPK | R-HSA-380972 | 6.430584e-01 | 0.192 | 0 | 0 |
| RORA,B,C and NR1D1 (REV-ERBA) regulate gene expression | R-HSA-9933387 | 6.430584e-01 | 0.192 | 0 | 0 |
| Transcriptional Regulation by VENTX | R-HSA-8853884 | 6.434543e-01 | 0.191 | 0 | 0 |
| Neurexins and neuroligins | R-HSA-6794361 | 6.457544e-01 | 0.190 | 0 | 0 |
| Uptake and actions of bacterial toxins | R-HSA-5339562 | 6.457544e-01 | 0.190 | 0 | 0 |
| Abortive elongation of HIV-1 transcript in the absence of Tat | R-HSA-167242 | 6.474222e-01 | 0.189 | 0 | 0 |
| Prostacyclin signalling through prostacyclin receptor | R-HSA-392851 | 6.474222e-01 | 0.189 | 0 | 0 |
| mRNA decay by 3' to 5' exoribonuclease | R-HSA-429958 | 6.474222e-01 | 0.189 | 0 | 0 |
| Mechanical load activates signaling by PIEZO1 and integrins in osteocytes | R-HSA-9856532 | 6.474222e-01 | 0.189 | 0 | 0 |
| Other interleukin signaling | R-HSA-449836 | 6.474222e-01 | 0.189 | 0 | 0 |
| STING mediated induction of host immune responses | R-HSA-1834941 | 6.474222e-01 | 0.189 | 0 | 0 |
| Pyruvate metabolism | R-HSA-70268 | 6.563839e-01 | 0.183 | 0 | 0 |
| NR1H2 and NR1H3-mediated signaling | R-HSA-9024446 | 6.644438e-01 | 0.178 | 0 | 0 |
| NFE2L2 regulating MDR associated enzymes | R-HSA-9818032 | 6.684765e-01 | 0.175 | 0 | 0 |
| CASP8 activity is inhibited | R-HSA-5218900 | 6.684765e-01 | 0.175 | 0 | 0 |
| p75NTR regulates axonogenesis | R-HSA-193697 | 6.684765e-01 | 0.175 | 0 | 0 |
| Estrogen-stimulated signaling through PRKCZ | R-HSA-9634635 | 6.684765e-01 | 0.175 | 0 | 0 |
| Regulation of signaling by NODAL | R-HSA-1433617 | 6.684765e-01 | 0.175 | 0 | 0 |
| MAPK1 (ERK2) activation | R-HSA-112411 | 6.684765e-01 | 0.175 | 0 | 0 |
| MASTL Facilitates Mitotic Progression | R-HSA-2465910 | 6.684765e-01 | 0.175 | 0 | 0 |
| Activation of the TFAP2 (AP-2) family of transcription factors | R-HSA-8866907 | 6.684765e-01 | 0.175 | 0 | 0 |
| Regulation of NPAS4 gene transcription | R-HSA-9768777 | 6.684765e-01 | 0.175 | 0 | 0 |
| Interleukin-1 processing | R-HSA-448706 | 6.684765e-01 | 0.175 | 0 | 0 |
| Regulated proteolysis of p75NTR | R-HSA-193692 | 6.684765e-01 | 0.175 | 0 | 0 |
| HuR (ELAVL1) binds and stabilizes mRNA | R-HSA-450520 | 6.684765e-01 | 0.175 | 0 | 0 |
| Co-inhibition by CTLA4 | R-HSA-389513 | 6.692082e-01 | 0.174 | 0 | 0 |
| Negative regulation of MET activity | R-HSA-6807004 | 6.692082e-01 | 0.174 | 0 | 0 |
| BBSome-mediated cargo-targeting to cilium | R-HSA-5620922 | 6.692082e-01 | 0.174 | 0 | 0 |
| Signaling by FGFR | R-HSA-190236 | 6.707341e-01 | 0.173 | 0 | 0 |
| Gastrulation | R-HSA-9758941 | 6.713793e-01 | 0.173 | 0 | 0 |
| Glucagon-like Peptide-1 (GLP1) regulates insulin secretion | R-HSA-381676 | 6.744582e-01 | 0.171 | 0 | 0 |
| MyD88:MAL(TIRAP) cascade initiated on plasma membrane | R-HSA-166058 | 6.775533e-01 | 0.169 | 0 | 0 |
| Toll Like Receptor TLR6:TLR2 Cascade | R-HSA-168188 | 6.775533e-01 | 0.169 | 0 | 0 |
| Diseases of mitotic cell cycle | R-HSA-9675126 | 6.785315e-01 | 0.168 | 0 | 0 |
| Inwardly rectifying K+ channels | R-HSA-1296065 | 6.785315e-01 | 0.168 | 0 | 0 |
| Developmental Lineage of Multipotent Pancreatic Progenitor Cells | R-HSA-9937080 | 6.785315e-01 | 0.168 | 0 | 0 |
| FOXO-mediated transcription | R-HSA-9614085 | 6.809694e-01 | 0.167 | 0 | 0 |
| Negative regulation of the PI3K/AKT network | R-HSA-199418 | 6.810150e-01 | 0.167 | 0 | 0 |
| Signaling by NOTCH3 | R-HSA-9012852 | 6.869470e-01 | 0.163 | 0 | 0 |
| MyD88 deficiency (TLR2/4) | R-HSA-5602498 | 6.898909e-01 | 0.161 | 0 | 0 |
| G-protein activation | R-HSA-202040 | 6.898909e-01 | 0.161 | 0 | 0 |
| ADP signalling through P2Y purinoceptor 12 | R-HSA-392170 | 6.898909e-01 | 0.161 | 0 | 0 |
| Acetylcholine Neurotransmitter Release Cycle | R-HSA-264642 | 6.898909e-01 | 0.161 | 0 | 0 |
| ERK/MAPK targets | R-HSA-198753 | 6.898909e-01 | 0.161 | 0 | 0 |
| Zygotic genome activation (ZGA) | R-HSA-9819196 | 6.898909e-01 | 0.161 | 0 | 0 |
| ABC-family proteins mediated transport | R-HSA-382556 | 6.910089e-01 | 0.161 | 0 | 0 |
| G-protein beta:gamma signalling | R-HSA-397795 | 6.952602e-01 | 0.158 | 0 | 0 |
| Regulation of MECP2 expression and activity | R-HSA-9022692 | 6.952602e-01 | 0.158 | 0 | 0 |
| TICAM1,TRAF6-dependent induction of TAK1 complex | R-HSA-9014325 | 6.976284e-01 | 0.156 | 0 | 0 |
| Erythropoietin activates Phospholipase C gamma (PLCG) | R-HSA-9027277 | 6.976284e-01 | 0.156 | 0 | 0 |
| Formation of apoptosome | R-HSA-111458 | 6.976284e-01 | 0.156 | 0 | 0 |
| Regulation of the apoptosome activity | R-HSA-9627069 | 6.976284e-01 | 0.156 | 0 | 0 |
| Defective RIPK1-mediated regulated necrosis | R-HSA-9693928 | 6.976284e-01 | 0.156 | 0 | 0 |
| MAPK3 (ERK1) activation | R-HSA-110056 | 6.976284e-01 | 0.156 | 0 | 0 |
| Josephin domain DUBs | R-HSA-5689877 | 6.976284e-01 | 0.156 | 0 | 0 |
| Adipogenesis | R-HSA-9843745 | 6.984496e-01 | 0.156 | 0 | 0 |
| Signaling by MET | R-HSA-6806834 | 6.985838e-01 | 0.156 | 0 | 0 |
| TNF signaling | R-HSA-75893 | 6.999313e-01 | 0.155 | 0 | 0 |
| Signaling by FGFR1 | R-HSA-5654736 | 6.999313e-01 | 0.155 | 0 | 0 |
| Toll Like Receptor TLR1:TLR2 Cascade | R-HSA-168179 | 7.047040e-01 | 0.152 | 0 | 0 |
| Toll Like Receptor 2 (TLR2) Cascade | R-HSA-181438 | 7.047040e-01 | 0.152 | 0 | 0 |
| RNA Polymerase III Transcription Initiation From Type 2 Promoter | R-HSA-76066 | 7.094959e-01 | 0.149 | 0 | 0 |
| IRAK4 deficiency (TLR2/4) | R-HSA-5603041 | 7.094959e-01 | 0.149 | 0 | 0 |
| Attachment and Entry | R-HSA-9694614 | 7.094959e-01 | 0.149 | 0 | 0 |
| FRS-mediated FGFR3 signaling | R-HSA-5654706 | 7.094959e-01 | 0.149 | 0 | 0 |
| Signaling by NTRK3 (TRKC) | R-HSA-9034015 | 7.094959e-01 | 0.149 | 0 | 0 |
| Developmental Lineage of Pancreatic Ductal Cells | R-HSA-9925563 | 7.102295e-01 | 0.149 | 0 | 0 |
| Glucagon signaling in metabolic regulation | R-HSA-163359 | 7.113214e-01 | 0.148 | 0 | 0 |
| PI5P, PP2A and IER3 Regulate PI3K/AKT Signaling | R-HSA-6811558 | 7.134304e-01 | 0.147 | 0 | 0 |
| Vasopressin regulates renal water homeostasis via Aquaporins | R-HSA-432040 | 7.173591e-01 | 0.144 | 0 | 0 |
| Signaling by Insulin receptor | R-HSA-74752 | 7.196095e-01 | 0.143 | 0 | 0 |
| NF-kB activation through FADD/RIP-1 pathway mediated by caspase-8 and -10 | R-HSA-933543 | 7.242184e-01 | 0.140 | 0 | 0 |
| Regulation of CDH11 mRNA translation by microRNAs | R-HSA-9759811 | 7.242184e-01 | 0.140 | 0 | 0 |
| vRNA Synthesis | R-HSA-192814 | 7.242184e-01 | 0.140 | 0 | 0 |
| Chylomicron assembly | R-HSA-8963888 | 7.242184e-01 | 0.140 | 0 | 0 |
| Propionyl-CoA catabolism | R-HSA-71032 | 7.242184e-01 | 0.140 | 0 | 0 |
| Activated NTRK3 signals through RAS | R-HSA-9034864 | 7.242184e-01 | 0.140 | 0 | 0 |
| Transport of RCbl within the body | R-HSA-9758890 | 7.242184e-01 | 0.140 | 0 | 0 |
| CD163 mediating an anti-inflammatory response | R-HSA-9662834 | 7.242184e-01 | 0.140 | 0 | 0 |
| Prostanoid ligand receptors | R-HSA-391908 | 7.242184e-01 | 0.140 | 0 | 0 |
| Interleukin-2 signaling | R-HSA-9020558 | 7.242184e-01 | 0.140 | 0 | 0 |
| Dissolution of Fibrin Clot | R-HSA-75205 | 7.242184e-01 | 0.140 | 0 | 0 |
| NR1H3 & NR1H2 regulate gene expression linked to cholesterol transport and efflux | R-HSA-9029569 | 7.247660e-01 | 0.140 | 0 | 0 |
| Antigen Presentation: Folding, assembly and peptide loading of class I MHC | R-HSA-983170 | 7.267220e-01 | 0.139 | 0 | 0 |
| eNOS activation | R-HSA-203615 | 7.267220e-01 | 0.139 | 0 | 0 |
| Signaling by CSF1 (M-CSF) in myeloid cells | R-HSA-9680350 | 7.267220e-01 | 0.139 | 0 | 0 |
| BMAL1:CLOCK,NPAS2 activates circadian expression | R-HSA-1368108 | 7.267220e-01 | 0.139 | 0 | 0 |
| RNA Polymerase III Transcription Initiation From Type 3 Promoter | R-HSA-76071 | 7.280526e-01 | 0.138 | 0 | 0 |
| Developmental Lineage of Mammary Stem Cells | R-HSA-9938206 | 7.280526e-01 | 0.138 | 0 | 0 |
| RNA Polymerase III Transcription Initiation From Type 1 Promoter | R-HSA-76061 | 7.280526e-01 | 0.138 | 0 | 0 |
| FRS-mediated FGFR4 signaling | R-HSA-5654712 | 7.280526e-01 | 0.138 | 0 | 0 |
| Regulation of IFNA/IFNB signaling | R-HSA-912694 | 7.280526e-01 | 0.138 | 0 | 0 |
| Dopamine Neurotransmitter Release Cycle | R-HSA-212676 | 7.280526e-01 | 0.138 | 0 | 0 |
| Downregulation of TGF-beta receptor signaling | R-HSA-2173788 | 7.280526e-01 | 0.138 | 0 | 0 |
| Translation of Replicase and Assembly of the Replication Transcription Complex | R-HSA-9694676 | 7.280526e-01 | 0.138 | 0 | 0 |
| Cytoprotection by HMOX1 | R-HSA-9707564 | 7.303685e-01 | 0.136 | 0 | 0 |
| TNFR2 non-canonical NF-kB pathway | R-HSA-5668541 | 7.303685e-01 | 0.136 | 0 | 0 |
| Regulation of TNFR1 signaling | R-HSA-5357905 | 7.306961e-01 | 0.136 | 0 | 0 |
| Purinergic signaling in leishmaniasis infection | R-HSA-9660826 | 7.306961e-01 | 0.136 | 0 | 0 |
| Cell recruitment (pro-inflammatory response) | R-HSA-9664424 | 7.306961e-01 | 0.136 | 0 | 0 |
| Diseases of DNA repair | R-HSA-9675135 | 7.306961e-01 | 0.136 | 0 | 0 |
| APC/C-mediated degradation of cell cycle proteins | R-HSA-174143 | 7.325853e-01 | 0.135 | 0 | 0 |
| Regulation of mitotic cell cycle | R-HSA-453276 | 7.325853e-01 | 0.135 | 0 | 0 |
| Toll-like Receptor Cascades | R-HSA-168898 | 7.331923e-01 | 0.135 | 0 | 0 |
| Oncogene Induced Senescence | R-HSA-2559585 | 7.414710e-01 | 0.130 | 0 | 0 |
| Signaling by the B Cell Receptor (BCR) | R-HSA-983705 | 7.418004e-01 | 0.130 | 0 | 0 |
| Asparagine N-linked glycosylation | R-HSA-446203 | 7.454891e-01 | 0.128 | 0 | 0 |
| RNA Pol II CTD phosphorylation and interaction with CE during HIV infection | R-HSA-167160 | 7.455938e-01 | 0.127 | 0 | 0 |
| RNA Pol II CTD phosphorylation and interaction with CE | R-HSA-77075 | 7.455938e-01 | 0.127 | 0 | 0 |
| Regulation of PTEN mRNA translation | R-HSA-8943723 | 7.455938e-01 | 0.127 | 0 | 0 |
| G beta:gamma signalling through PI3Kgamma | R-HSA-392451 | 7.455938e-01 | 0.127 | 0 | 0 |
| Interleukin receptor SHC signaling | R-HSA-912526 | 7.455938e-01 | 0.127 | 0 | 0 |
| Estrogen-dependent nuclear events downstream of ESR-membrane signaling | R-HSA-9634638 | 7.455938e-01 | 0.127 | 0 | 0 |
| Beta-catenin independent WNT signaling | R-HSA-3858494 | 7.471617e-01 | 0.127 | 0 | 0 |
| Sema4D mediated inhibition of cell attachment and migration | R-HSA-416550 | 7.484716e-01 | 0.126 | 0 | 0 |
| Synthesis of diphthamide-EEF2 | R-HSA-5358493 | 7.484716e-01 | 0.126 | 0 | 0 |
| Cytochrome c-mediated apoptotic response | R-HSA-111461 | 7.484716e-01 | 0.126 | 0 | 0 |
| Endosomal/Vacuolar pathway | R-HSA-1236977 | 7.484716e-01 | 0.126 | 0 | 0 |
| POLB-Dependent Long Patch Base Excision Repair | R-HSA-110362 | 7.484716e-01 | 0.126 | 0 | 0 |
| Plasmalogen biosynthesis | R-HSA-75896 | 7.484716e-01 | 0.126 | 0 | 0 |
| ERKs are inactivated | R-HSA-202670 | 7.484716e-01 | 0.126 | 0 | 0 |
| Inhibition of replication initiation of damaged DNA by RB1/E2F1 | R-HSA-113501 | 7.484716e-01 | 0.126 | 0 | 0 |
| Activated NTRK2 signals through RAS | R-HSA-9026519 | 7.484716e-01 | 0.126 | 0 | 0 |
| tRNA processing | R-HSA-72306 | 7.501896e-01 | 0.125 | 0 | 0 |
| Co-stimulation by CD28 | R-HSA-389356 | 7.559418e-01 | 0.122 | 0 | 0 |
| Metal ion SLC transporters | R-HSA-425410 | 7.559418e-01 | 0.122 | 0 | 0 |
| Recognition of DNA damage by PCNA-containing replication complex | R-HSA-110314 | 7.621546e-01 | 0.118 | 0 | 0 |
| Signaling by FLT3 ITD and TKD mutants | R-HSA-9703648 | 7.621546e-01 | 0.118 | 0 | 0 |
| Norepinephrine Neurotransmitter Release Cycle | R-HSA-181430 | 7.621546e-01 | 0.118 | 0 | 0 |
| Interleukin-6 family signaling | R-HSA-6783589 | 7.621546e-01 | 0.118 | 0 | 0 |
| Signaling by FGFR in disease | R-HSA-1226099 | 7.637791e-01 | 0.117 | 0 | 0 |
| CLEC7A (Dectin-1) signaling | R-HSA-5607764 | 7.659925e-01 | 0.116 | 0 | 0 |
| NOTCH1 Intracellular Domain Regulates Transcription | R-HSA-2122947 | 7.678608e-01 | 0.115 | 0 | 0 |
| Metabolism of folate and pterines | R-HSA-196757 | 7.690604e-01 | 0.114 | 0 | 0 |
| Erythropoietin activates Phosphoinositide-3-kinase (PI3K) | R-HSA-9027276 | 7.705932e-01 | 0.113 | 0 | 0 |
| Signaling by NOTCH1 HD Domain Mutants in Cancer | R-HSA-2691230 | 7.705932e-01 | 0.113 | 0 | 0 |
| Constitutive Signaling by NOTCH1 HD Domain Mutants | R-HSA-2691232 | 7.705932e-01 | 0.113 | 0 | 0 |
| RUNX3 regulates p14-ARF | R-HSA-8951936 | 7.705932e-01 | 0.113 | 0 | 0 |
| Beta oxidation of myristoyl-CoA to lauroyl-CoA | R-HSA-77285 | 7.705932e-01 | 0.113 | 0 | 0 |
| Beta oxidation of palmitoyl-CoA to myristoyl-CoA | R-HSA-77305 | 7.705932e-01 | 0.113 | 0 | 0 |
| Repression of WNT target genes | R-HSA-4641265 | 7.705932e-01 | 0.113 | 0 | 0 |
| Serotonin clearance from the synaptic cleft | R-HSA-380615 | 7.705932e-01 | 0.113 | 0 | 0 |
| Regulation of FOXO transcriptional activity by acetylation | R-HSA-9617629 | 7.705932e-01 | 0.113 | 0 | 0 |
| MET activates RAS signaling | R-HSA-8851805 | 7.705932e-01 | 0.113 | 0 | 0 |
| Polymerase switching | R-HSA-69091 | 7.705932e-01 | 0.113 | 0 | 0 |
| Leading Strand Synthesis | R-HSA-69109 | 7.705932e-01 | 0.113 | 0 | 0 |
| Disorders of Nervous System Development | R-HSA-9697154 | 7.705932e-01 | 0.113 | 0 | 0 |
| SHC-related events triggered by IGF1R | R-HSA-2428933 | 7.705932e-01 | 0.113 | 0 | 0 |
| Loss of function of MECP2 in Rett syndrome | R-HSA-9005891 | 7.705932e-01 | 0.113 | 0 | 0 |
| Pervasive developmental disorders | R-HSA-9005895 | 7.705932e-01 | 0.113 | 0 | 0 |
| Erythrocytes take up oxygen and release carbon dioxide | R-HSA-1247673 | 7.705932e-01 | 0.113 | 0 | 0 |
| Reversal of alkylation damage by DNA dioxygenases | R-HSA-73943 | 7.705932e-01 | 0.113 | 0 | 0 |
| OAS antiviral response | R-HSA-8983711 | 7.705932e-01 | 0.113 | 0 | 0 |
| Acyl chain remodelling of PS | R-HSA-1482801 | 7.777717e-01 | 0.109 | 0 | 0 |
| PIWI-interacting RNA (piRNA) biogenesis | R-HSA-5601884 | 7.777717e-01 | 0.109 | 0 | 0 |
| FRS-mediated FGFR1 signaling | R-HSA-5654693 | 7.777717e-01 | 0.109 | 0 | 0 |
| MET promotes cell motility | R-HSA-8875878 | 7.819278e-01 | 0.107 | 0 | 0 |
| Regulation of insulin secretion | R-HSA-422356 | 7.829212e-01 | 0.106 | 0 | 0 |
| Signaling by NOTCH1 | R-HSA-1980143 | 7.830291e-01 | 0.106 | 0 | 0 |
| Insulin receptor signalling cascade | R-HSA-74751 | 7.902648e-01 | 0.102 | 0 | 0 |
| CD28 dependent Vav1 pathway | R-HSA-389359 | 7.907705e-01 | 0.102 | 0 | 0 |
| Platelet Adhesion to exposed collagen | R-HSA-75892 | 7.907705e-01 | 0.102 | 0 | 0 |
| HDR through MMEJ (alt-NHEJ) | R-HSA-5685939 | 7.907705e-01 | 0.102 | 0 | 0 |
| CREB1 phosphorylation through the activation of Adenylate Cyclase | R-HSA-442720 | 7.907705e-01 | 0.102 | 0 | 0 |
| Reversible hydration of carbon dioxide | R-HSA-1475029 | 7.907705e-01 | 0.102 | 0 | 0 |
| Processing of SMDT1 | R-HSA-8949664 | 7.907705e-01 | 0.102 | 0 | 0 |
| Disease | R-HSA-1643685 | 7.918942e-01 | 0.101 | 0 | 0 |
| Translation of Structural Proteins | R-HSA-9694635 | 7.921975e-01 | 0.101 | 0 | 0 |
| Resolution of AP sites via the multiple-nucleotide patch replacement pathway | R-HSA-110373 | 7.924829e-01 | 0.101 | 0 | 0 |
| Regulation of RUNX1 Expression and Activity | R-HSA-8934593 | 7.924829e-01 | 0.101 | 0 | 0 |
| Caspase activation via extrinsic apoptotic signalling pathway | R-HSA-5357769 | 7.924829e-01 | 0.101 | 0 | 0 |
| MECP2 regulates neuronal receptors and channels | R-HSA-9022699 | 7.924829e-01 | 0.101 | 0 | 0 |
| Differentiation of Keratinocytes in Interfollicular Epidermis in Mammalian Skin | R-HSA-9725554 | 7.941972e-01 | 0.100 | 0 | 0 |
| SARS-CoV-1 activates/modulates innate immune responses | R-HSA-9692916 | 8.008857e-01 | 0.096 | 0 | 0 |
| ABC transporter disorders | R-HSA-5619084 | 8.010661e-01 | 0.096 | 0 | 0 |
| Immune System | R-HSA-168256 | 8.015329e-01 | 0.096 | 0 | 0 |
| SLC transporter disorders | R-HSA-5619102 | 8.016034e-01 | 0.096 | 0 | 0 |
| Downstream TCR signaling | R-HSA-202424 | 8.034648e-01 | 0.095 | 0 | 0 |
| Generation of second messenger molecules | R-HSA-202433 | 8.058850e-01 | 0.094 | 0 | 0 |
| Interleukin-2 family signaling | R-HSA-451927 | 8.058850e-01 | 0.094 | 0 | 0 |
| Processive synthesis on the C-strand of the telomere | R-HSA-174414 | 8.063268e-01 | 0.093 | 0 | 0 |
| Cristae formation | R-HSA-8949613 | 8.063268e-01 | 0.093 | 0 | 0 |
| CD28 dependent PI3K/Akt signaling | R-HSA-389357 | 8.063268e-01 | 0.093 | 0 | 0 |
| Removal of the Flap Intermediate | R-HSA-69166 | 8.091741e-01 | 0.092 | 0 | 0 |
| Regulation of CDH1 mRNA translation by microRNAs | R-HSA-9764562 | 8.091741e-01 | 0.092 | 0 | 0 |
| Hydrolysis of LPC | R-HSA-1483115 | 8.091741e-01 | 0.092 | 0 | 0 |
| IRAK2 mediated activation of TAK1 complex upon TLR7/8 or 9 stimulation | R-HSA-975163 | 8.091741e-01 | 0.092 | 0 | 0 |
| Prolactin receptor signaling | R-HSA-1170546 | 8.091741e-01 | 0.092 | 0 | 0 |
| Respiratory syncytial virus genome transcription | R-HSA-9828642 | 8.091741e-01 | 0.092 | 0 | 0 |
| Signaling by FGFR4 in disease | R-HSA-5655291 | 8.091741e-01 | 0.092 | 0 | 0 |
| Formation of the cornified envelope | R-HSA-6809371 | 8.140112e-01 | 0.089 | 0 | 0 |
| Purine ribonucleoside monophosphate biosynthesis | R-HSA-73817 | 8.170085e-01 | 0.088 | 0 | 0 |
| Resolution of Abasic Sites (AP sites) | R-HSA-73933 | 8.170085e-01 | 0.088 | 0 | 0 |
| FLT3 Signaling | R-HSA-9607240 | 8.170085e-01 | 0.088 | 0 | 0 |
| Kidney development | R-HSA-9830369 | 8.181217e-01 | 0.087 | 0 | 0 |
| FRS-mediated FGFR2 signaling | R-HSA-5654700 | 8.193420e-01 | 0.087 | 0 | 0 |
| Transcriptional activation of mitochondrial biogenesis | R-HSA-2151201 | 8.259133e-01 | 0.083 | 0 | 0 |
| RNA Polymerase III Chain Elongation | R-HSA-73780 | 8.259600e-01 | 0.083 | 0 | 0 |
| Processive synthesis on the lagging strand | R-HSA-69183 | 8.259600e-01 | 0.083 | 0 | 0 |
| InlB-mediated entry of Listeria monocytogenes into host cell | R-HSA-8875360 | 8.259600e-01 | 0.083 | 0 | 0 |
| p38MAPK events | R-HSA-171007 | 8.259600e-01 | 0.083 | 0 | 0 |
| Beta oxidation of butanoyl-CoA to acetyl-CoA | R-HSA-77352 | 8.259600e-01 | 0.083 | 0 | 0 |
| Protein lipoylation | R-HSA-9857492 | 8.259600e-01 | 0.083 | 0 | 0 |
| Dopamine clearance from the synaptic cleft | R-HSA-379401 | 8.259600e-01 | 0.083 | 0 | 0 |
| Lysosphingolipid and LPA receptors | R-HSA-419408 | 8.259600e-01 | 0.083 | 0 | 0 |
| Signaling by PDGFRA extracellular domain mutants | R-HSA-9673770 | 8.259600e-01 | 0.083 | 0 | 0 |
| Signaling by PDGFRA transmembrane, juxtamembrane and kinase domain mutants | R-HSA-9673767 | 8.259600e-01 | 0.083 | 0 | 0 |
| DNA Damage Reversal | R-HSA-73942 | 8.259600e-01 | 0.083 | 0 | 0 |
| Late SARS-CoV-2 Infection Events | R-HSA-9772573 | 8.266113e-01 | 0.083 | 0 | 0 |
| FOXO-mediated transcription of oxidative stress, metabolic and neuronal genes | R-HSA-9615017 | 8.275853e-01 | 0.082 | 0 | 0 |
| Translation of Structural Proteins | R-HSA-9683701 | 8.275853e-01 | 0.082 | 0 | 0 |
| G alpha (z) signalling events | R-HSA-418597 | 8.299995e-01 | 0.081 | 0 | 0 |
| mRNA Capping | R-HSA-72086 | 8.315672e-01 | 0.080 | 0 | 0 |
| Downstream signaling of activated FGFR3 | R-HSA-5654708 | 8.315672e-01 | 0.080 | 0 | 0 |
| Regulation of pyruvate dehydrogenase (PDH) complex | R-HSA-204174 | 8.315672e-01 | 0.080 | 0 | 0 |
| MAPK targets/ Nuclear events mediated by MAP kinases | R-HSA-450282 | 8.315672e-01 | 0.080 | 0 | 0 |
| Glucagon-type ligand receptors | R-HSA-420092 | 8.315672e-01 | 0.080 | 0 | 0 |
| Respiratory Syncytial Virus Infection Pathway | R-HSA-9820952 | 8.361642e-01 | 0.078 | 0 | 0 |
| Interferon alpha/beta signaling | R-HSA-909733 | 8.369342e-01 | 0.077 | 0 | 0 |
| Cytosolic tRNA aminoacylation | R-HSA-379716 | 8.376339e-01 | 0.077 | 0 | 0 |
| Activation of GABAB receptors | R-HSA-991365 | 8.376339e-01 | 0.077 | 0 | 0 |
| GABA B receptor activation | R-HSA-977444 | 8.376339e-01 | 0.077 | 0 | 0 |
| Ca-dependent events | R-HSA-111996 | 8.376339e-01 | 0.077 | 0 | 0 |
| Constitutive Signaling by Aberrant PI3K in Cancer | R-HSA-2219530 | 8.408142e-01 | 0.075 | 0 | 0 |
| Phosphorylation of the APC/C | R-HSA-176412 | 8.412702e-01 | 0.075 | 0 | 0 |
| Defective GALNT3 causes HFTC | R-HSA-5083625 | 8.412702e-01 | 0.075 | 0 | 0 |
| Defective GALNT12 causes CRCS1 | R-HSA-5083636 | 8.412702e-01 | 0.075 | 0 | 0 |
| Aberrant regulation of mitotic exit in cancer due to RB1 defects | R-HSA-9687136 | 8.412702e-01 | 0.075 | 0 | 0 |
| Induction of Cell-Cell Fusion | R-HSA-9733458 | 8.412702e-01 | 0.075 | 0 | 0 |
| TP53 Regulates Transcription of Genes Involved in G1 Cell Cycle Arrest | R-HSA-6804116 | 8.412702e-01 | 0.075 | 0 | 0 |
| Negative regulation of FLT3 | R-HSA-9706369 | 8.412702e-01 | 0.075 | 0 | 0 |
| Regulation of glycolysis by fructose 2,6-bisphosphate metabolism | R-HSA-9634600 | 8.412702e-01 | 0.075 | 0 | 0 |
| Activation of SMO | R-HSA-5635838 | 8.412702e-01 | 0.075 | 0 | 0 |
| WNT5A-dependent internalization of FZD4 | R-HSA-5099900 | 8.412702e-01 | 0.075 | 0 | 0 |
| SEMA3A-Plexin repulsion signaling by inhibiting Integrin adhesion | R-HSA-399955 | 8.412702e-01 | 0.075 | 0 | 0 |
| Transcription of E2F targets under negative control by p107 (RBL1) and p130 (RBL2) in complex with HDAC1 | R-HSA-1362300 | 8.412702e-01 | 0.075 | 0 | 0 |
| Atorvastatin ADME | R-HSA-9754706 | 8.412702e-01 | 0.075 | 0 | 0 |
| Virus Assembly and Release | R-HSA-168268 | 8.412702e-01 | 0.075 | 0 | 0 |
| Nucleotide Excision Repair | R-HSA-5696398 | 8.416243e-01 | 0.075 | 0 | 0 |
| Fatty acyl-CoA biosynthesis | R-HSA-75105 | 8.429235e-01 | 0.074 | 0 | 0 |
| Thrombin signalling through proteinase activated receptors (PARs) | R-HSA-456926 | 8.430406e-01 | 0.074 | 0 | 0 |
| Downstream signaling of activated FGFR4 | R-HSA-5654716 | 8.430406e-01 | 0.074 | 0 | 0 |
| Neurotransmitter clearance | R-HSA-112311 | 8.430406e-01 | 0.074 | 0 | 0 |
| GABA synthesis, release, reuptake and degradation | R-HSA-888590 | 8.430406e-01 | 0.074 | 0 | 0 |
| Tetrahydrobiopterin (BH4) synthesis, recycling, salvage and regulation | R-HSA-1474151 | 8.430406e-01 | 0.074 | 0 | 0 |
| NOTCH3 Intracellular Domain Regulates Transcription | R-HSA-9013508 | 8.430406e-01 | 0.074 | 0 | 0 |
| Fcgamma receptor (FCGR) dependent phagocytosis | R-HSA-2029480 | 8.457984e-01 | 0.073 | 0 | 0 |
| IRS-mediated signalling | R-HSA-112399 | 8.473721e-01 | 0.072 | 0 | 0 |
| Platelet homeostasis | R-HSA-418346 | 8.479898e-01 | 0.072 | 0 | 0 |
| Disorders of transmembrane transporters | R-HSA-5619115 | 8.491265e-01 | 0.071 | 0 | 0 |
| Rab regulation of trafficking | R-HSA-9007101 | 8.491652e-01 | 0.071 | 0 | 0 |
| Leishmania phagocytosis | R-HSA-9664417 | 8.529074e-01 | 0.069 | 0 | 0 |
| Parasite infection | R-HSA-9664407 | 8.529074e-01 | 0.069 | 0 | 0 |
| FCGR3A-mediated phagocytosis | R-HSA-9664422 | 8.529074e-01 | 0.069 | 0 | 0 |
| Respiratory syncytial virus (RSV) attachment and entry | R-HSA-9820960 | 8.537998e-01 | 0.069 | 0 | 0 |
| Evasion by RSV of host interferon responses | R-HSA-9833109 | 8.537998e-01 | 0.069 | 0 | 0 |
| TP53 Regulates Transcription of Genes Involved in G2 Cell Cycle Arrest | R-HSA-6804114 | 8.552344e-01 | 0.068 | 0 | 0 |
| STAT5 activation downstream of FLT3 ITD mutants | R-HSA-9702518 | 8.552344e-01 | 0.068 | 0 | 0 |
| Inactivation of APC/C via direct inhibition of the APC/C complex | R-HSA-141430 | 8.552344e-01 | 0.068 | 0 | 0 |
| Heme assimilation | R-HSA-9927020 | 8.552344e-01 | 0.068 | 0 | 0 |
| mitochondrial fatty acid beta-oxidation of unsaturated fatty acids | R-HSA-77288 | 8.552344e-01 | 0.068 | 0 | 0 |
| Inhibition of the proteolytic activity of APC/C required for the onset of anaphase by mitotic spindle checkpoint components | R-HSA-141405 | 8.552344e-01 | 0.068 | 0 | 0 |
| TRAF3-dependent IRF activation pathway | R-HSA-918233 | 8.552344e-01 | 0.068 | 0 | 0 |
| Passive transport by Aquaporins | R-HSA-432047 | 8.552344e-01 | 0.068 | 0 | 0 |
| SHC1 events in ERBB4 signaling | R-HSA-1250347 | 8.552344e-01 | 0.068 | 0 | 0 |
| Coenzyme A biosynthesis | R-HSA-196783 | 8.552344e-01 | 0.068 | 0 | 0 |
| Synthesis, secretion, and inactivation of Glucose-dependent Insulinotropic Polypeptide (GIP) | R-HSA-400511 | 8.552344e-01 | 0.068 | 0 | 0 |
| Defects of contact activation system (CAS) and kallikrein/kinin system (KKS) | R-HSA-9651496 | 8.552344e-01 | 0.068 | 0 | 0 |
| DAP12 interactions | R-HSA-2172127 | 8.562203e-01 | 0.067 | 0 | 0 |
| Potassium Channels | R-HSA-1296071 | 8.603575e-01 | 0.065 | 0 | 0 |
| Peroxisomal protein import | R-HSA-9033241 | 8.632203e-01 | 0.064 | 0 | 0 |
| Assembly of collagen fibrils and other multimeric structures | R-HSA-2022090 | 8.632203e-01 | 0.064 | 0 | 0 |
| ADORA2B mediated anti-inflammatory cytokines production | R-HSA-9660821 | 8.647957e-01 | 0.063 | 0 | 0 |
| Ca2+ pathway | R-HSA-4086398 | 8.648687e-01 | 0.063 | 0 | 0 |
| Removal of the Flap Intermediate from the C-strand | R-HSA-174437 | 8.679709e-01 | 0.061 | 0 | 0 |
| Defective C1GALT1C1 causes TNPS | R-HSA-5083632 | 8.679709e-01 | 0.061 | 0 | 0 |
| Conversion from APC/C:Cdc20 to APC/C:Cdh1 in late anaphase | R-HSA-176407 | 8.679709e-01 | 0.061 | 0 | 0 |
| Elevation of cytosolic Ca2+ levels | R-HSA-139853 | 8.679709e-01 | 0.061 | 0 | 0 |
| Regulation of FZD by ubiquitination | R-HSA-4641263 | 8.679709e-01 | 0.061 | 0 | 0 |
| Metabolism of ingested H2SeO4 and H2SeO3 into H2Se | R-HSA-2408550 | 8.679709e-01 | 0.061 | 0 | 0 |
| Choline catabolism | R-HSA-6798163 | 8.679709e-01 | 0.061 | 0 | 0 |
| Mismatch repair (MMR) directed by MSH2:MSH3 (MutSbeta) | R-HSA-5358606 | 8.679709e-01 | 0.061 | 0 | 0 |
| Uptake and function of anthrax toxins | R-HSA-5210891 | 8.679709e-01 | 0.061 | 0 | 0 |
| Mismatch repair (MMR) directed by MSH2:MSH6 (MutSalpha) | R-HSA-5358565 | 8.679709e-01 | 0.061 | 0 | 0 |
| Signaling by NOTCH1 in Cancer | R-HSA-2644603 | 8.706019e-01 | 0.060 | 0 | 0 |
| Signaling by NOTCH1 PEST Domain Mutants in Cancer | R-HSA-2644602 | 8.706019e-01 | 0.060 | 0 | 0 |
| Signaling by NOTCH1 HD+PEST Domain Mutants in Cancer | R-HSA-2894858 | 8.706019e-01 | 0.060 | 0 | 0 |
| Constitutive Signaling by NOTCH1 PEST Domain Mutants | R-HSA-2644606 | 8.706019e-01 | 0.060 | 0 | 0 |
| Constitutive Signaling by NOTCH1 HD+PEST Domain Mutants | R-HSA-2894862 | 8.706019e-01 | 0.060 | 0 | 0 |
| tRNA Aminoacylation | R-HSA-379724 | 8.706019e-01 | 0.060 | 0 | 0 |
| Post-translational protein phosphorylation | R-HSA-8957275 | 8.722653e-01 | 0.059 | 0 | 0 |
| IRS-related events triggered by IGF1R | R-HSA-2428928 | 8.776376e-01 | 0.057 | 0 | 0 |
| Aquaporin-mediated transport | R-HSA-445717 | 8.776376e-01 | 0.057 | 0 | 0 |
| PCNA-Dependent Long Patch Base Excision Repair | R-HSA-5651801 | 8.795875e-01 | 0.056 | 0 | 0 |
| PKA activation | R-HSA-163615 | 8.795875e-01 | 0.056 | 0 | 0 |
| Trafficking of GluR2-containing AMPA receptors | R-HSA-416993 | 8.795875e-01 | 0.056 | 0 | 0 |
| PKA activation in glucagon signalling | R-HSA-164378 | 8.795875e-01 | 0.056 | 0 | 0 |
| Apoptotic factor-mediated response | R-HSA-111471 | 8.795875e-01 | 0.056 | 0 | 0 |
| Polo-like kinase mediated events | R-HSA-156711 | 8.795875e-01 | 0.056 | 0 | 0 |
| FOXO-mediated transcription of cell death genes | R-HSA-9614657 | 8.795875e-01 | 0.056 | 0 | 0 |
| Mismatch Repair | R-HSA-5358508 | 8.795875e-01 | 0.056 | 0 | 0 |
| Vitamin D (calciferol) metabolism | R-HSA-196791 | 8.795875e-01 | 0.056 | 0 | 0 |
| Acyl chain remodelling of PC | R-HSA-1482788 | 8.821559e-01 | 0.054 | 0 | 0 |
| Vitamin B5 (pantothenate) metabolism | R-HSA-199220 | 8.821559e-01 | 0.054 | 0 | 0 |
| Synthesis of PIPs at the plasma membrane | R-HSA-1660499 | 8.843393e-01 | 0.053 | 0 | 0 |
| GPER1 signaling | R-HSA-9634597 | 8.878743e-01 | 0.052 | 0 | 0 |
| Pre-NOTCH Processing in Golgi | R-HSA-1912420 | 8.901827e-01 | 0.051 | 0 | 0 |
| APC/C:Cdc20 mediated degradation of Cyclin B | R-HSA-174048 | 8.901827e-01 | 0.051 | 0 | 0 |
| Signaling by FGFR2 IIIa TM | R-HSA-8851708 | 8.901827e-01 | 0.051 | 0 | 0 |
| PI-3K cascade:FGFR3 | R-HSA-5654710 | 8.901827e-01 | 0.051 | 0 | 0 |
| Specification of the neural plate border | R-HSA-9834899 | 8.901827e-01 | 0.051 | 0 | 0 |
| Diseases of hemostasis | R-HSA-9671793 | 8.901827e-01 | 0.051 | 0 | 0 |
| Translesion Synthesis by POLH | R-HSA-110320 | 8.901827e-01 | 0.051 | 0 | 0 |
| Erythrocytes take up carbon dioxide and release oxygen | R-HSA-1237044 | 8.901827e-01 | 0.051 | 0 | 0 |
| E2F mediated regulation of DNA replication | R-HSA-113510 | 8.901827e-01 | 0.051 | 0 | 0 |
| O2/CO2 exchange in erythrocytes | R-HSA-1480926 | 8.901827e-01 | 0.051 | 0 | 0 |
| Dual Incision in GG-NER | R-HSA-5696400 | 8.904166e-01 | 0.050 | 0 | 0 |
| Regulation of TLR by endogenous ligand | R-HSA-5686938 | 8.904166e-01 | 0.050 | 0 | 0 |
| DNA Damage Bypass | R-HSA-73893 | 8.947458e-01 | 0.048 | 0 | 0 |
| Chemokine receptors bind chemokines | R-HSA-380108 | 8.947458e-01 | 0.048 | 0 | 0 |
| Integrin cell surface interactions | R-HSA-216083 | 8.956911e-01 | 0.048 | 0 | 0 |
| Regulation of Insulin-like Growth Factor (IGF) transport and uptake by Insulin-like Growth Factor Binding Proteins (IGFBPs) | R-HSA-381426 | 8.964881e-01 | 0.047 | 0 | 0 |
| IGF1R signaling cascade | R-HSA-2428924 | 8.967882e-01 | 0.047 | 0 | 0 |
| Nucleotide-binding domain, leucine rich repeat containing receptor (NLR) signaling pathways | R-HSA-168643 | 8.967882e-01 | 0.047 | 0 | 0 |
| Acyl chain remodelling of PE | R-HSA-1482839 | 8.981367e-01 | 0.047 | 0 | 0 |
| Downstream signaling of activated FGFR2 | R-HSA-5654696 | 8.981367e-01 | 0.047 | 0 | 0 |
| Downstream signaling of activated FGFR1 | R-HSA-5654687 | 8.981367e-01 | 0.047 | 0 | 0 |
| Transferrin endocytosis and recycling | R-HSA-917977 | 8.981367e-01 | 0.047 | 0 | 0 |
| Defects in vitamin and cofactor metabolism | R-HSA-3296482 | 8.981367e-01 | 0.047 | 0 | 0 |
| Regulation of PD-L1(CD274) translation | R-HSA-9909620 | 8.998461e-01 | 0.046 | 0 | 0 |
| Formation of ATP by chemiosmotic coupling | R-HSA-163210 | 8.998461e-01 | 0.046 | 0 | 0 |
| PI-3K cascade:FGFR4 | R-HSA-5654720 | 8.998461e-01 | 0.046 | 0 | 0 |
| Wax and plasmalogen biosynthesis | R-HSA-8848584 | 8.998461e-01 | 0.046 | 0 | 0 |
| Creatine metabolism | R-HSA-71288 | 8.998461e-01 | 0.046 | 0 | 0 |
| Acyl chain remodelling of PI | R-HSA-1482922 | 8.998461e-01 | 0.046 | 0 | 0 |
| Common Pathway of Fibrin Clot Formation | R-HSA-140875 | 8.998461e-01 | 0.046 | 0 | 0 |
| Protein hydroxylation | R-HSA-9629569 | 8.998461e-01 | 0.046 | 0 | 0 |
| Eicosanoid ligand-binding receptors | R-HSA-391903 | 8.998461e-01 | 0.046 | 0 | 0 |
| PI3K Cascade | R-HSA-109704 | 9.012365e-01 | 0.045 | 0 | 0 |
| Signaling by Type 1 Insulin-like Growth Factor 1 Receptor (IGF1R) | R-HSA-2404192 | 9.025587e-01 | 0.045 | 0 | 0 |
| Opioid Signalling | R-HSA-111885 | 9.030410e-01 | 0.044 | 0 | 0 |
| Lysosome Vesicle Biogenesis | R-HSA-432720 | 9.053473e-01 | 0.043 | 0 | 0 |
| Calmodulin induced events | R-HSA-111933 | 9.053473e-01 | 0.043 | 0 | 0 |
| CaM pathway | R-HSA-111997 | 9.053473e-01 | 0.043 | 0 | 0 |
| Glycosphingolipid transport | R-HSA-9845576 | 9.053473e-01 | 0.043 | 0 | 0 |
| Triglyceride catabolism | R-HSA-163560 | 9.053473e-01 | 0.043 | 0 | 0 |
| Formation of Fibrin Clot (Clotting Cascade) | R-HSA-140877 | 9.053473e-01 | 0.043 | 0 | 0 |
| APC-Cdc20 mediated degradation of Nek2A | R-HSA-179409 | 9.086598e-01 | 0.042 | 0 | 0 |
| Lagging Strand Synthesis | R-HSA-69186 | 9.086598e-01 | 0.042 | 0 | 0 |
| PKA-mediated phosphorylation of CREB | R-HSA-111931 | 9.086598e-01 | 0.042 | 0 | 0 |
| Signalling to RAS | R-HSA-167044 | 9.086598e-01 | 0.042 | 0 | 0 |
| SHC-mediated cascade:FGFR3 | R-HSA-5654704 | 9.086598e-01 | 0.042 | 0 | 0 |
| NOTCH2 Activation and Transmission of Signal to the Nucleus | R-HSA-2979096 | 9.086598e-01 | 0.042 | 0 | 0 |
| Synthesis, secretion, and deacylation of Ghrelin | R-HSA-422085 | 9.086598e-01 | 0.042 | 0 | 0 |
| Acyl chain remodelling of PG | R-HSA-1482925 | 9.086598e-01 | 0.042 | 0 | 0 |
| Prevention of phagosomal-lysosomal fusion | R-HSA-9636383 | 9.086598e-01 | 0.042 | 0 | 0 |
| Intrinsic Pathway of Fibrin Clot Formation | R-HSA-140837 | 9.086598e-01 | 0.042 | 0 | 0 |
| Mitochondrial biogenesis | R-HSA-1592230 | 9.134571e-01 | 0.039 | 0 | 0 |
| Peptide hormone metabolism | R-HSA-2980736 | 9.134571e-01 | 0.039 | 0 | 0 |
| Collagen formation | R-HSA-1474290 | 9.152479e-01 | 0.038 | 0 | 0 |
| Gap-filling DNA repair synthesis and ligation in GG-NER | R-HSA-5696397 | 9.166983e-01 | 0.038 | 0 | 0 |
| SHC-mediated cascade:FGFR4 | R-HSA-5654719 | 9.166983e-01 | 0.038 | 0 | 0 |
| Molybdenum cofactor biosynthesis | R-HSA-947581 | 9.166983e-01 | 0.038 | 0 | 0 |
| Metabolism of Angiotensinogen to Angiotensins | R-HSA-2022377 | 9.166983e-01 | 0.038 | 0 | 0 |
| Glutathione synthesis and recycling | R-HSA-174403 | 9.166983e-01 | 0.038 | 0 | 0 |
| SLC-mediated transport of inorganic anions | R-HSA-9958790 | 9.183583e-01 | 0.037 | 0 | 0 |
| Nucleotide biosynthesis | R-HSA-8956320 | 9.185949e-01 | 0.037 | 0 | 0 |
| PI-3K cascade:FGFR1 | R-HSA-5654689 | 9.240298e-01 | 0.034 | 0 | 0 |
| WNT ligand biogenesis and trafficking | R-HSA-3238698 | 9.240298e-01 | 0.034 | 0 | 0 |
| RAF-independent MAPK1/3 activation | R-HSA-112409 | 9.240298e-01 | 0.034 | 0 | 0 |
| Signaling by phosphorylated juxtamembrane, extracellular and kinase domain KIT mutants | R-HSA-9670439 | 9.240298e-01 | 0.034 | 0 | 0 |
| LDL clearance | R-HSA-8964038 | 9.240298e-01 | 0.034 | 0 | 0 |
| Signaling by KIT in disease | R-HSA-9669938 | 9.240298e-01 | 0.034 | 0 | 0 |
| Neurotoxicity of clostridium toxins | R-HSA-168799 | 9.240298e-01 | 0.034 | 0 | 0 |
| RAS processing | R-HSA-9648002 | 9.242144e-01 | 0.034 | 0 | 0 |
| Synthesis, secretion, and inactivation of Glucagon-like Peptide-1 (GLP-1) | R-HSA-381771 | 9.242144e-01 | 0.034 | 0 | 0 |
| Signaling by ALK | R-HSA-201556 | 9.242144e-01 | 0.034 | 0 | 0 |
| Transcriptional regulation of white adipocyte differentiation | R-HSA-381340 | 9.273065e-01 | 0.033 | 0 | 0 |
| Mitochondrial tRNA aminoacylation | R-HSA-379726 | 9.296725e-01 | 0.032 | 0 | 0 |
| Tryptophan catabolism | R-HSA-71240 | 9.296725e-01 | 0.032 | 0 | 0 |
| Termination of O-glycan biosynthesis | R-HSA-977068 | 9.307164e-01 | 0.031 | 0 | 0 |
| Response of EIF2AK1 (HRI) to heme deficiency | R-HSA-9648895 | 9.307164e-01 | 0.031 | 0 | 0 |
| Formation of the ureteric bud | R-HSA-9830674 | 9.307164e-01 | 0.031 | 0 | 0 |
| Synthesis of UDP-N-acetyl-glucosamine | R-HSA-446210 | 9.307164e-01 | 0.031 | 0 | 0 |
| Mitochondrial mRNA modification | R-HSA-9937008 | 9.307164e-01 | 0.031 | 0 | 0 |
| Carnitine shuttle | R-HSA-200425 | 9.307164e-01 | 0.031 | 0 | 0 |
| Interleukin-20 family signaling | R-HSA-8854691 | 9.307164e-01 | 0.031 | 0 | 0 |
| C-type lectin receptors (CLRs) | R-HSA-5621481 | 9.319808e-01 | 0.031 | 0 | 0 |
| Interferon gamma signaling | R-HSA-877300 | 9.326843e-01 | 0.030 | 0 | 0 |
| Translesion synthesis by Y family DNA polymerases bypasses lesions on DNA template | R-HSA-110313 | 9.347575e-01 | 0.029 | 0 | 0 |
| SHC-mediated cascade:FGFR1 | R-HSA-5654688 | 9.368149e-01 | 0.028 | 0 | 0 |
| Mitochondrial RNA degradation | R-HSA-9836573 | 9.368149e-01 | 0.028 | 0 | 0 |
| Plasma lipoprotein assembly | R-HSA-8963898 | 9.368149e-01 | 0.028 | 0 | 0 |
| Complex III assembly | R-HSA-9865881 | 9.368149e-01 | 0.028 | 0 | 0 |
| TNFs bind their physiological receptors | R-HSA-5669034 | 9.368149e-01 | 0.028 | 0 | 0 |
| Telomere C-strand (Lagging Strand) Synthesis | R-HSA-174417 | 9.394925e-01 | 0.027 | 0 | 0 |
| SLC-mediated transport of neurotransmitters | R-HSA-442660 | 9.394925e-01 | 0.027 | 0 | 0 |
| PI-3K cascade:FGFR2 | R-HSA-5654695 | 9.423769e-01 | 0.026 | 0 | 0 |
| MicroRNA (miRNA) biogenesis | R-HSA-203927 | 9.423769e-01 | 0.026 | 0 | 0 |
| Beta-oxidation of pristanoyl-CoA | R-HSA-389887 | 9.423769e-01 | 0.026 | 0 | 0 |
| Polymerase switching on the C-strand of the telomere | R-HSA-174411 | 9.423769e-01 | 0.026 | 0 | 0 |
| Laminin interactions | R-HSA-3000157 | 9.423769e-01 | 0.026 | 0 | 0 |
| Signaling by ERBB4 | R-HSA-1236394 | 9.428899e-01 | 0.026 | 0 | 0 |
| Incretin synthesis, secretion, and inactivation | R-HSA-400508 | 9.438999e-01 | 0.025 | 0 | 0 |
| Amino acid transport across the plasma membrane | R-HSA-352230 | 9.452283e-01 | 0.024 | 0 | 0 |
| MET activates PTK2 signaling | R-HSA-8874081 | 9.474496e-01 | 0.023 | 0 | 0 |
| Urea cycle | R-HSA-70635 | 9.474496e-01 | 0.023 | 0 | 0 |
| Sphingolipid catabolism | R-HSA-9845614 | 9.474496e-01 | 0.023 | 0 | 0 |
| Abacavir ADME | R-HSA-2161522 | 9.474496e-01 | 0.023 | 0 | 0 |
| Suppression of phagosomal maturation | R-HSA-9637687 | 9.474496e-01 | 0.023 | 0 | 0 |
| GABA receptor activation | R-HSA-977443 | 9.487879e-01 | 0.023 | 0 | 0 |
| Developmental Cell Lineages of the Exocrine Pancreas | R-HSA-9820448 | 9.491474e-01 | 0.023 | 0 | 0 |
| Cyclin D associated events in G1 | R-HSA-69231 | 9.518144e-01 | 0.021 | 0 | 0 |
| G1 Phase | R-HSA-69236 | 9.518144e-01 | 0.021 | 0 | 0 |
| Transcriptional Regulation by MECP2 | R-HSA-8986944 | 9.518186e-01 | 0.021 | 0 | 0 |
| Phosphorylation of CD3 and TCR zeta chains | R-HSA-202427 | 9.520760e-01 | 0.021 | 0 | 0 |
| SHC-mediated cascade:FGFR2 | R-HSA-5654699 | 9.520760e-01 | 0.021 | 0 | 0 |
| Maturation of hRSV A proteins | R-HSA-9828806 | 9.520760e-01 | 0.021 | 0 | 0 |
| Signaling by BMP | R-HSA-201451 | 9.520760e-01 | 0.021 | 0 | 0 |
| Signaling by FGFR3 in disease | R-HSA-5655332 | 9.520760e-01 | 0.021 | 0 | 0 |
| PLC beta mediated events | R-HSA-112043 | 9.521311e-01 | 0.021 | 0 | 0 |
| mitochondrial fatty acid beta-oxidation of saturated fatty acids | R-HSA-77286 | 9.553601e-01 | 0.020 | 0 | 0 |
| DAG and IP3 signaling | R-HSA-1489509 | 9.553601e-01 | 0.020 | 0 | 0 |
| Phase 0 - rapid depolarisation | R-HSA-5576892 | 9.562954e-01 | 0.019 | 0 | 0 |
| Prednisone ADME | R-HSA-9757110 | 9.562954e-01 | 0.019 | 0 | 0 |
| Inactivation, recovery and regulation of the phototransduction cascade | R-HSA-2514859 | 9.586552e-01 | 0.018 | 0 | 0 |
| Thyroxine biosynthesis | R-HSA-209968 | 9.601435e-01 | 0.018 | 0 | 0 |
| Activation of Matrix Metalloproteinases | R-HSA-1592389 | 9.601435e-01 | 0.018 | 0 | 0 |
| Platelet calcium homeostasis | R-HSA-418360 | 9.601435e-01 | 0.018 | 0 | 0 |
| Termination of translesion DNA synthesis | R-HSA-5656169 | 9.601435e-01 | 0.018 | 0 | 0 |
| Signaling by CSF3 (G-CSF) | R-HSA-9674555 | 9.601435e-01 | 0.018 | 0 | 0 |
| Transcriptional regulation by RUNX2 | R-HSA-8878166 | 9.603417e-01 | 0.018 | 0 | 0 |
| Synthesis of PC | R-HSA-1483191 | 9.617164e-01 | 0.017 | 0 | 0 |
| Aberrant regulation of mitotic cell cycle due to RB1 defects | R-HSA-9687139 | 9.636530e-01 | 0.016 | 0 | 0 |
| Stimuli-sensing channels | R-HSA-2672351 | 9.637829e-01 | 0.016 | 0 | 0 |
| Molecules associated with elastic fibres | R-HSA-2129379 | 9.668536e-01 | 0.015 | 0 | 0 |
| Negative regulators of DDX58/IFIH1 signaling | R-HSA-936440 | 9.668536e-01 | 0.015 | 0 | 0 |
| N-glycan trimming in the ER and Calnexin/Calreticulin cycle | R-HSA-532668 | 9.671986e-01 | 0.014 | 0 | 0 |
| G-protein mediated events | R-HSA-112040 | 9.682688e-01 | 0.014 | 0 | 0 |
| SLC-mediated transport of amino acids | R-HSA-9958863 | 9.682688e-01 | 0.014 | 0 | 0 |
| Signaling by FGFR2 in disease | R-HSA-5655253 | 9.696482e-01 | 0.013 | 0 | 0 |
| Collagen biosynthesis and modifying enzymes | R-HSA-1650814 | 9.703988e-01 | 0.013 | 0 | 0 |
| The phototransduction cascade | R-HSA-2514856 | 9.719209e-01 | 0.012 | 0 | 0 |
| Synthesis of IP3 and IP4 in the cytosol | R-HSA-1855204 | 9.724347e-01 | 0.012 | 0 | 0 |
| Cardiogenesis | R-HSA-9733709 | 9.724347e-01 | 0.012 | 0 | 0 |
| RAB GEFs exchange GTP for GDP on RABs | R-HSA-8876198 | 9.730889e-01 | 0.012 | 0 | 0 |
| COPII-mediated vesicle transport | R-HSA-204005 | 9.742594e-01 | 0.011 | 0 | 0 |
| Gamma carboxylation, hypusinylation, hydroxylation, and arylsulfatase activation | R-HSA-163841 | 9.747700e-01 | 0.011 | 0 | 0 |
| Miscellaneous transport and binding events | R-HSA-5223345 | 9.748625e-01 | 0.011 | 0 | 0 |
| Heme degradation | R-HSA-189483 | 9.748625e-01 | 0.011 | 0 | 0 |
| Calnexin/calreticulin cycle | R-HSA-901042 | 9.770766e-01 | 0.010 | 0 | 0 |
| Signaling by NOTCH2 | R-HSA-1980145 | 9.770766e-01 | 0.010 | 0 | 0 |
| Metabolism of ingested SeMet, Sec, MeSec into H2Se | R-HSA-2408508 | 9.790958e-01 | 0.009 | 0 | 0 |
| Leishmania infection | R-HSA-9658195 | 9.803395e-01 | 0.009 | 0 | 0 |
| Parasitic Infection Pathways | R-HSA-9824443 | 9.803395e-01 | 0.009 | 0 | 0 |
| Neurotransmitter release cycle | R-HSA-112310 | 9.805568e-01 | 0.009 | 0 | 0 |
| Transport of vitamins, nucleosides, and related molecules | R-HSA-425397 | 9.805928e-01 | 0.009 | 0 | 0 |
| FGFR2 mutant receptor activation | R-HSA-1839126 | 9.809372e-01 | 0.008 | 0 | 0 |
| Gap-filling DNA repair synthesis and ligation in TC-NER | R-HSA-6782210 | 9.810305e-01 | 0.008 | 0 | 0 |
| Ion homeostasis | R-HSA-5578775 | 9.810305e-01 | 0.008 | 0 | 0 |
| RSV-host interactions | R-HSA-9833110 | 9.814393e-01 | 0.008 | 0 | 0 |
| Iron uptake and transport | R-HSA-917937 | 9.819263e-01 | 0.008 | 0 | 0 |
| Degradation of the extracellular matrix | R-HSA-1474228 | 9.823714e-01 | 0.008 | 0 | 0 |
| NCAM1 interactions | R-HSA-419037 | 9.826166e-01 | 0.008 | 0 | 0 |
| Voltage gated Potassium channels | R-HSA-1296072 | 9.826166e-01 | 0.008 | 0 | 0 |
| TRAF6 mediated IRF7 activation | R-HSA-933541 | 9.826166e-01 | 0.008 | 0 | 0 |
| Beta-oxidation of very long chain fatty acids | R-HSA-390247 | 9.826166e-01 | 0.008 | 0 | 0 |
| Collagen chain trimerization | R-HSA-8948216 | 9.826166e-01 | 0.008 | 0 | 0 |
| Dual incision in TC-NER | R-HSA-6782135 | 9.838062e-01 | 0.007 | 0 | 0 |
| Elastic fibre formation | R-HSA-1566948 | 9.841481e-01 | 0.007 | 0 | 0 |
| alpha-linolenic acid (ALA) metabolism | R-HSA-2046106 | 9.841481e-01 | 0.007 | 0 | 0 |
| Transcriptional regulation of pluripotent stem cells | R-HSA-452723 | 9.841481e-01 | 0.007 | 0 | 0 |
| Infection with Mycobacterium tuberculosis | R-HSA-9635486 | 9.846695e-01 | 0.007 | 0 | 0 |
| Extension of Telomeres | R-HSA-180786 | 9.850418e-01 | 0.007 | 0 | 0 |
| Triglyceride metabolism | R-HSA-8979227 | 9.850418e-01 | 0.007 | 0 | 0 |
| Antigen activates B Cell Receptor (BCR) leading to generation of second messengers | R-HSA-983695 | 9.850733e-01 | 0.007 | 0 | 0 |
| Plasma lipoprotein clearance | R-HSA-8964043 | 9.855447e-01 | 0.006 | 0 | 0 |
| RAB geranylgeranylation | R-HSA-8873719 | 9.861854e-01 | 0.006 | 0 | 0 |
| Signaling by Retinoic Acid | R-HSA-5362517 | 9.861854e-01 | 0.006 | 0 | 0 |
| Neddylation | R-HSA-8951664 | 9.865974e-01 | 0.006 | 0 | 0 |
| Nuclear signaling by ERBB4 | R-HSA-1251985 | 9.868184e-01 | 0.006 | 0 | 0 |
| Mitochondrial Fatty Acid Beta-Oxidation | R-HSA-77289 | 9.869392e-01 | 0.006 | 0 | 0 |
| Collagen degradation | R-HSA-1442490 | 9.872438e-01 | 0.006 | 0 | 0 |
| MAP kinase activation | R-HSA-450294 | 9.872438e-01 | 0.006 | 0 | 0 |
| Cell surface interactions at the vascular wall | R-HSA-202733 | 9.877104e-01 | 0.005 | 0 | 0 |
| Maturation of spike protein | R-HSA-9694548 | 9.879799e-01 | 0.005 | 0 | 0 |
| Scavenging by Class A Receptors | R-HSA-3000480 | 9.890391e-01 | 0.005 | 0 | 0 |
| Complex I biogenesis | R-HSA-6799198 | 9.891286e-01 | 0.005 | 0 | 0 |
| Antigen processing: Ubiquitination & Proteasome degradation | R-HSA-983168 | 9.893110e-01 | 0.005 | 0 | 0 |
| Methylation | R-HSA-156581 | 9.916892e-01 | 0.004 | 0 | 0 |
| Cobalamin (Cbl, vitamin B12) transport and metabolism | R-HSA-196741 | 9.916892e-01 | 0.004 | 0 | 0 |
| Surfactant metabolism | R-HSA-5683826 | 9.916892e-01 | 0.004 | 0 | 0 |
| Class I MHC mediated antigen processing & presentation | R-HSA-983169 | 9.918545e-01 | 0.004 | 0 | 0 |
| FCERI mediated NF-kB activation | R-HSA-2871837 | 9.920939e-01 | 0.003 | 0 | 0 |
| PI Metabolism | R-HSA-1483255 | 9.924080e-01 | 0.003 | 0 | 0 |
| Cardiac conduction | R-HSA-5576891 | 9.925685e-01 | 0.003 | 0 | 0 |
| Formation of TC-NER Pre-Incision Complex | R-HSA-6781823 | 9.930898e-01 | 0.003 | 0 | 0 |
| alpha-linolenic (omega3) and linoleic (omega6) acid metabolism | R-HSA-2046104 | 9.936989e-01 | 0.003 | 0 | 0 |
| Interleukin-17 signaling | R-HSA-448424 | 9.938169e-01 | 0.003 | 0 | 0 |
| Plasma lipoprotein remodeling | R-HSA-8963899 | 9.942544e-01 | 0.003 | 0 | 0 |
| Diseases associated with O-glycosylation of proteins | R-HSA-3906995 | 9.942990e-01 | 0.002 | 0 | 0 |
| Metabolism of cofactors | R-HSA-8978934 | 9.942990e-01 | 0.002 | 0 | 0 |
| ECM proteoglycans | R-HSA-3000178 | 9.942990e-01 | 0.002 | 0 | 0 |
| Synthesis of Prostaglandins (PG) and Thromboxanes (TX) | R-HSA-2162123 | 9.952229e-01 | 0.002 | 0 | 0 |
| ROS and RNS production in phagocytes | R-HSA-1222556 | 9.955346e-01 | 0.002 | 0 | 0 |
| Complex IV assembly | R-HSA-9864848 | 9.956441e-01 | 0.002 | 0 | 0 |
| Cytosolic sulfonation of small molecules | R-HSA-156584 | 9.956441e-01 | 0.002 | 0 | 0 |
| Transcription-Coupled Nucleotide Excision Repair (TC-NER) | R-HSA-6781827 | 9.958848e-01 | 0.002 | 0 | 0 |
| Fc epsilon receptor (FCERI) signaling | R-HSA-2454202 | 9.962679e-01 | 0.002 | 0 | 0 |
| Interleukin-10 signaling | R-HSA-6783783 | 9.967813e-01 | 0.001 | 0 | 0 |
| Metabolism of nucleotides | R-HSA-15869 | 9.969133e-01 | 0.001 | 0 | 0 |
| Paracetamol ADME | R-HSA-9753281 | 9.969891e-01 | 0.001 | 0 | 0 |
| Keratinization | R-HSA-6805567 | 9.970084e-01 | 0.001 | 0 | 0 |
| Metabolism of amine-derived hormones | R-HSA-209776 | 9.972546e-01 | 0.001 | 0 | 0 |
| Synthesis of PA | R-HSA-1483166 | 9.974968e-01 | 0.001 | 0 | 0 |
| Dectin-2 family | R-HSA-5621480 | 9.974968e-01 | 0.001 | 0 | 0 |
| Metabolism of carbohydrates and carbohydrate derivatives | R-HSA-71387 | 9.976718e-01 | 0.001 | 0 | 0 |
| Innate Immune System | R-HSA-168249 | 9.980100e-01 | 0.001 | 0 | 0 |
| Peroxisomal lipid metabolism | R-HSA-390918 | 9.980369e-01 | 0.001 | 0 | 0 |
| Sphingolipid de novo biosynthesis | R-HSA-1660661 | 9.981025e-01 | 0.001 | 0 | 0 |
| Glutathione conjugation | R-HSA-156590 | 9.981025e-01 | 0.001 | 0 | 0 |
| Metabolism of water-soluble vitamins and cofactors | R-HSA-196849 | 9.981304e-01 | 0.001 | 0 | 0 |
| Ion channel transport | R-HSA-983712 | 9.986811e-01 | 0.001 | 0 | 0 |
| CD22 mediated BCR regulation | R-HSA-5690714 | 9.986887e-01 | 0.001 | 0 | 0 |
| Class B/2 (Secretin family receptors) | R-HSA-373080 | 9.989023e-01 | 0.000 | 0 | 0 |
| tRNA modification in the nucleus and cytosol | R-HSA-6782315 | 9.989099e-01 | 0.000 | 0 | 0 |
| Synthesis of bile acids and bile salts via 7alpha-hydroxycholesterol | R-HSA-193368 | 9.990061e-01 | 0.000 | 0 | 0 |
| Nicotinate metabolism | R-HSA-196807 | 9.990061e-01 | 0.000 | 0 | 0 |
| O-linked glycosylation of mucins | R-HSA-913709 | 9.990938e-01 | 0.000 | 0 | 0 |
| Plasma lipoprotein assembly, remodeling, and clearance | R-HSA-174824 | 9.991456e-01 | 0.000 | 0 | 0 |
| FCERI mediated MAPK activation | R-HSA-2871796 | 9.991628e-01 | 0.000 | 0 | 0 |
| Glycosphingolipid catabolism | R-HSA-9840310 | 9.992468e-01 | 0.000 | 0 | 0 |
| Metal ion assimilation from the host | R-HSA-9638482 | 9.993133e-01 | 0.000 | 0 | 0 |
| Metabolism of porphyrins | R-HSA-189445 | 9.993133e-01 | 0.000 | 0 | 0 |
| Citric acid cycle (TCA cycle) | R-HSA-71403 | 9.995255e-01 | 0.000 | 0 | 0 |
| Synthesis of bile acids and bile salts | R-HSA-192105 | 9.995635e-01 | 0.000 | 0 | 0 |
| PPARA activates gene expression | R-HSA-1989781 | 9.995919e-01 | 0.000 | 0 | 0 |
| SLC-mediated transport of organic anions | R-HSA-9955298 | 9.996404e-01 | 0.000 | 0 | 0 |
| Regulation of lipid metabolism by PPARalpha | R-HSA-400206 | 9.996462e-01 | 0.000 | 0 | 0 |
| Developmental Lineage of Pancreatic Acinar Cells | R-HSA-9925561 | 9.996722e-01 | 0.000 | 0 | 0 |
| Metabolic disorders of biological oxidation enzymes | R-HSA-5579029 | 9.996722e-01 | 0.000 | 0 | 0 |
| Respiratory electron transport | R-HSA-611105 | 9.997205e-01 | 0.000 | 0 | 0 |
| G alpha (q) signalling events | R-HSA-416476 | 9.997357e-01 | 0.000 | 0 | 0 |
| Peptide ligand-binding receptors | R-HSA-375276 | 9.998397e-01 | 0.000 | 0 | 0 |
| Bile acid and bile salt metabolism | R-HSA-194068 | 9.998420e-01 | 0.000 | 0 | 0 |
| Sulfur amino acid metabolism | R-HSA-1614635 | 9.998436e-01 | 0.000 | 0 | 0 |
| Metabolism of amino acids and derivatives | R-HSA-71291 | 9.998572e-01 | 0.000 | 0 | 0 |
| Binding and Uptake of Ligands by Scavenger Receptors | R-HSA-2173782 | 9.998614e-01 | 0.000 | 0 | 0 |
| Aerobic respiration and respiratory electron transport | R-HSA-1428517 | 9.998731e-01 | 0.000 | 0 | 0 |
| G alpha (s) signalling events | R-HSA-418555 | 9.998804e-01 | 0.000 | 0 | 0 |
| FCERI mediated Ca+2 mobilization | R-HSA-2871809 | 9.999130e-01 | 0.000 | 0 | 0 |
| Drug ADME | R-HSA-9748784 | 9.999411e-01 | 0.000 | 0 | 0 |
| Scavenging of heme from plasma | R-HSA-2168880 | 9.999435e-01 | 0.000 | 0 | 0 |
| Mitochondrial translation elongation | R-HSA-5389840 | 9.999485e-01 | 0.000 | 0 | 0 |
| G alpha (i) signalling events | R-HSA-418594 | 9.999577e-01 | 0.000 | 0 | 0 |
| Mitochondrial ribosome-associated quality control | R-HSA-9937383 | 9.999731e-01 | 0.000 | 0 | 0 |
| Anti-inflammatory response favouring Leishmania parasite infection | R-HSA-9662851 | 9.999783e-01 | 0.000 | 0 | 0 |
| Leishmania parasite growth and survival | R-HSA-9664433 | 9.999783e-01 | 0.000 | 0 | 0 |
| Metabolism of steroids | R-HSA-8957322 | 9.999813e-01 | 0.000 | 0 | 0 |
| Antimicrobial peptides | R-HSA-6803157 | 9.999883e-01 | 0.000 | 0 | 0 |
| Glycerophospholipid biosynthesis | R-HSA-1483206 | 9.999890e-01 | 0.000 | 0 | 0 |
| Mitochondrial translation | R-HSA-5368287 | 9.999907e-01 | 0.000 | 0 | 0 |
| Bacterial Infection Pathways | R-HSA-9824439 | 9.999932e-01 | 0.000 | 0 | 0 |
| SLC-mediated transmembrane transport | R-HSA-425407 | 9.999956e-01 | 0.000 | 0 | 0 |
| Visual phototransduction | R-HSA-2187338 | 9.999961e-01 | 0.000 | 0 | 0 |
| Phospholipid metabolism | R-HSA-1483257 | 9.999962e-01 | 0.000 | 0 | 0 |
| Glycosphingolipid metabolism | R-HSA-1660662 | 9.999968e-01 | 0.000 | 0 | 0 |
| Arachidonate metabolism | R-HSA-2142753 | 9.999975e-01 | 0.000 | 0 | 0 |
| FCGR3A-mediated IL10 synthesis | R-HSA-9664323 | 9.999978e-01 | 0.000 | 0 | 0 |
| Class A/1 (Rhodopsin-like receptors) | R-HSA-373076 | 9.999981e-01 | 0.000 | 0 | 0 |
| Metabolism of vitamins and cofactors | R-HSA-196854 | 9.999986e-01 | 0.000 | 0 | 0 |
| Synthesis of substrates in N-glycan biosythesis | R-HSA-446219 | 9.999987e-01 | 0.000 | 0 | 0 |
| O-linked glycosylation | R-HSA-5173105 | 9.999993e-01 | 0.000 | 0 | 0 |
| GPCR downstream signalling | R-HSA-388396 | 9.999997e-01 | 0.000 | 0 | 0 |
| Sphingolipid metabolism | R-HSA-428157 | 9.999997e-01 | 0.000 | 0 | 0 |
| Fatty acid metabolism | R-HSA-8978868 | 9.999997e-01 | 0.000 | 0 | 0 |
| Immunoregulatory interactions between a Lymphoid and a non-Lymphoid cell | R-HSA-198933 | 9.999998e-01 | 0.000 | 0 | 0 |
| Diseases of glycosylation | R-HSA-3781865 | 9.999999e-01 | 0.000 | 0 | 0 |
| Biosynthesis of the N-glycan precursor (dolichol lipid-linked oligosaccharide, LLO) and transfer to a nascent protein | R-HSA-446193 | 9.999999e-01 | 0.000 | 0 | 0 |
| Transport of small molecules | R-HSA-382551 | 1.000000e+00 | 0.000 | 0 | 0 |
| Phase II - Conjugation of compounds | R-HSA-156580 | 1.000000e+00 | 0.000 | 0 | 0 |
| Signaling by GPCR | R-HSA-372790 | 1.000000e+00 | 0.000 | 0 | 0 |
| Infection with Enterobacteria | R-HSA-9640148 | 1.000000e+00 | 0.000 | 0 | 0 |
| Phase I - Functionalization of compounds | R-HSA-211945 | 1.000000e+00 | 0.000 | 0 | 0 |
| GPCR ligand binding | R-HSA-500792 | 1.000000e+00 | 0.000 | 0 | 0 |
| Diseases of metabolism | R-HSA-5668914 | 1.000000e+00 | 0.000 | 0 | 0 |
| Biological oxidations | R-HSA-211859 | 1.000000e+00 | 0.000 | 0 | 0 |
| Metabolism of lipids | R-HSA-556833 | 1.000000e+00 | -0.000 | 0 | 0 |
| Metabolism | R-HSA-1430728 | 1.000000e+00 | -0.000 | 0 | 0 |
| Sensory Perception | R-HSA-9709957 | 1.000000e+00 | -0.000 | 0 | 0 |